Original Article
Concurrent Chemotherapy and Radiotherapy for Organ Preservation in Advanced Laryngeal Cancer
N Engl J Med 2003; 349:2091-2098November 27, 2003
- Abstract
Background
Induction chemotherapy with cisplatin plus fluorouracil followed by radiotherapy is the standard alternative to total laryngectomy for patients with locally advanced laryngeal cancer. The value of adding chemotherapy to radiotherapy and the optimal timing of chemotherapy are unknown.
Methods
We randomly assigned patients with locally advanced cancer of the larynx to one of three treatments: induction cisplatin plus fluorouracil followed by radiotherapy, radiotherapy with concurrent administration of cisplatin, or radiotherapy alone. The primary end point was preservation of the larynx.
Results
A total of 547 patients were randomly assigned to one of the three study groups. The median follow-up period was 3.8 years. At two years, the proportion of patients who had an intact larynx after radiotherapy with concurrent cisplatin (88 percent) differed significantly from the proportions in the groups given induction chemotherapy followed by radiotherapy (75 percent, P=0.005) or radiotherapy alone (70 percent, P<0.001). The rate of locoregional control was also significantly better with radiotherapy and concurrent cisplatin (78 percent, vs. 61 percent with induction cisplatin plus fluorouracil followed by radiotherapy and 56 percent with radiotherapy alone). Both of the chemotherapy-based regimens suppressed distant metastases and resulted in better disease-free survival than radiotherapy alone. However, overall survival rates were similar in all three groups. The rate of high-grade toxic effects was greater with the chemotherapy-based regimens (81 percent with induction cisplatin plus fluorouracil followed by radiotherapy and 82 percent with radiotherapy with concurrent cisplatin, vs. 61 percent with radiotherapy alone). The mucosal toxicity of concurrent radiotherapy and cisplatin was nearly twice as frequent as the mucosal toxicity of the other two treatments during radiotherapy.
Conclusions
In patients with laryngeal cancer, radiotherapy with concurrent administration of cisplatin is superior to induction chemotherapy followed by radiotherapy or radiotherapy alone for laryngeal preservation and locoregional control.
Media in This Article
Figure 1
Rates of Laryngeal Preservation According to the Treatment Group.Figure 2
Rates of Locoregional Control According to the Treatment Group.Article Activity
- Article
Each year, approximately 9500 persons in the United States receive the diagnosis of cancer of the larynx.1 Until the early 1990s, the standard treatment for locally advanced disease was total laryngectomy. This practice changed, however, after the landmark trial conducted by the Department of Veterans Affairs Laryngeal Cancer Study Group, in which induction chemotherapy (cisplatin plus fluorouracil) followed by radiotherapy was compared with surgery plus adjuvant radiotherapy.2 The larynx was preserved in 64 percent of the patients who received the nonsurgical treatment, and the two-year survival rate was 68 percent in both groups. No significant difference in survival has been reported after more than 10 years of follow-up.3 The ability to preserve the larynx without jeopardizing survival established the use of induction chemotherapy followed by radiotherapy as an alternative to laryngectomy for locally advanced laryngeal cancer.
To determine the contributions of chemotherapy and radiotherapy to larynx-preserving treatment, the Radiation Therapy Oncology Group and the Head and Neck Intergroup conducted a randomized trial (RTOG 91-11) to investigate three radiation-based treatments: induction cisplatin plus fluorouracil followed by radiotherapy if there was a response to the chemotherapy (a regimen identical to that given the “experimental” group in the Department of Veterans Affairs Laryngeal Cancer Study Group trial), radiotherapy with concurrent administration of cisplatin, and radiotherapy alone. The rationale for the second group was based on the enhancement of radiation effects on tumor cells by concurrent treatment with cisplatin. The primary objective of the trial was to compare the rates of laryngeal preservation associated with the three treatments. The study involved investigators from the Radiation Therapy Oncology Group (the coordinating group), the Southwest Oncology Group, and the Eastern Cooperative Oncology Group.
Methods
Patients
Patients were eligible if they had biopsy-proven, previously untreated stage III or IV (according to the staging system of the American Joint Commission on Cancer) squamous-cell carcinoma of the glottic or supraglottic larynx, the surgical treatment of which would require total laryngectomy. Patients with a stage T1 primary tumor (defined as tumor limited to one subsite of the supraglottis or limited to the vocal cords, with normal vocal-cord mobility, according to the tumor–node–metastasis [TNM] staging system) or with large-volume stage T4 disease (defined as a tumor penetrating through the cartilage or extending more than 1 cm into the base of the tongue) were not eligible. The disease had to be considered curable with surgery and postoperative radiotherapy. A Karnofsky performance score of at least 60 (on a scale from 0 to 100, with higher scores indicating better performance and with a score of 60 indicating that the patient requires occasional assistance but is able to care for most of his or her own needs) was required. To be eligible, patients also had to have a white-cell count of at least 3500 per cubic millimeter, a platelet count of at least 100,000 per cubic millimeter, a normal serum calcium level, and a creatinine clearance of at least 50 ml per minute. All the patients gave written informed consent in accordance with institutional guidelines.
Pretreatment staging, involving laryngoscopy, measurement of the tumor, and high-resolution computed tomographic (CT) scanning of the primary tumor and the neck, was performed within four weeks before entry into the study. To rule out synchronous primary cancers, either CT imaging of the chest and barium esophagography or pan-endoscopy (i.e., esophagoscopy and bronchoscopy) was performed. Imaging was performed as clinically indicated to rule out metastatic disease.
Treatment
Chemotherapy
Induction chemotherapy consisted of cisplatin given intravenously at a dose of 100 mg per square meter of body-surface area on day 1 and fluorouracil given at a dose of 1000 mg per square meter every 24 hours by continuous intravenous infusion for 120 hours, every three weeks for two courses. Patients then underwent evaluation by indirect laryngoscopy and CT imaging of the neck. If these examinations showed a complete or partial response of the primary tumor and no sign of progression in the neck, a third course of cisplatin plus fluorouracil was given, followed by radiotherapy. Patients with a less than partial response of the primary tumor or with progression in the neck underwent laryngectomy followed by adjuvant radiotherapy. Patients assigned to radiotherapy with concurrent cisplatin received intravenous cisplatin at a dose of 100 mg per square meter on days 1, 22, and 43 of radiotherapy.
Radiotherapy
The dose of radiation and radiotherapy schedule were the same in all three study groups. The dose of radiation to the primary tumor and clinically positive nodes was 70 Gy, given in 35 fractions of 2 Gy each over a seven-week period. The entire neck, including the supraclavicular areas and the posterior neck, was irradiated with a minimum of 50 Gy. The dose to the clinically positive nodes was supplemented with the beams that covered the primary tumor, with electrons, or with tangential anteroposterior beams. The patients assigned to induction chemotherapy followed by radiotherapy who underwent salvage surgery because of a poor response to the chemotherapy received adjuvant radiotherapy (50 to 70 Gy), depending on the status of the margins on pathological review.
Surgery
Patients who had either a single lymph node 3 cm or greater in diameter or multiple lymph-node metastases on initial clinical staging of the neck were required to undergo neck dissection eight weeks after the completion of radiotherapy. Laryngectomy was performed in patients who had histologically proven persistent or recurrent carcinoma after the completion of treatment or who had an inadequate response after two courses of induction chemotherapy.
Follow-up after the Completion of Treatment
All the patients were evaluated eight weeks after the completion of therapy by examination of the head and neck and CT imaging. If persistent disease was suspected, examination while the patient was under anesthesia and direct laryngoscopy were performed. Complete examination of the head and neck, with evaluation for late toxicity, was performed at scheduled follow-up visits.
Two questionnaires, to be completed by the patients, were used to evaluate quality of life: the Functional Assessment of Cancer Therapy — Head and Neck Scale, version 2,4 and the University of Washington Quality of Life instrument.5 These questionnaires were to be filled out at base line and at each follow-up visit. Results with respect to swallowing ability and speech are reported in this article.
Study Design
Randomization
Patients were stratified according to the site of the primary tumor (glottic or supraglottic), N stage (stage N0 or N1 or stage N2 or N3), and primary tumor stage (T2; T3 with fixed cord involvement; T3 with no cord fixation but with invasion of the postcricoird area, medial wall of the pyriform sinus, or preepiglottic tissues; or T4). The randomization scheme described by Zelen6 was used to achieve balance in the treatment assignments among the institutions.
Study End Points
The primary end point was preservation of the larynx. Treatment was considered to have failed on the date laryngectomy was performed. Other end points analyzed were overall survival, disease-free survival, local control, locoregional control, the time to distant metastasis, and laryngectomy-free survival. All events were measured from the date of randomization to the date of their occurrence or the date of the last follow-up visit. Toxic effects were graded according to the National Cancer Institute Common Toxicity Criteria, version 1.0, during induction chemotherapy and according to the Radiation Therapy Oncology Group toxicity criteria during radiotherapy. All deaths occurring during treatment or within 30 days after the completion of treatment were considered to be possibly treatment-related.
Statistical Analysis
The trial was designed to test whether concurrent chemotherapy and radiotherapy or radiotherapy alone resulted in higher rates of laryngeal preservation than that achieved with standard induction chemotherapy followed by radiotherapy. Since the protocol involved the comparison of two groups receiving experimental treatments with a single control group, Dunnett's two-sided test7 was used to adjust for multiple comparisons. The sample size was calculated with the use of Bristol's modification.8 The study was designed to detect an absolute difference of 15 percent with type I and type II error rates of 0.05 and 0.20. The sample size was further increased by 10 percent to account for patients deemed ineligible or lost to follow-up before two years had elapsed. The targeted sample size was 546 patients, assuming a two-year laryngectomy-free survival rate of 65 percent.
Rates of overall survival, disease-free survival, and laryngectomy-free survival were estimated by means of the Kaplan–Meier method with the log-rank test.9 Rates of laryngeal preservation, local control, locoregional control, and distant metastasis were estimated by the method of cumulative incidence10 and were tested according to Gray's method.11
Differences in the timing of protocol-specified assessments of disease among the treatment groups could bias the results. For example, patients in the induction-chemotherapy group could proceed to laryngectomy earlier than the other patients because of the evaluation performed at six weeks. To minimize such bias, all laryngectomies performed within the first six months after the start of treatment were considered to be early treatment failures and were analyzed as if they had occurred at the same time.
Results
Patient Population
From August 1992 to May 2000, 547 patients were enrolled and randomly assigned to one of the three treatment groups. Twenty-one of these patients proved to be ineligible, one withdrew consent after randomization, and seven were excluded because eligibility or outcome information was not submitted. Thus, data from 518 patients were included in the analysis. The characteristics of the patients are shown in Table 1Table 1
Characteristics of the Patients According to the Treatment Group.. The site of the primary tumor and stage of disease were balanced among the three treatment groups.Toxic Effects
Severe acute toxic effects are listed in Table 2Table 2
Grade 3 or 4 Acute Toxic Effects, According to the Treatment Group.. During induction chemotherapy with cisplatin and fluorouracil, toxicity was manifested primarily as neutropenia, stomatitis, and nausea or vomiting.The grade and frequency of toxic effects occurring during radiotherapy recorded in the group that received induction cisplatin plus fluorouracil followed by radiotherapy and the group that received radiotherapy alone were nearly identical and consisted mainly of grade 3 in-field effects on the skin and mucous membrane. In contrast, patients receiving radiotherapy with concurrent cisplatin had chemotherapy-related toxic effects (e.g., neutropenia and nausea or vomiting) and increased rates of severe radiation-related mucosal, pharyngeal, and esophageal effects.
The incidence of grade 3 or 4 late toxic effects was 24 percent in the group that received induction cisplatin plus fluorouracil followed by radiotherapy, 30 percent in the group that received radiotherapy with concurrent cisplatin, and 36 percent in the group that received radiotherapy alone. Most of these effects were grade 3 and referable to the larynx, pharynx and esophagus, salivary glands, and subcutaneous tissues.
The total rates of severe toxic effects (acute and late) reported for all phases of the study were 81 percent in the group assigned to induction cisplatin plus fluorouracil followed by radiotherapy, 82 percent in the group assigned to radiotherapy with concurrent cisplatin, and 61 percent in the group assigned to radiotherapy alone. The total numbers of deaths that may have been related to treatment were five (3 percent), nine (5 percent), and five (3 percent), respectively; the relation of the death to treatment was confirmed for four, eight, and two of these deaths, respectively.
Response to Treatment and Compliance
A total of 168 of the 173 patients assigned to receive induction cisplatin plus fluorouracil followed by radiotherapy received induction chemotherapy. The response of the primary tumor after two courses of cisplatin and fluorouracil was complete in 36 of these patients (21 percent) and partial in 108 (64 percent). Eighty-four patients had nodal involvement, and the response was complete in 19 of them (23 percent), partial in 34 (40 percent), and stable in 15 (18 percent). Thus, 144 patients could proceed to receive a third course of chemotherapy and a full course of radiotherapy. Of these, 134 received the third course; the remaining 10 discontinued chemotherapy.
Among the 24 patients in whom the response of the primary tumor to induction chemotherapy was less than partial, only 7 proceeded to immediate laryngectomy. Of the remaining 17 patients, 11 received additional chemotherapy or radiotherapy. All 11 had a complete response, and only 1 subsequently required a laryngectomy. Of the 172 patients randomly assigned to receive radiotherapy with concurrent cisplatin, 120 (70 percent) received all three planned doses of cisplatin and 40 (23 percent) received two doses.
Most of the patients (84 percent of those assigned to induction cisplatin plus fluorouracil followed by radiotherapy, 91 percent of those assigned to radiotherapy with concurrent cisplatin, and 94 percent of those assigned to radiotherapy alone) received more than 95 percent of the intended dose of radiotherapy (i.e., at least 67 Gy). At the completion of radiotherapy, 150 of the patients assigned to induction cisplatin plus fluorouracil followed by radiotherapy, 154 of those assigned to radiotherapy with concurrent cisplatin, and 148 of those assigned to radiotherapy alone had had a complete response.
Preservation of the Larynx
The rate of laryngeal preservation at a median follow-up of 3.8 years was significantly higher among patients receiving radiotherapy with concurrent cisplatin (145 of 172 patients [84 percent]) than among those receiving induction chemotherapy followed by radiotherapy (125 of 173 patients [72 percent], P=0.005) or radiotherapy alone (116 of 173 patients [67 percent], P<0.001). There was no significant difference between the group receiving induction chemotherapy followed by radiotherapy and the group receiving radiotherapy alone (P=0.27) (Figure 1Figure 1
Rates of Laryngeal Preservation According to the Treatment Group.).Speech and Swallowing
Information on speech and swallowing collected from patients who were disease-free and had an intact larynx was available from 74 percent of those assigned to induction cisplatin plus fluorouracil followed by radiotherapy, 78 percent of those assigned to radiotherapy with concurrent cisplatin, and 80 percent of those assigned to radiotherapy alone. There was no difference among the three treatment groups with regard to speech at either 12 or 24 months of follow-up. The reporting of moderate speech impairment (difficulty in pronouncing some words and being understood on the telephone) or worse speech impairment did not differ among the groups at one year (6 percent, 11 percent, and 13 percent, respectively) or two years (3 percent, 6 percent, and 8 percent, respectively).
At one year, 23 percent of the patients assigned to radiotherapy with concurrent cisplatin were able to swallow only soft foods or liquids, and 3 percent could not swallow at all. By contrast, of the patients assigned to induction cisplatin plus fluorouracil followed by radiotherapy, 9 percent were limited to soft foods or liquids, and none were unable to swallow (P=0.004). The results for the patients who received only radiotherapy did not differ significantly from those for the patients in the other two groups; 15 percent were limited to soft foods or liquids, and 3 percent could not swallow. At two years, there was no significant difference among the groups in the percentage of patients reporting difficulty in swallowing (16 percent of those assigned to induction cisplatin plus fluorouracil followed by radiotherapy, 15 percent of those assigned to radiotherapy with concurrent cisplatin, and 14 percent of those assigned to radiotherapy alone).
For the composite end point of laryngectomy-free survival (on which the sample size of the trial was predicated), either laryngectomy or death from any cause constituted treatment failure. The two-year and five-year estimated rates of this end point were 59 percent and 43 percent, respectively, for patients assigned to induction cisplatin plus fluorouracil followed by radiotherapy, 66 percent and 45 percent for those assigned to radiotherapy with concurrent cisplatin, and 53 percent and 38 percent for those assigned to radiotherapy alone. The protocol-specified test of statistical significance did not yield a significant difference (P<0.05) in pairwise comparisons between induction cisplatin plus fluorouracil followed by radiotherapy and radiotherapy with concurrent cisplatin (P=0.49) or between induction cisplatin plus fluorouracil followed by radiotherapy and radiotherapy alone (P=0.08). However, there was a significant difference in laryngectomy-free survival when concurrent radiotherapy and cisplatin was compared with radiotherapy alone (P=0.01).
Survival Outcomes
The median follow-up among surviving patients was 3.8 years. Two-year and five-year estimates of overall survival did not differ significantly according to the treatment: they were 76 percent and 55 percent, respectively, for induction cisplatin plus fluorouracil followed by radiotherapy, 74 percent and 54 percent for radiotherapy with concurrent cisplatin, and 75 percent and 56 percent for radiotherapy alone. Two-year and five-year estimates of disease-free survival were 52 percent and 38 percent, respectively, for induction cisplatin plus fluorouracil followed by radiotherapy, 61 percent and 36 percent for radiotherapy with concurrent cisplatin, and 44 percent and 27 percent for radiotherapy alone. Patients who received chemotherapy had significantly improved disease-free survival as compared with those who received radiotherapy alone (P=0.02 for the comparison between induction cisplatin plus fluorouracil followed by radiotherapy and radiotherapy alone, and P=0.006 for the comparison between radiotherapy with concurrent cisplatin and radiotherapy alone).
Pattern of Failure
At two years, the number of local treatment failures was 61 for induction cisplatin plus fluorouracil followed by radiotherapy, 35 for radiotherapy with concurrent cisplatin, and 72 for radiotherapy alone. The rates of local control were 64 percent, 80 percent, and 58 percent, respectively. Patients who received radiotherapy with concurrent cisplatin had significantly fewer failures than those who received induction cisplatin plus fluorouracil followed by radiotherapy (P=0.004) and significantly fewer than those who received radiotherapy alone (P<0.001). There was no significant difference with respect to treatment failures between patients who received induction cisplatin plus fluorouracil followed by radiotherapy and those who received radiotherapy alone (P=0.15). Locoregional control was significantly better among the patients who received radiotherapy with concurrent cisplatin than among those who received either of the other treatments (Figure 2Figure 2
Rates of Locoregional Control According to the Treatment Group.).Distant Metastasis
Chemotherapy reduced the rate of distant metastasis. At two years, distant metastases had developed in 9 percent of the patients who had received induction cisplatin plus fluorouracil followed by radiotherapy, 8 percent of those who had received radiotherapy with concurrent cisplatin, and 16 percent of those who had received radiotherapy alone. At five years, the cumulative recurrence rates were 15 percent, 12 percent, and 22 percent, respectively. Overall, only the difference between the rates among those who received radiotherapy with concurrent cisplatin and those who received radiotherapy alone was significant (P=0.03).
Discussion
In this trial, the overall survival among patients with stage III or IV laryngeal cancer was excellent (75 percent at two years) and did not differ significantly according to the treatment. Laryngeal preservation was best achieved with radiotherapy plus concurrent cisplatin; induction chemotherapy followed by radiotherapy was not significantly better than radiotherapy alone. With concurrent therapy, there was an absolute reduction in the rate of laryngectomy of 43 percent.
In addition, we found that chemotherapy suppressed distant metastasis. At two years, 91 percent of the patients who had received induction cisplatin plus fluorouracil followed by radiotherapy and 92 percent of those who had received radiotherapy with concurrent cisplatin were metastasis-free, as compared with 84 percent of those who had received radiotherapy alone. At five years, these rates were 85 percent, 88 percent, and 78 percent, respectively. Hence, the development of distant metastases was not merely delayed by chemotherapy.
Induction chemotherapy followed by radiotherapy was as toxic as concurrent therapy. Patients assigned to induction cisplatin plus fluorouracil followed by radiotherapy had chemotherapy-related toxic effects during the induction (preradiotherapy) phase. The rate of toxic effects on the mucous membranes and skin during radiotherapy in that group was nearly identical to the rate in the group assigned to radiotherapy alone, but the group assigned to radiotherapy with concurrent cisplatin had nearly twice the rate of mucosal effects. The increased rate of acute toxic effects on the mucous membranes with the use of radiotherapy with concurrent cisplatin probably contributed to the delayed recovery of swallowing in this group (according to patients' reported quality-of-life assessment).
Induction chemotherapy followed by radiotherapy, as compared with radiotherapy alone, did not significantly improve the rate of laryngeal preservation or survival. It did suppress the development of distant metastases and improve disease-free survival, but rates of locoregional control did not differ significantly from those achieved with radiotherapy alone. In addition, total toxicity was substantially increased as compared with radiotherapy alone. Thus, for patients who desire laryngeal preservation when concurrent administration of chemotherapy and radiotherapy is not feasible, radiotherapy alone should be recommended.
Our finding — that concurrent administration of chemotherapy and radiotherapy is superior to sequential therapy or radiotherapy alone for achieving locoregional control — applies only to patients with stage III or IV disease (a T2, T3, or low-volume T4 primary tumor). It does not apply to patients with significant invasion of the tongue base or gross destruction of cartilage. Radiotherapy with concurrent cisplatin should be considered standard care for patients desiring laryngeal preservation whose cancer is within the categories of disease studied in this trial, and laryngectomy should be performed only as salvage therapy. We believe that in most patients with laryngeal cancer, the disease can be managed without a primary surgical approach.
Supported by research grants (CA21661, CA37422, CA32115, CA06294, CA-32102, CA-20319, CA-46282, and CA49957) from the National Cancer Institute.
We are indebted to Dr. Victor Marcial for the development of this trial; to the clinical investigators, statisticians, clinical research associates, administrative staff, and dosimetrists who contributed to the success of this trial for their dedication and hard work; to Mr. Brian A. Berkey for contributions to the statistical analysis; to Ms. JoAnn Stetz and Ms. Rebecca Allegretto for contributions to data management; and to Ms. Elizabeth Martin for contributions to quality assurance.
Source Information
From the Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins, Baltimore (A.A.F., D.-J.L.); the University of Texas M.D. Anderson Cancer Center, Houston (H.G., M.M., R.W., W.M., B.G., C.C.); Radiation Therapy Oncology Group Headquarters, Philadelphia (T.F.P.); the H. Lee Moffitt Cancer Center and Research Institute, University of South Florida, Tampa (A.T.); Fox Chase Cancer Center, Philadelphia (J.A.R.); the Department of Radiation Oncology, University of Alabama, Birmingham (G.P.); the Department of Veterans Affairs New York Harbor Healthcare System, Brooklyn (A.L.); the Karmanos Cancer Institute, Wayne State University School of Medicine, Detroit (J.E.); and the Department of Radiation Oncology, New York University Medical Center, New York (J.C.).
Address reprint requests to Dr. Forastiere at the Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins, 1650 Orleans St., Suite G90, Baltimore, MD 21231-1000, or at af@jhmi.edu.
- References
References
1
Jemal A ,Murray T ,Samuels A ,Ghafoor A ,Ward E ,Thun MJ . Cancer statistics, 2003. CA Cancer J Clin 2003;53:5-26
CrossRef | Web of Science | Medline2
The Department of Veterans Affairs Laryngeal Cancer Study Group
Full Text | Web of Science | Medline3
Hong WK ,Lippman SM ,Wolf GT . Recent advances in head and neck cancer -- larynx preservation and cancer chemoprevention: the Seventeenth Annual Richard and Hinda Rosenthal Foundation Award Lecture. Cancer Res 1993;53:5113-5120
Web of Science | Medline4
List MA ,D'Antonio LL ,Cella DF , et al. The Performance Status Scale for Head and Neck Cancer Patients and the Functional Assessment of Cancer Therapy -- Head and Neck Scale: a study of utility and validity. Cancer 1996;77:2294-2301
CrossRef | Web of Science | Medline5
Weymuller EA Jr ,Alsarraf R ,Yueh B ,Deleyiannis FW ,Coltrera MD . Analysis of the performance characteristics of the University of Washington Quality of Life instrument and its modification (UW-QOL-R). Arch Otolaryngol Head Neck Surg 2001;127:489-493
Web of Science | Medline6
Zelen M . The randomization and stratification of patients to clinical trials. J Chronic Dis 1974;27:365-375
CrossRef | Medline7
Dunnett CW . A multiple comparison procedure from comparing several treatments with a control. J Am Stat Assoc 1955;50:1096-1121
CrossRef | Web of Science8
Bristol DR . Designing clinical trials for two-sided multiple comparisons with a control. Control Clin Trials 1989;10:142-152
CrossRef | Medline9
Kaplan EL ,Meier P . Nonparametric estimation from incomplete observations. J Am Stat Assoc 1958;53:457-481
CrossRef | Web of Science10
Mantel N . Evaluation of survival data and two new rank order statistics arising in its consideration. Cancer Chemother Rep 1966;50:163-170
Medline11
Gray RJ . A class of K-sample tests for comparing the cumulative incidence of a competing risk. Ann Stat 1988;16:1141-1154
CrossRef | Web of Science
- Citing Articles (572)
Citing Articles
1
Yue-Can Zeng, Ming Xue, Feng Chi, Zhao-Guo Xu, Guo-Liang Fan, Rong Wu, Yu-Chen Fan, Wen-Zhao Zhong, Si-Liang Wang, Xiao-Ye Zhang, Li-Na Wu, Xiao-Dong Chen, Xue-Ying Jin, Qiong-Yu Duan, Ru Xu, Wei Chen, Hao-Chu Qian, Yu-Ping Xiao. (2012) C-reactive protein level predicts prognosis in patients with locoregionally advanced laryngeal carcinoma treated with chemoradiotherapy. Tumor Biology
CrossRef2
Bénédicte Comet, Andrew Kramar, Mathieu Faivre-Pierret, Sylvain Dewas, Bernard Coche-Dequeant, Marian Degardin, Jean-Louis Lefebvre, Thomas Lacornerie, Eric F. Lartigau. (2012) Salvage Stereotactic Reirradiation With or Without Cetuximab for Locally Recurrent Head-and-Neck Cancer: A Feasibility Study. International Journal of Radiation Oncology*Biology*Physics
CrossRef3
Katherine Y. Fan, Hrishikesh Gogineni, David Zaboli, Spencer Lake, Marianna L. Zahurak, Simon R. Best, Marshall A. Levine, Mei Tang, Eva S. Zinreich, John R. Saunders, Joseph A. Califano, Ray G. Blanco, Sara I. Pai, Barbara Messing, Patrick K. Ha. (2012) Comparison of Acute Toxicities in Two Primary Chemoradiation Regimens in the Treatment of Advanced Head and Neck Squamous Cell Carcinoma. Annals of Surgical Oncology
CrossRef4
J. Thariat, Y. Pointreau, R. -J. Bensadoun. (2012) 10e biennale monégasque de cancérologie: nouveautés ORL. Oncologie
CrossRef5
M. Nakayama, O. Laccourreye, F. C. Holsinger, M. Okamoto, K. Hayakawa. (2012) Functional Organ Preservation for Laryngeal Cancer: Past, Present and Future. Japanese Journal of Clinical Oncology
CrossRef6
Keigo Nakamura, Tomoki Toda, Hiroshi Saruwatari, Kiyohiro Shikano. (2012) Speaking-aid systems using GMM-based voice conversion for electrolaryngeal speech. Speech Communication 54:1, 134-146
CrossRef7
Young Min Park, Won Shik Kim, Armando De Virgilio, So Yoon Lee, Jeong Hun Seol, Se-Heon Kim. (2012) Transoral robotic surgery for hypopharyngeal squamous cell carcinoma: 3-Year oncologic and functional analysis. Oral Oncology
CrossRef8
H.E. Eckel. (2012) Aktuelle Therapieoptionen bei Larynx- und Hypopharynxkarzinomen. HNO 60:1, 6-18
CrossRef9
A. Dietz, A. Boehm, G. Wichmann, D. Niederwieser, S. Dietzsch, M. Fuchs. (2012) Multimodaler Larynxerhalt. HNO 60:1, 19-31
CrossRef10
Peter A. Paximadis, Michael E. Christensen, Greg Dyson, Dev P. Kamdar, Ammar Sukari, Ho-Sheng Lin, George H. Yoo, Harold E. Kim. (2012) Up-front neck dissection followed by concurrent chemoradiation in patients with regionally advanced head and neck cancer. Head & Neckn/a-n/a
CrossRef11
Thomas Mücke, Janett Koschinski, Stefan Wagenpfeil, Klaus-Dietrich Wolff, Anastasios Kanatas, David A. Mitchell, Herbert Deppe, Marco R. Kesting. (2011) Functional outcome after different oncological interventions in head and neck cancer patients. Journal of Cancer Research and Clinical Oncology
CrossRef12
Mukund Seshadri, Nuno T. Sacadura, Tonya Coulthard. (2011) Monitoring antivascular therapy in head and neck cancer xenografts using contrast-enhanced MR and US imaging. Angiogenesis 14:4, 491-501
CrossRef13
Simon R. Best, Patrick K. Ha, Ray G. Blanco, John R. Saunders, Eva S. Zinreich, Marshall A. Levine, Sara I. Pai, Melissa Walker, Jaclyn Trachta, Karen Ulmer, Peter Murakami, Richard Thompson, Joseph A. Califano, Barbara P. Messing. (2011) Factors associated with pharyngoesophageal stricture in patients treated with concurrent chemotherapy and radiation therapy for oropharyngeal squamous cell carcinoma. Head & Neck 33:12, 1727-1734
CrossRef14
Bruce H. Haughey, Michael L. Hinni, John R. Salassa, Richard E. Hayden, David G. Grant, Jason T. Rich, Simon Milov, James S. Lewis, Murli Krishna. (2011) Transoral laser microsurgery as primary treatment for advanced-stage oropharyngeal cancer: A united states multicenter study. Head & Neck 33:12, 1683-1694
CrossRef15
Yasunao Kogashiwa, Naoki Oishi, Kohichi Yamauchi, Naoyuki Kohno. (2011) Advanced hypopharyngeal cancer with amyotrophic lateral sclerosis. Auris Nasus Larynx 38:6, 750-752
CrossRef16
Nai-Wen Su, Yi-Shing Leu, Jehn-Chuan Lee, Yu-Jen Chen, Hong-Wen Chen, Chung-Ji Liu, Yi-Fang Chang. (2011) Comparison of the efficacy and toxicity of two dose levels of cisplatin/5-fluorouracil as the chemoradiotherapy regimen for the treatment of locally advanced squamous cell carcinoma of the head and neck. Acta Oto-laryngologica 131:12, 1333-1340
CrossRef17
Ping Jiang, Yuliang Jiang, Jun-jie Wang, Na Meng, Weiqiang Ran, Ang Qu, Ruijie Yang. (2011) Percutaneous Ultrasonography-Guided Permanent Iodine-125 Implantation as Salvage Therapy for Recurrent Head and Neck Carcimonas. Cancer Biotherapy & Radiopharmaceuticals111201124150002
CrossRef18
Scott G. Soltys, Clara Y.H. Choi, Willard E. Fee, Harlan A. Pinto, Quynh-Thu Le. (2011) A Planned Neck Dissection is Not Necessary in All Patients with N2–3 Head-and-Neck Cancer After Sequential Chemoradiotherapy. International Journal of Radiation Oncology*Biology*Physics
CrossRef19
Gillian F. Williams, Mark T.W. Teo, Mehmet Sen, Karen E. Dyker, Catherine Coyle, Robin J.D. Prestwich. (2011) Enteral feeding outcomes after chemoradiotherapy for oropharynx cancer: A role for a prophylactic gastrostomy?. Oral Oncology
CrossRef20
Lucia D’Alatri, Francesco Bussu, Emanuele Scarano, Gaetano Paludetti, Maria Raffaella Marchese. (2011) Objective and Subjective Assessment of Tracheoesophageal Prosthesis Voice Outcome. Journal of Voice
CrossRef21
Lies Pottel, Tom Boterberg, Hans Pottel, Laurence Goethals, Nele Van Den Noortgate, Fréderic Duprez, Wilfried De Neve, Sylvie Rottey, Kurt Geldhof, Koen Van Eygen, Khalil Kargar-Samani, Véronique Ghekiere, Frank Cornelis, Supriya Mohile, Philip R. Debruyne. (2011) Determination of an adequate screening tool for identification of vulnerable elderly head and neck cancer patients treated with radio(chemo)therapy. Journal of Geriatric Oncology
CrossRef22
Susie A. Chen, Susan Muller, Amy Y. Chen, Patricia A. Hudgins, Dong M. Shin, Fadlo Khuri, Nabil F. Saba, Jonathan J. Beitler. (2011) Patterns of extralaryngeal spread of laryngeal cancer. Cancer 117:22, 5047-5051
CrossRef23
Adrian R. Levy, Karissa M. Johnston, Jennifer Sambrook, Bonnie Donato, John R. Penrod, Mitra Corral, Martin Chasen. (2011) Indirect comparison of the efficacy of cetuximab and cisplatin in squamous cell carcinoma of the head and neck. Current Medical Research and Opinion1-7
CrossRef24
Robin J. Prestwich, Didem Çolpan Öksüz, Karen Dyker, Catherine Coyle, Mehmet Şen. (2011) Feasibility and Efficacy of Induction Docetaxel, Cisplatin, and 5-Fluorouracil Chemotherapy Combined With Cisplatin Concurrent Chemoradiotherapy for Nonmetastatic Stage IV Head-and-Neck Squamous Cell Carcinomas. International Journal of Radiation Oncology*Biology*Physics 81:4, e237-e243
CrossRef25
Frank Hoebers, Wilma Heemsbergen, Suzanne Moor, Marta Lopez, Martin Klop, Margot Tesselaar, Coen Rasch. (2011) Reirradiation for Head-and-Neck Cancer: Delicate Balance Between Effectiveness and Toxicity. International Journal of Radiation Oncology*Biology*Physics 81:3, e111-e118
CrossRef26
N. Daly-Schveitzer, M. Juliéron, Y. Gan Tao, A. Moussier, J. Bourhis. (2011) La radiothérapie conformationnelle en modulation d’intensité (RCMI) : vers un nouveau standard en radiothérapie des cancers ORL ?. Annales françaises d'Oto-rhino-laryngologie et de Pathologie Cervico-faciale 128:5, 284-291
CrossRef27
Thomas J. Dilling, Kyounghwa Bae, Rebecca Paulus, Deborah Watkins-Bruner, Adam S. Garden, Arlene Forastiere, K. Kian Ang, Benjamin Movsas. (2011) Impact of Gender, Partner Status, and Race on Locoregional Failure and Overall Survival in Head and Neck Cancer Patients in Three Radiation Therapy Oncology Group Trials. International Journal of Radiation Oncology*Biology*Physics 81:3, e101-e109
CrossRef28
Lawrence Koutcher, Eric Sherman, Matthew Fury, Suzanne Wolden, Zhigang Zhang, Qianxing Mo, Laschelle Stewart, Karen Schupak, Daphna Gelblum, Richard Wong, Dennis Kraus, Jatin Shah, Michael Zelefsky, David Pfister, Nancy Lee. (2011) Concurrent Cisplatin and Radiation Versus Cetuximab and Radiation for Locally Advanced Head-and-Neck Cancer. International Journal of Radiation Oncology*Biology*Physics 81:4, 915-922
CrossRef29
Dana M. Hartl, Alfio Ferlito, Daniel F. Brasnu, Johannes A. Langendijk, Alessandra Rinaldo, Carl E. Silver, Gregory T. Wolf, David W. Eisele. (2011) Evidence-based review of treatment options for patients with glottic cancer. Head & Neck 33:11, 1638-1648
CrossRef30
Harold J. Wanebo, Ritesh Rathore, Prakash Chougule, Michael R. DiSiena, R. James Koness, Robert G. McRae, Peter T. Nigri, Kathy Radie-Keane, Neal Ready. (2011) Selective Organ Preservation in Operable Locally Advanced Head and Neck Squamous Cell Carcinomas Guided by Primary Site Restaging Biopsy: Long-Term Results of Two Sequential Brown University Oncology Group Chemoradiotherapy Studies. Annals of Surgical Oncology 18:12, 3479-3485
CrossRef31
M. Guibert, B. Lepage, V. Woisard, M. Rives, E. Serrano, S. Vergez. (2011) Qualité de vie de patients traités de cancers pharyngolaryngés avancés. Annales françaises d'Oto-rhino-laryngologie et de Pathologie Cervico-faciale 128:5, 259-265
CrossRef32
Tomohiro Sakashita, Akihiro Homma, Nobuhiko Oridate, Hiromitsu Hatakeyama, Satoshi Kano, Takatsugu Mizumachi, Satoshi Fukuda. (2011) Evaluation of nodal response after intra-arterial chemoradiation for node-positive head and neck cancer. European Archives of Oto-Rhino-Laryngology
CrossRef33
Jason T. Rich, Jingxia Liu, Bruce H. Haughey. (2011) Swallowing function after transoral laser microsurgery (TLM) ± adjuvant therapy for advanced-stage oropharyngeal cancer. The Laryngoscope 121:11, 2381-2390
CrossRef34
Myriam Loyo, Jonas T. Johnson, William H. Westra, Simion I. Chiosea, Christine G. Gourin. (2011) Management of the “Violated Neck” in the era of chemoradiation. The Laryngoscope 121:11, 2349-2358
CrossRef35
Harry Quon, Traci Leong, Robert Haselow, Bruce Leipzig, Jay Cooper, Arlene Forastiere. (2011) Phase III Study of Radiation Therapy With or Without Cis-Platinum in Patients With Unresectable Squamous or Undifferentiated Carcinoma of the Head and Neck: An Intergroup Trial of the Eastern Cooperative Oncology Group (E2382). International Journal of Radiation Oncology*Biology*Physics 81:3, 719-725
CrossRef36
Abrahim Al-Mamgani, Lisa Tans, Peter van Rooij, Peter C. Levendag. (2011) A Single-Institutional Experience of 15 Years of Treating T3 Laryngeal Cancer with Primary Radiotherapy, with or Without Chemotherapy. International Journal of Radiation Oncology*Biology*Physics
CrossRef37
Marc Hamoir, Alfio Ferlito, Sandra Schmitz, François-Xavier Hanin, Juliette Thariat, Birgit Weynand, Jean-Pascal Machiels, Vincent Grégoire, K. Thomas Robbins, Carl E. Silver, Primož Strojan, Alessandra Rinaldo, June Corry, Robert P. Takes. (2011) The role of neck dissection in the setting of chemoradiation therapy for head and neck squamous cell carcinoma with advanced neck disease. Oral Oncology
CrossRef38
Hans Paul van der Laan, Miranda E.M.C. Christianen, Hendrik P. Bijl, Cornelis Schilstra, Johannes A. Langendijk. (2011) The potential benefit of swallowing sparing intensity modulated radiotherapy to reduce swallowing dysfunction: An in silico planning comparative study. Radiotherapy and Oncology
CrossRef39
M. Guibert, B. Lepage, V. Woisard, M. Rives, E. Serrano, S. Vergez. (2011) Quality of life in patients treated for advanced hypopharyngeal or laryngeal cancer. European Annals of Otorhinolaryngology, Head and Neck Diseases 128:5, 218-223
CrossRef40
N. Daly-Schveitzer, M. Juliéron, Y. Gan Tao, A. Moussier, J. Bourhis. (2011) Intensity-modulated radiation therapy (IMRT): Toward a new standard for radiation therapy of head and neck cancer?. European Annals of Otorhinolaryngology, Head and Neck Diseases 128:5, 241-247
CrossRef41
Aniel Sewnaik, Stijn Keereweer, Abrahim Al-Mamgani, Robert J. Baatenburg de Jong, Marjan H. Wieringa, Cees A. Meeuwis, Jeroen D.F. Kerrebijn. (2011) High complication risk of salvage surgery after chemoradiation failures. Acta Oto-laryngologica1-5
CrossRef42
Kevin S. Choe, Daniel J. Haraf, Abhishek Solanki, Ezra E. W. Cohen, Tanguy Y. Seiwert, Kerstin M. Stenson, Elizabeth A. Blair, Louis Portugal, Victoria M. Villaflor, Mary Ellyn Witt, Everett E. Vokes, Joseph K. Salama. (2011) Prior chemoradiotherapy adversely impacts outcomes of recurrent and second primary head and neck cancer treated with concurrent chemotherapy and reirradiation. Cancer 117:20, 4671-4678
CrossRef43
T. Yokota, Y. Onozawa, N. Boku, S. Hamauchi, T. Tsushima, H. Taniguchi, A. Todaka, N. Machida, K. Yamazaki, A. Fukutomi, H. Yasui. (2011) S-1 Monotherapy for Recurrent or Metastatic Squamous Cell Carcinoma of the Head and Neck After Progression on Platinum-based Chemotherapy. Japanese Journal of Clinical Oncology
CrossRef44
Shigenari Taki, Akihiro Homma, Fumiyuki Suzuki, Nobuhiko Oridate, Hiromitsu Hatakeyama, Takatsugu Mizumachi, Satoshi Kano, Jun Furusawa, Tomohiro Sakashita, Naoya Inamura, Daisuke Yoshida, Rikiya Onimaru, Hiroki Shirato, Satoshi Fukuda. (2011) Combined modality therapy for laryngeal cancer with superselective intra-arterial cisplatin infusion and concomitant radiotherapy. International Journal of Clinical Oncology
CrossRef45
Christine H. Chung, Qiang Zhang, Elizabeth M. Hammond, Andy M. Trotti, Huijun Wang, Sharon Spencer, Hua-Zhong Zhang, Jay Cooper, Richard Jordan, Marvin H. Rotman, K. Kian Ang. (2011) Integrating Epidermal Growth Factor Receptor Assay With Clinical Parameters Improves Risk Classification for Relapse and Survival in Head-and-Neck Squamous Cell Carcinoma. International Journal of Radiation Oncology*Biology*Physics 81:2, 331-338
CrossRef46
Thomas Mücke, Mario Konen, Stefan Wagenpfeil, Marco R. Kesting, Klaus-Dietrich Wolff, Frank Hölzle. (2011) Low-Dose Preoperative Chemoradiation Therapy Compared with Surgery Alone with or Without Postoperative Radiotherapy in Patients with Head and Neck Carcinoma. Annals of Surgical Oncology 18:10, 2739-2747
CrossRef47
Jimmy J. Caudell, William R. Carroll, Sharon A. Spencer, James A. Bonner. (2011) Examination of laryngoesophageal dysfunction-free survival as an endpoint in nonsurgical treatment of squamous cell carcinomas of the larynx and hypopharynx. Cancer 117:19, 4447-4451
CrossRef48
Makiko Mori, Mamoru Tsukuda, Hideki Matsuda, Choichi Horiuchi, Takahide Taguchi, Masahiro Takahashi, Goshi Nishimura, Masanori Komatsu, Tatsuo Niho, Naoko Sakuma, Asako Miyakoshi, Yasuhiro Isono, Sayaka Iwahana. (2011) Efficacy and toxicity of concurrent chemoradiotherapy in patients with advanced oropharyngeal squamous cell carcinoma. Cancer Chemotherapy and Pharmacology 68:4, 855-862
CrossRef49
T.-L. Tsai, P.-Y. Chu, S.-K. Tai, Y.-F. Wang, M.-H. Yang, L.-W. Wang, J.-F. Lirng, S.-Y. Chang. (2011) Promising Long-term Results with Attenuated Adverse Effects by Methotrexate-containing Sequential Chemoradiation Therapy in Locally Advanced Head and Neck Squamous Cell Carcinoma. Japanese Journal of Clinical Oncology 41:10, 1182-1193
CrossRef50
Atsuko Sakakibara, Mamoru Tsukuda, Norio Kondo, Yukari Ishiguro, Machiko Kimura, Kyoko Fujita, Hideaki Takahashi, Hideki Matsuda. (2011) Examination of the optimal condition on the in vitro sensitivity to telomelysin in head and neck cancer cell lines. Auris Nasus Larynx 38:5, 589-599
CrossRef51
Sadamoto Zenda, Kazuto Matsuura, Hiroyuki Tachibana, Akihiro Homma, Tadaaki Kirita, Nobuya Monden, Shigemichi Iwae, Yojiro Ota, Tetsuo Akimoto, Hiroshi Otsuru, Makoto Tahara, Kengo Kato, Masao Asai. (2011) Multicenter phase II study of an opioid-based pain control program for head and neck cancer patients receiving chemoradiotherapy. Radiotherapy and Oncology
CrossRef52
Jason D. Howard, Bo Lu, Christine H. Chung. (2011) Therapeutic targets in head and neck squamous cell carcinoma: Identification, evaluation, and clinical translation. Oral Oncology
CrossRef53
H Deng, PJ Sambrook, RM Logan. (2011) The treatment of oral cancer: an overview for dental professionals. Australian Dental Journal 56:3, 244-252
CrossRef54
Dorota Kiprian, Andrzej Kawecki, Andrzej Jarząbski, Wojciech Michalski, Beata Pawłowska-Sendułka. (2011) Ocena wyników i tolerancji zachowawczego leczenia oszczędzającego narząd u chorych na lokoregionalnie zaawansowanego raka krtani i krtaniowej części gardła. Otolaryngologia Polska 65:5, 363-368
CrossRef55
Dorota Kiprian, Andrzej Jarząbski, Beata Pawłowska, Wojciech Michalski, Andrzej Kawecki. (2011) Zastosowanie techniki SIB-IMRT w leczeniu skojarzonym z jednoczesną chemioterapią u chorych na nowotwory głowy i szyi w III i IVa stopniu zaawansowania. Ocena wczesnych wyników i tolerancji leczenia. Otolaryngologia Polska 65:5, 117-125
CrossRef56
Paolo Boscolo-Rizzo, Enrico Muzzi, Franco Trabalzini, Alessandro Gava, Marco Stellin, Maria Cristina Mosto. (2011) Functional organ preservation after chemoradiotherapy in elderly patients with loco-regionally advanced head and neck squamous cell carcinoma. European Archives of Oto-Rhino-Laryngology 268:9, 1349-1355
CrossRef57
Zulfiquer OTTY, Monika Buhrer SKINNER, Joshua DASS, Michael COLLINS, Jennifer MOOI, Kandeepan THURAISINGAM, Sabe SABESAN. (2011) Efficacy and tolerability of weekly low-dose cisplatin concurrent with radiotherapy in head and neck cancer patients. Asia-Pacific Journal of Clinical Oncology 7:3, 287-292
CrossRef58
C-E. Huang, C-H. Lu, P-T. Chen, C-H. H. Chan, W-C. Chen, W-H. Wang, J-Y. Wu, F-C. Kuan, K-D. Lee, C-C. Chen. (2011) Efficacy and safety of dose-modified docetaxel plus cisplatin-based induction chemotherapy in Asian patients with locally advanced head and neck cancer. Journal of Clinical Pharmacy and Therapeuticsno-no
CrossRef59
Satoru Shinriki, Hirofumi Jono, Mitsuharu Ueda, Kazutoshi Ota, Tomoko Ota, Takanao Sueyoshi, Yuichi Oike, Mutsuko Ibusuki, Akimitsu Hiraki, Hideki Nakayama, Masanori Shinohara, Yukio Ando. (2011) Interleukin-6 signalling regulates vascular endothelial growth factor-C synthesis and lymphangiogenesis in human oral squamous cell carcinoma. The Journal of Pathology 225:1, 142-150
CrossRef60
David I PRYOR, Benjamin SOLOMON, Sandro V PORCEDDU. (2011) The emerging era of personalized therapy in squamous cell carcinoma of the head and neck. Asia-Pacific Journal of Clinical Oncology 7:3, 236-251
CrossRef61
R. Hitt, A. Irigoyen, H. Cortes-Funes, J. J. Grau, J. A. Garcia-Saenz, J. J. Cruz-Hernandez, . (2011) Phase II study of the combination of cetuximab and weekly paclitaxel in the first-line treatment of patients with recurrent and/or metastatic squamous cell carcinoma of head and neck. Annals of Oncology
CrossRef62
Valentina Mirisola, Renzo Mora, Alessia Isabella Esposito, Luca Guastini, Flavia Tabacchiera, Laura Paleari, Adriana Amaro, Giovanna Angelini, Massimo Dellepiane, Ulrich Pfeffer, Angelo Salami. (2011) A prognostic multigene classifier for squamous cell carcinomas of the larynx. Cancer Letters 307:1, 37-46
CrossRef63
Doug Angel, Philip C Doyle, Kevin Fung. (2011) Measuring voice outcomes following treatment for laryngeal cancer. Expert Review of Pharmacoeconomics & Outcomes Research 11:4, 415-420
CrossRef64
G. Maschmeyer, K. Koch, M. Jungehülsing. (2011) Kopf-Hals-Tumoren. best practice onkologie 6:4, 4-20
CrossRef65
Jean-Claude M. Rwigema, Dwight E. Heron, Robert L. Ferris, Regiane S. Andrade, Michael K. Gibson, Yong Yang, Cihat Ozhasoglu, Athanassios E. Argiris, Jennifer R. Grandis, Steven A. Burton. (2011) The Impact of Tumor Volume and Radiotherapy Dose on Outcome in Previously Irradiated Recurrent Squamous Cell Carcinoma of the Head and Neck Treated With Stereotactic Body Radiation Therapy. American Journal of Clinical Oncology 34:4, 372-379
CrossRef66
P. Boscolo-Rizzo, A. Gava, C. Marchiori, V. Baggio, M. C. Da Mosto. (2011) Functional organ preservation in patients with locoregionally advanced head and neck squamous cell carcinoma treated by platinum-based multidrug induction chemotherapy and concurrent chemoradiotherapy. Annals of Oncology 22:8, 1894-1901
CrossRef67
Peter Nagele, Lesley K. Rao, Mrudula Penta, Dorina Kallogjeri, Edward L. Spitznagel, Laura F. Cavallone, Brian Nussenbaum, Jay F. Piccirillo. (2011) Postoperative myocardial injury after major head and neck cancer surgery. Head & Neck 33:8, 1085-1091
CrossRef68
Mark W. McDonald, Joshua Lawson, Madhur Kumar Garg, Harry Quon, John A. Ridge, Nabil Saba, Joseph K. Salama, Richard V. Smith, Anamaria Reyna Yeung, Sue S. Yom, Jonathan J. Beitler. (2011) ACR Appropriateness Criteria® Retreatment of Recurrent Head and Neck Cancer After Prior Definitive Radiation. International Journal of Radiation Oncology*Biology*Physics 80:5, 1292-1298
CrossRef69
Gen Suzuki, Etsuyo Ogo, Ryuichiro Tanoue, Norimitsu Tanaka, Yuko Watanabe, Toshi Abe, Osamu Iwamoto, Jingo Kusukawa, Naofumi Hayabuchi. (2011) Primary gingival angiosarcoma successfully treated by radiotherapy with concurrent intra-arterial chemotherapy. International Journal of Clinical Oncology 16:4, 439-443
CrossRef70
Gregory J. Kubicek, Bruce F. Kimler, Fen Wang, Eashwer K. Reddy, Douglas A. Girod, Steven K. Williamson. (2011) Chemotherapy in Head and Neck Cancer. American Journal of Clinical Oncology 34:4, 380-384
CrossRef71
Yoann Pointreau, Ibrahim Atean, Jérôme Fayette, Gilles Calais, Jean Louis Lefebvre. (2011) Induction chemotherapy in head and neck cancer. Anti-Cancer Drugs 22:7, 613-620
CrossRef72
M. Ishizuka, Y. Fujimoto, Y. Itoh, K. Kitagawa, M. Sano, Y. Miyagawa, A. Ando, M. Hiramatsu, N. Hirasawa, S. Ishihara, T. Nakashima, K. Yamada. (2011) Relationship Between Hematotoxicity and Serum Albumin Level in the Treatment of Head and Neck Cancers with Concurrent Chemoradiotherapy Using Cisplatin. Japanese Journal of Clinical Oncology 41:8, 973-979
CrossRef73
A. Homma, N. Inamura, N. Oridate, S. Suzuki, H. Hatakeyama, T. Mizumachi, S. Kano, T. Sakashita, R. Onimaru, K. Yasuda, H. Shirato, S. Fukuda. (2011) Concomitant Weekly Cisplatin and Radiotherapy for Head and Neck Cancer. Japanese Journal of Clinical Oncology 41:8, 980-986
CrossRef74
F. Arias de la Vega, J. Contreras, M. de las Heras, A. de la Torre, V. Arrazubi, I. Herruzo, I. Prieto, J. A. Garcia-Saenz, J. Romero, F. A. Calvo, . (2011) Erlotinib and chemoradiation in patients with surgically resected locally advanced squamous cell carcinoma of the head and neck: a GICOR phase I trial. Annals of Oncology
CrossRef75
T Jiffar, T Yilmaz, J Lee, E Hanna, A El-Naggar, D Yu, J N Myers, M E Kupferman. (2011) KiSS1 mediates platinum sensitivity and metastasis suppression in head and neck squamous cell carcinoma. Oncogene 30:28, 3163-3173
CrossRef76
Stijn Keereweer, Jeroen D. F. Kerrebijn, Abrahim Al-Mamgani, Aniel Sewnaik, Robert J. Baatenburg Jong, Esther Meerten. (2011) Chemoradiation for advanced hypopharyngeal carcinoma: a retrospective study on efficacy, morbidity and quality of life. European Archives of Oto-Rhino-Laryngology
CrossRef77
Ryoji Yoshida, Tetsuhiro Fujimoto, Shinji Kudoh, Masashi Nagata, Hideki Nakayama, Masanori Shinohara, Takaaki Ito. (2011) Nucleostemin affects the proliferation but not differentiation of oral squamous cell carcinoma cells. Cancer Science 102:7, 1418-1423
CrossRef78
Hosam A. Kader, Aminudin R. Mydin, Matthew Wilson, Cheryl Alexander, Jeevin Shahi, Irvin Pathak, Jonn S. Wu, Pauline T. Truong. (2011) Treatment Outcomes of Locally Advanced Oropharyngeal Cancer: A Comparison Between Combined Modality Radio-Chemotherapy and Two Variants of Single Modality Altered Fractionation Radiotherapy. International Journal of Radiation Oncology*Biology*Physics 80:4, 1030-1036
CrossRef79
Sohit Paul Kanotra, Sonika Kanotra, Ashutosh Gupta, J. Paul. (2011) Chemoradiation in Advanced Head and Neck Cancers: A Comparison of two Radiosensitizers, Paclitaxel and Cisplatin. Indian Journal of Otolaryngology and Head & Neck Surgery 63:3, 229-236
CrossRef80
Atul Sharma, G.K. Rath, S.P. Chaudhary, Alok Thakar, Bidhu Kalyan Mohanti, Sudhir Bahadur. (2011) Lactobacillus brevis CD2 lozenges reduce radiation- and chemotherapy-induced mucositis in patients with head and neck cancer: A randomized double-blind placebo-controlled study. European Journal of Cancer
CrossRef81
Dirk Rades, Ursula Schroeder, Amira Bajrovic, Steven E. Schild. (2011) Radiochemotherapy versus surgery plus radio(chemo)therapy for stage T3/T4 larynx and hypopharynx cancer – Results of a matched-pair analysis. European Journal of Cancer
CrossRef82
Linda-Lotta Kokko, Saija Hurme, Sanna-Mari Maula, Kalle Alanen, Reidar Grénman, Ilpo Kinnunen, Sami Ventelä. (2011) Significance of site-specific prognosis of cancer stem cell marker CD44 in head and neck squamous-cell carcinoma. Oral Oncology 47:6, 510-516
CrossRef83
Peter Paximadis, George Yoo, Ho-Sheng Lin, John Jacobs, Ammar Sukari, Greg Dyson, Michael Christensen, Harold Kim. (2011) Concurrent Chemoradiotherapy Improves Survival in Patients with Hypopharyngeal Cancer. International Journal of Radiation Oncology*Biology*Physics
CrossRef84
François Meyer, André Fortin, Chang Shu Wang, Geoffrey Liu, Isabelle Bairati. (2011) Predictors of Severe Acute and Late Toxicities in Patients with Localized Head and Neck Cancer Treated with Radiation Therapy. International Journal of Radiation Oncology*Biology*Physics
CrossRef85
Shousong Cao, Farukh A. Durrani, Karoly Toth, Youcef M. Rustum, Mukund Seshadri. (2011) Bevacizumab enhances the therapeutic efficacy of Irinotecan against human head and neck squamous cell carcinoma xenografts. Oral Oncology 47:6, 459-466
CrossRef86
Antonio Rueda, Oscar Cazorla, Lidia Pérez, Martina Álvarez, Maximino Redondo, Elena Gallego, Maribel Sáez, José Antonio Medina, José Solano, Alfredo Matilla. (2011) Vascular endothelial growth factor and vascular endothelial growth factor receptor-2 tumor expression in patients with advanced laryngeal cancer after induction chemotherapy for organ preservation. Head & Neck 33:6, 808-816
CrossRef87
Mohan Suntharalingam, Young Kwok, Olga Goloubeva, Arti Parekh, Rodney Taylor, Jeffrey Wolf, Ann Zimrin, Scott Strome, Robert Ord, Kevin J Cullen. (2011) Phase II Study Evaluating the Addition of Cetuximab to the Concurrent Delivery of Weekly Carboplatin, Paclitaxel, and Daily Radiotherapy for Patients With Locally Advanced Squamous Cell Carcinomas of the Head and Neck. International Journal of Radiation Oncology*Biology*Physics
CrossRef88
Shimpei Miyamoto, Minoru Sakuraba, Shogo Nagamatsu, Ryuichi Hayashi. (2011) Salvage total pharyngolaryngectomy and free jejunum transfer. The Laryngoscope 121:5, 947-951
CrossRef89
M. R. Posner, J. H. Lorch, O. Goloubeva, M. Tan, L. M. Schumaker, N. J. Sarlis, R. I. Haddad, K. J. Cullen. (2011) Survival and human papillomavirus in oropharynx cancer in TAX 324: a subset analysis from an international phase III trial. Annals of Oncology 22:5, 1071-1077
CrossRef90
Juan Pablo Rodrigo, Andrés Coca-Pelaz, Carlos Suárez. (2011) The Current Role of Partial Surgery As a Strategy for Functional Preservation in Laryngeal Carcinoma. Acta Otorrinolaringologica (English Edition) 62:3, 231-238
CrossRef91
Juan Pablo Rodrigo, Andrés Coca-Pelaz, Carlos Suárez. (2011) El papel actual de la cirugía parcial como estrategia de preservación funcional en el carcinoma de laringe. Acta Otorrinolaringológica Española 62:3, 231-238
CrossRef92
Stuart J. Wong, Paul M. Harari, Adam S. Garden, Marc Schwartz, Lisa Bellm, Amy Chen, Walter J. Curran, Barbara A. Murphy, K. Kian Ang. (2011) Longitudinal oncology registry of head and neck carcinoma (LORHAN). Cancer 117:8, 1679-1686
CrossRef93
Charles Woods, Jason Sohn, Min Yao. (2011) The Application of PET in Radiation Treatment Planning for Head and Neck Cancer. PET Clinics 6:2, 149-163
CrossRef94
C.-J. Wang, R. Knecht. (2011) Current concepts of organ preservation in head and neck cancer. European Archives of Oto-Rhino-Laryngology 268:4, 481-487
CrossRef95
Hugo Villeneuve, Philippe Després, Bernard Fortin, Edith Filion, David Donath, Denis Soulières, Louis Guertin, Tarek Ayad, Apostolos Christopoulos, Phuc Felix Nguyen-Tan. (2011) Cervical Lymph Node Metastases From Unknown Primary Cancer: A Single-Institution Experience With Intensity-Modulated Radiotherapy. International Journal of Radiation Oncology*Biology*Physics
CrossRef96
Christine G. Gourin, Arlene A. Forastiere, Giuseppe Sanguineti, Shanthi Marur, Wayne M. Koch, Robert E. Bristow. (2011) Volume-based trends in surgical care of patients with oropharyngeal cancer. The Laryngoscope 121:4, 738-745
CrossRef97
Anthony C. Nichols, Peter J. Kneuertz, Daniel G. Deschler, Derrick T. Lin, Kevin S. Emerick, John R. Clark, Paul W. Busse, James W. Rocco. (2011) Surgical salvage of the oropharynx after failure of organ-sparing therapy. Head & Neck 33:4, 516-524
CrossRef98
June Corry, Danny Rischin, Sue Cotton, Ieta D'Costa, Margaret Chua, Neil Vallance, Bernard Lyons, Stephen Kleid, Andrew Sizeland, Lester J Peters. (2011) Larynx preservation with primary non-surgical treatment for loco-regionally advanced larynx cancer. Journal of Medical Imaging and Radiation Oncology 55:2, 229-235
CrossRef99
Brian Kim, Robert O. Dillman, Peter Chen, Russell Hafer, Craig Cox, Neil Barth, R. Matthew Carroll, Louis VanderMolen, Minh Nguyen, JinChu Huang, Annamarie Minion, Marianne Plunkett, Ralph Mackintosh. (2011) A retrospective study of induction chemotherapy with docetaxel, cisplatinum, and 5-fluorouracil followed by concurrent radiotherapy with cetuximab in locally advanced head and neck cancer. American Journal of Otolaryngology
CrossRef100
A. Jegannathen, K. Mais, A. Sykes, L. Lee, B. Yap, A. Birzgalis, J. Homer, W.D. Ryder, N. Slevin. (2011) Synchronous Chemoradiotherapy in Patients with Locally Advanced Squamous Cell Carcinoma of the Head and Neck using Capecitabine: a Single-centre, Open-label, Single-group Phase II Study. Clinical Oncology 23:2, 149-158
CrossRef101
T. Ohashi, M. Ohnishi, S. Tanahashi, M. Murai. (2011) Efficacy and Toxicity of Concurrent Chemoradiotherapy with Nedaplatin and S-1 for Head and Neck Cancer. Japanese Journal of Clinical Oncology 41:3, 348-352
CrossRef102
Jaiprakash Agarwal, Vijay Palwe, Debnarayan Dutta, Tejpal Gupta, Sarbani Ghosh Laskar, Ashwini Budrukkar, Vedang Murthy, Pankaj Chaturvedi, Prathamesh Pai, Devendra Chaukar, Anil K. D’Cruz, Suyash Kulkarni, Aniruddha Kulkarni, Gurmit Baccher, Shyam Kishore Shrivastava. (2011) Objective Assessment of Swallowing Function After Definitive Concurrent (Chemo)radiotherapy in Patients with Head and Neck Cancer. Dysphagia
CrossRef103
David J. Sher, Marshall R. Posner, Roy B. Tishler, Nicholas J. Sarlis, Robert I. Haddad, Edward J. Holupka, Phillip M. Devlin. (2011) Relationship Between Radiation Treatment Time and Overall Survival After Induction Chemotherapy for Locally Advanced Head-and-Neck Carcinoma: A Subset Analysis of TAX 324. International Journal of Radiation OncologyBiologyPhysics
CrossRef104
Pirus Ghadjar, Mathew Simcock, Gabriela Studer, Abdelkarim S. Allal, Mahmut Ozsahin, Jacques Bernier, Michael Töpfer, Frank Zimmermann, Michael Betz, Christoph Glanzmann. (2011) Concomitant Cisplatin and Hyperfractionated Radiotherapy in Locally Advanced Head and Neck Cancer: 10-Year Follow-up of a Randomized Phase III Trial (SAKK 10/94). International Journal of Radiation OncologyBiologyPhysics
CrossRef105
Geert O. Janssens, Chris H. Terhaard, Patricia A. Doornaert, Hendrik P. Bijl, Piet van den Ende, Alim Chin, Lucas A. Pop, Johannes H. Kaanders. (2011) Acute Toxicity Profile and Compliance to Accelerated Radiotherapy Plus Carbogen and Nicotinamide for Clinical Stage T2–4 Laryngeal Cancer: Results of a Phase III Randomized Trial. International Journal of Radiation OncologyBiologyPhysics
CrossRef106
Guohua Sun, Yu Wang, Yongxue Zhu, Caiping Huang, Qinghai Ji. (2011) Duffy antigen receptor for chemokines in laryngeal squamous cell carcinoma as a negative regulator. Acta Oto-laryngologica 131:2, 197-203
CrossRef107
E. Esteller, M. C. Vega, M. López, M. Quer, X. León. (2011) Salvage surgery after locoregional failure in head and neck carcinoma patients treated with chemoradiotherapy. European Archives of Oto-Rhino-Laryngology 268:2, 295-301
CrossRef108
Martín Granados García, María Fátima Chilaca Rosas, Arturo Javier Lavín Lozano, Federico Maldonado Magos, Mauricio Frías Mendivil, Gustavo Cabrera Aquino, Blanca Angélica Segura Pacheco, María Montserrat Montes Luis, Daniela Olvera Caraza, José Luis Aguilar Ponce. (2011) Cetuximab concomitant with gemcitabine and radiotherapy in advanced squamous cell carcinomas of upper aerodigestive tract: a pilot study. Clinical and Translational Oncology 13:2, 109-114
CrossRef109
Neal E. Ready, Ritesh Rathore, Tirrell T. Johnson, Ahmed Nadeem, Prakash Chougule, Charles Ruhl, Kathy Radie-Keane, Kathy Theall, Harold J. Wanebo, Jennifer Marcello, Teresa Kennedy. (2011) Weekly Paclitaxel and Carboplatin Induction Chemotherapy Followed by Concurrent Chemoradiotherapy in Locally Advanced Squamous Cell Carcinoma of the Head and Neck. American Journal of Clinical Oncology1
CrossRef110
Kristin A. Higgins, Jenny K. Hoang, Michael C. Roach, Junzo Chino, David S. Yoo, Timothy G. Turkington, David M. Brizel. (2011) Analysis of Pretreatment FDG-PET SUV Parameters in Head-and-Neck Cancer: Tumor SUVmean has Superior Prognostic Value. International Journal of Radiation OncologyBiologyPhysics
CrossRef111
Johan Bussink, Johannes H. A. M. Kaanders, Winette T. A. van der Graaf, Wim J. G. Oyen. (2011) PET–CT for radiotherapy treatment planning and response monitoring in solid tumors. Nature Reviews Clinical Oncology 8:4, 233-242
CrossRef112
Johnny Kao, Eric M. Genden, Vishal Gupta, Edelweiss L. Policarpio, Ryan J. Burri, Michael Rivera, Vivek Gurudutt, Peter M. Som, Marita Teng, Stuart H. Packer. (2011) Phase 2 trial of concurrent 5-fluorouracil, hydroxyurea, cetuximab, and hyperfractionated intensity-modulated radiation therapy for locally advanced head and neck cancer. Cancer 117:2, 318-326
CrossRef113
Aisha B. Miah, Shreerang A. Bhide, M. Teresa Guerrero-Urbano, Catharine Clark, A. Margaret Bidmead, Suzanne St. Rose, Yolanda Barbachano, Roger A’Hern, Mary Tanay, Jennifer Hickey. (2011) Dose-Escalated Intensity-Modulated Radiotherapy Is Feasible and May Improve Locoregional Control and Laryngeal Preservation in Laryngo-hypopharyngeal Cancers. International Journal of Radiation OncologyBiologyPhysics
CrossRef114
Urjeet A. Patel, Lori K. Howell. (2011) Local response to chemoradiation in T4 larynx cancer with cartilage invasion. The Laryngoscope 121:1, 106-110
CrossRef115
In Sun Ryu, Myung Woul Han, Jong-Lyel Roh, Soon Yuhl Nam, Sang Yoon Kim, Seung-Ho Choi. (2011) Outcomes of Salvage Surgery after Concurrent Chemoradiation for Advanced Hypopharyngeal Cancer. Korean Journal of Otorhinolaryngology-Head and Neck Surgery 54:10, 703
CrossRef116
Megan E. Daly, Quynh-Thu Le, Anshu K. Jain, Peter G. Maxim, Annie Hsu, Billy W. Loo, Michael J. Kaplan, Nancy J. Fischbein, A. Dimitrios Colevas, Harlan Pinto, Daniel T. Chang. (2011) Intensity-modulated radiotherapy for locally advanced cancers of the larynx and hypopharynx. Head & Neck 33:1, 103-111
CrossRef117
Jackie Nemunaitis, John Nemunaitis, David W. Eisele. (2011) Head and neck cancer: Response to p53-based therapeutics. Head & Neck 33:1, 131-134
CrossRef118
Kerstin M. Stenson, Ellen MacCracken, Rangesh Kunnavakkam, Ezra E. W. Cohen, Louis D. Portugal, Victoria Villaflor, Tanguy Seiwert, Elizabeth Blair, Daniel J. Haraf, Joseph K. Salama, Everett E. Vokes. (2011) Chemoradiation for patients with large-volume laryngeal cancers. Head & Neckn/a-n/a
CrossRef119
Eric M. Genden, Bert W. O'Malley, Gregory S. Weinstein, Chaz L. Stucken, Jesse C. Selber, Alessandra Rinaldo, Neil G. Hockstein, Enver Ozer, Yann Mallet, Richard M. Satava, Eric J. Moore, Carl E. Silver, Alfio Ferlito, David W. Eisele. (2011) Transoral robotic surgery: Role in the management of upper aerodigestive tract tumors. Head & Neckn/a-n/a
CrossRef120
Smith Apisarnthanarax, Nirav Dhruva, Farhad Ardeshirpour, Joel E. Tepper, Carol G. Shores, Julian G. Rosenman, William W. Shockley, Michele C. Hayward, D. Neil Hayes. (2011) Concomitant Radiotherapy and Chemotherapy for High-Risk Nonmelanoma Skin Carcinomas of the Head and Neck. International Journal of Surgical Oncology 2011, 1-8
CrossRef121
Hong Zhang, Lois B. Travis, Rui Chen, Ollivier Hyrien, Michael T. Milano, Shawn D. Newlands, Yuhchyau Chen. (2011) Impact of radiotherapy on laryngeal cancer survival. Cancern/a-n/a
CrossRef122
Tai-Jan Chiu, Chang-Han Chen, Chih-Yen Chien, Shau-Hsuan Li, Hsin-Ting Tsai, Yi-Ju Chen. (2011) High ERCC1 expression predicts cisplatin-based chemotherapy resistance and poor outcome in unresectable squamous cell carcinoma of head and neck in a betel-chewing area. Journal of Translational Medicine 9:1, 31
CrossRef123
Akihiro Sakai, Kenji Okami, Ryousuke Sugimoto, Koji Ebisumoto, Hikaru Yamamoto, Hiroyuki Furuya, Masahiro Iida. (2011) Multivariate Analysis of Wound Complications after Surgery for Laryngeal and Hypopharyngeal Cancers. ORL 73:2, 100-104
CrossRef124
Christine G. Gourin, Arlene A. Forastiere, Giuseppe Sanguineti, Shanthi Marur, Wayne M. Koch, Robert E. Bristow. (2011) Volume-based trends in laryngeal cancer surgery. The Laryngoscope 121:1, 77-84
CrossRef125
Yoshihiro Akazawa, Shoji Watanabe, Shigeru Kasugai, Mistuhiro Mukaide, Takashi Otsuka, Takao Oikawa, Koshi Mikami, Izumi Koizuka. (2011) Clinical Study of Advanced Laryngeal Carcinoma. Practica Oto-Rhino-Laryngologica 104:6, 447-453
CrossRef126
Marc Rubinstein, William B. Armstrong. (2011) Transoral laser microsurgery for laryngeal cancer: A primer and review of laser dosimetry. Lasers in Medical Science 26:1, 113-124
CrossRef127
Takahito Kondo, Hiroyuki Ito, Kiyoaki Tsukahara, Akira Shimizu, Isaku Okamoto, Takuro Okada, Tomoyuki Yoshida, Mamoru Suzuki. (2011) Clinical Study of Hypopharyngeal Squamous Cell Carcinoma. Nihon Kikan Shokudoka Gakkai Kaiho 62:4, 384-392
CrossRef128
Pen-Yuan Chu, Tsung-Lun Lee, Shyue-Yih Chang. (2011) Impact and management of airway obstruction in patients with squamous cell carcinoma of the larynx. Head & Neck 33:1, 98-102
CrossRef129
Jong-Lyel Roh, Myung Woul Han. (2011) Functional Organ Preservation Surgery for Head and Neck Cancer. Korean Journal of Otorhinolaryngology-Head and Neck Surgery 54:1, 1
CrossRef130
Ivan Marcelo Gonçalves Agra, Alfio Ferlito, Robert P. Takes, Carl E. Silver, Kerry D. Olsen, Sandro J. Stoeckli, Primož Strojan, Juan P. Rodrigo, João Gonçalves Filho, Eric M. Genden, Missak Haigentz, Avi Khafif, Randal S. Weber, Peter Zbären, Carlos Suárez, Dana M. Hartl, Alessandra Rinaldo, Kwang Hyun Kim, Luiz P. Kowalski, David W. Eisele. (2011) Diagnosis and treatment of recurrent laryngeal cancer following initial nonsurgical therapy. Head & Neckn/a-n/a
CrossRef131
Walter T. Lee, David S. Yoo, Liana Puscas, David Witsell, Seth M. Cohen, Samuel R. Fisher, Richard Scher, Gloria Broadwater, Neal Ready, David R. Brizel, Ramon M. Esclamado. (2011) Treatment-induced changes in vocal cord mobility and subsequent local recurrence after organ preservation therapy for laryngeal carcinoma. Head & Neckn/a-n/a
CrossRef132
Carlos Suárez, Juan P. Rodrigo, Carl E. Silver, Dana M. Hartl, Robert P. Takes, Alessandra Rinaldo, Primozõ Strojan, Alfio Ferlito. (2011) Laser surgery for early to moderately advanced glottic, supraglottic, and hypopharyngeal cancers. Head & Neckn/a-n/a
CrossRef133
Kayoko OHNISHI, Yoshiyuki SHIOYAMA, Katsumasa NAKAMURA, Torahiko NAKASHIMA, Saiji OHGA, Takeshi NONOSHITA, Tadamasa YOSHITAKE, Kotarou TERASHIMA, Shizuo KOMUNE, Hiroshi HONDA. (2011) Concurrent Chemoradiotherapy with S-1 as First-line Treatment for Patients with Oropharyngeal Cancer. Journal of Radiation Research 52:1, 47-53
CrossRef134
Valerie H. Lau, Rebecca J. Leonard, Susan Goodrich, Quang Luu, D. Gregory Farwell, Derick H. Lau, James A. Purdy, Allen M. Chen. (2011) Voice quality after organ-preservation therapy with definitive radiotherapy for laryngeal cancer. Head & Neckn/a-n/a
CrossRef135
Fazilat F. Mohammed, Ian Poon, Liying Zhang, Liz Elliott, Ian D. Hodson, Stephen M. Sagar, James Wright. (2011) Acute-phase response reactants as objective biomarkers of radiation-induced mucositis in head and neck cancer. Head & Neckn/a-n/a
CrossRef136
Mitsuhiko Kawashima, Ryuichi Hayashi, Makoto Tahara, Satoko Arahira, Masakazu Miyazaki, Minoru Sakuraba, Sadamoto Zenda, Takashi Ogino. (2011) Prospective trial of chemotherapy-enhanced accelerated radiotherapy for larynx preservation in patients with intermediate-volume hypopharyngeal cancer. Head & Neckn/a-n/a
CrossRef137
Sandeep Samant, Michiel W. van den Brekel, Merrill S. Kies, Jim Wan, K. Thomas Robbins, David I. Rosenthal, Coen Rasch, Randal S. Weber. (2011) Concurrent chemoradiation for adenoid cystic carcinoma of the head and neck. Head & Neckn/a-n/a
CrossRef138
Anthony Yuen Bun Teoh, Philip Wai Yan Chiu, Tiffany Cho Lam Wong, Shirley Yuk Wah Liu, Simon Kin Hung Wong, Enders Kwok Wai Ng. (2011) Functional Performance and Quality of Life in Patients With Squamous Esophageal Carcinoma Receiving Surgery or Chemoradiation. Annals of Surgery 253:1, 1-5
CrossRef139
Stephanie A. Michal, David J. Adelstein, Lisa A. Rybicki, Cristina P. Rodriguez, Jerrold P. Saxton, Benjamin G. Wood, Joseph Scharpf, Denise I. Ives. (2011) Multi-agent concurrent chemoradiotherapy for locally advanced head and neck squamous cell cancer in the elderly. Head & Neckn/a-n/a
CrossRef140
Sabine Semrau, Frank Waldfahrer, Michael Lell, Rainer Linke, Gunther Klautke, Torsten Kuwert, Michael Uder, Heinrich Iro, Rainer Fietkau. (2011) Feasibility, Toxicity, and Efficacy of Short Induction Chemotherapy of Docetaxel Plus Cisplatin or Carboplatin (TP) Followed by Concurrent Chemoradio therapy for Organ Preservation in Advanced Cancer of the Hypopharynx, Larynx, and Base of Tongue. Strahlentherapie und Onkologie 187:1, 15-22
CrossRef141
Francesco Bussu, Francesco Miccichè, Mario Rigante, Nicola Dinapoli, Claudio Parrilla, Pierluigi Bonomo, Gabriella Cadoni, Giovanna Mantini, Jacopo Galli, Vittoria Rufini, Giovanni Almadori, Vincenzo Valentini, Gaetano Paludetti. (2011) Oncologic outcomes in advanced laryngeal squamous cell carcinomas treated with different modalities in a single institution: A retrospective analysis of 65 cases. Head & Neckn/a-n/a
CrossRef142
Alexandra D Jensen, Jürgen Krauss, Wilko Weichert, Zazie P Bergmann, Kolja Freier, Jürgen Debus, Marc W Münter. (2011) Disease control and functional outcome in three modern combined organ preserving regimens for locally advanced squamous cell carcinoma of the head and neck (SCCHN). Radiation Oncology 6:1, 122
CrossRef143
Kengo Kato, Kazuto Matsuura, Sadamoto Zenda, Hiroyuki Tachibana, Akihiro Homma, Tadaaki Kirita, Nobuya Monden, Yojiro Ota, Shigemichi Iwae, Hiroshi Otsuru, Tetsuo Akimoto, Makoto Tahara, Masao Asai. (2011) An opioid-based pain control program for head and neck cancer patients undergoing chemoradiation therapy achieves a high completion rate of radiation. Toukeibu Gan 37:1, 153-157
CrossRef144
Stuart M. Robertson, Justin C. L. Yeo, Catherine Dunnet, David Young, Kenneth MacKenzie. (2011) Voice, swallowing, and quality of life after total laryngectomy-Results of the west of Scotland laryngectomy audit. Head & Neckn/a-n/a
CrossRef145
Cristina P. Rodriguez, David J. Adelstein, Lisa A. Rybicki, Jerrold P. Saxton, Robert R. Lorenz, Benjamin G. Wood, Joseph Scharpf, Denise I. Ives. (2011) Single-arm phase II study of multiagent concurrent chemoradiotherapy and gefitinib in locoregionally advanced squamous cell carcinoma of the head and neck. Head & Neckn/a-n/a
CrossRef146
Kazuto Matsuura, Shun Sagai, Katsunori Katagiri, Takayuki Imai, Eiichi Ishida, Kiyoto Shiga, Shigeru Saijo. (2011) Efficacy and safety of chemoradiotherapy when performed by head and neck surgeon. Toukeibu Gan 37:4, 454-459
CrossRef147
Norimitsu Tanaka, Gen Suzuki, Toshi Abe, Yusuke Uchiyama, Kazuyuki Kojima, Tadashi Nakashima, Naofumi Hayabuchi. (2011) Intra-arterial chemoradiation therapy for head and neck carcinomas: Consideration of indication by sub-location. Toukeibu Gan 37:4, 498-502
CrossRef148
Christine G. Gourin, Kevin D. Frick. (2011) National trends in oropharyngeal cancer surgery and the effect of surgeon and hospital volume on short-term outcomes and cost of care. The Laryngoscopen/a-n/a
CrossRef149
Melissa Hu, Fred Ampil, Cheryl Clark, Kunal Sonavane, Gloria Caldito, Cherie-Ann O. Nathan. (2011) Comorbid predictors of poor response to chemoradiotherapy for laryngeal squamous cell carcinoma. The Laryngoscopen/a-n/a
CrossRef150
Aline Gouvêa de Lima, Rosângela Correa Villar, Gilberto de Castro Jr., Reynaldo Antequera, Erlon Gil, Mauro Cabral Rosalmeida, Miriam Hatsue Honda Federico, Igor Moisés Longo Snitcovsky. (2010) Oral Mucositis Prevention by Low-Level Laser Therapy in Head-and-Neck Cancer Patients Undergoing Concurrent Chemoradiotherapy: A Phase III Randomized Study. International Journal of Radiation OncologyBiologyPhysics
CrossRef151
Akio Akahane, Miyuki Sone, Shigeru Ehara, Kenichi Kato, Ryoichi Tanaka, Tatsuhiko Nakasato. (2010) Subclavian Vein Versus Arm Vein for Totally Implantable Central Venous Port for Patients with Head and Neck Cancer: A Retrospective Comparative Analysis. CardioVascular and Interventional Radiology
CrossRef152
Samy Horn, Mahmut Ozsahin, Jean-Louis Lefèbvre, Jean-Claude Horiot, Eric Lartigau. (2010) Larynx preservation: What is the standard treatment?. Critical Reviews in Oncology/Hematology
CrossRef153
Luca Calabrese, Angelo Ostuni, Mohssen Ansarin, Gioacchino Giugliano, Fausto Maffini, Daniela Alterio, Maria Cossu Rocca, Giuseppe Petralia, Roberto Bruschini, Fausto Chiesa. (2010) Future challenges in head and neck cancer: From the bench to the bedside?. Critical Reviews in Oncology/Hematology
CrossRef154
A.M. Mumme, F. Reitmeier, R. Knecht. (2010) Aktueller Stellenwert der Induktionschemotherapie. HNO 58:12, 1156-1162
CrossRef155
Jesse C. Selber. (2010) Transoral Robotic Reconstruction of Oropharyngeal Defects: A Case Series. Plastic and Reconstructive Surgery 126:6, 1978-1987
CrossRef156
Ly Do, Nisar Syed, Ajmel Puthawala, Samar Azawi, Richard Williams, Nayana Vora. (2010) Prognostic Significance of Bone or Cartilage Invasion of Locally Advanced Head and Neck Cancers. American Journal of Clinical Oncology 33:6, 591-594
CrossRef157
Jonathan D. Schoenfeld, David J. Sher, Charles M. Norris Jr., Robert I. Haddad, Marshall R. Posner, Tracy A. Balboni, Roy B. Tishler. (2010) Salivary Gland Tumors Treated With Adjuvant Intensity-Modulated Radiotherapy With or Without Concurrent Chemotherapy. International Journal of Radiation OncologyBiologyPhysics
CrossRef158
Allen M. Chen, Bao-Qing Li, Derick H. Lau, D. Gregory Farwell, Quang Luu, Kerri Stuart, Kathleen Newman, James A. Purdy, Srinivasan Vijayakumar. (2010) Evaluating the Role of Prophylactic Gastrostomy Tube Placement Prior to Definitive Chemoradiotherapy for Head and Neck Cancer. International Journal of Radiation Oncology*Biology*Physics 78:4, 1026-1032
CrossRef159
J. Hamdan, L. Feldman. (2010) Survival after organ preserving treatment for T4a laryngeal squamous cell carcinoma. Annals of Oncology 21:11, 2292-2293
CrossRef160
Daniel Herchenhorn, Fernando L. Dias, Célia M.P. Viegas, Miriam H. Federico, Carlos Manoel M. Araújo, Isabelle Small, Marcos Bezerra, Karina Fontão, Renata E. Knust, Carlos G. Ferreira, Renato G. Martins. (2010) Phase I/II Study of Erlotinib Combined With Cisplatin and Radiotherapy in Patients With Locally Advanced Squamous Cell Carcinoma of the Head and Neck. International Journal of Radiation Oncology*Biology*Physics 78:3, 696-702
CrossRef161
Aaron W. Pederson, Daniel J. Haraf, Mary-Ellyn Witt, Kerstin M. Stenson, Everett E. Vokes, Elizabeth A. Blair, Joseph K. Salama. (2010) Chemoradiotherapy for locoregionally advanced squamous cell carcinoma of the base of tongue. Head & Neck 32:11, 1519-1527
CrossRef162
Chien-Yu Lin, Hung-Ming Wang, Chung-Jan Kang, Li-Yu Lee, Shiang-Fu Huang, Kang-Hsing Fan, Eric Yen-Chao Chen, I-How Chen, Chun-Ta Liao, Joseph Tung-Chieh Chang. (2010) Primary Tumor Site as a Predictor of Treatment Outcome for Definitive Radiotherapy of Advanced-Stage Oral Cavity Cancers. International Journal of Radiation Oncology*Biology*Physics 78:4, 1011-1019
CrossRef163
Anthony Prince, Julio Aguirre-Ghizo, Eric Genden, Marshall Posner, Andrew Sikora. (2010) Head and Neck Squamous Cell Carcinoma: New Translational Therapies. Mount Sinai Journal of Medicine: A Journal of Translational and Personalized Medicine 77:6, 684-699
CrossRef164
Shinpei Kada, Shigeru Hirano, Ichiro Tateya, Morimasa Kitamura, Seiji Ishikawa, Tomoko Kanda, Ryo Asato, Shinzo Tanaka, Juichi Ito. (2010) Ten years single institutional experience of treatment for advanced laryngeal cancer in Kyoto University. Acta Oto-laryngologica 130:S563, 68-73
CrossRef165
Ricard Mesía Nin, Miguel Pastor Borgoñón, Juan Jesús Cruz Hernández, Dolores Isla Casado. (2010) SEOM clinical guidelines for the treatment of head and neck cancer. Clinical and Translational Oncology 12:11, 742-748
CrossRef166
David J. Sher, Robert I. Haddad, Charles M. Norris, Marshall R. Posner, Lori J. Wirth, Laura A. Goguen, Donald Annino, Tracy Balboni, Aaron Allen, Roy B. Tishler. (2010) Efficacy and toxicity of reirradiation using intensity-modulated radiotherapy for recurrent or second primary head and neck cancer. Cancer 116:20, 4761-4768
CrossRef167
L. Hadjiiski, S. K. Mukherji, S. K. Gujar, B. Sahiner, M. Ibrahim, E. Street, J. Moyer, F. P. Worden, H.- P. Chan. (2010) Treatment Response Assessment of Head and Neck Cancers on CT Using Computerized Volume Analysis. American Journal of Neuroradiology 31:9, 1744-1751
CrossRef168
Heather E. Newlin, Robert J. Amdur, Charles E. Riggs, Christopher G. Morris, Jessica M. Kirwan, William M. Mendenhall. (2010) Concomitant weekly cisplatin and altered fractionation radiotherapy in locally advanced head and neck cancer. Cancer 116:19, 4533-4540
CrossRef169
Heming Lu, Jiaxin Chen, Baoqin Huang, Jinjian Cheng, Luxing Peng, Yanrong Hao, Chaolong Liao, Ying Mo, Danling Wu, Jian Qin. (2010) Feasibility and efficacy study of weekly cisplatin with concurrent intensity-modulated radiation therapy for nasopharyngeal carcinoma: Preliminary results. Oral Oncology 46:10, 743-747
CrossRef170
M. Nakayama, K. Hayakawa, M. Okamoto, Y. Niibe, H. Ishiyama, S. Kotani. (2010) Phase I/II Trial of Concurrent Use of S-1 and Radiation Therapy for T2 Glottic Cancer. Japanese Journal of Clinical Oncology 40:10, 921-926
CrossRef171
E. Soudry, T. Hadar, J. Shvero, K. Segal, T. Shpitzer, B.I. Nageris, R. Feinmesser. (2010) The impact of positive resection margins in partial laryngectomy for advanced laryngeal carcinomas and radiation failures. Clinical Otolaryngology 35:5, 402-408
CrossRef172
Takenori Ogawa, Kazumi Ogawa, Kiyoto Shiga, Toru Furukawa, Hiroki Nagase, Sho Hashimoto, Toshimitsu Kobayashi, Akira Horii. (2010) Upregulation of IGF2 is associated with an acquired resistance for cis-diamminedichloroplatinum in human head and neck squamous cell carcinoma. European Archives of Oto-Rhino-Laryngology 267:10, 1599-1606
CrossRef173
Clint T. Allen, James S. Lewis, Samir K. El-Mofty, Bruce H. Haughey, Brian Nussenbaum. (2010) Human papillomavirus and oropharynx cancer: Biology, detection and clinical implications. The Laryngoscope 120:9, 1756-1772
CrossRef174
Piet Dirix, Maarten Lambrecht, Sandra Nuyts. (2010) Radiotherapy for laryngeal squamous cell carcinoma: current standards. Expert Review of Anticancer Therapy 10:9, 1461-1469
CrossRef175
Mamoru Tsukuda, Junichi Ishitoya, Hideki Matsuda, Choichi Horiuchi, Takahide Taguchi, Masahiro Takahashi, Goshi Nishimura, Mariko Kawakami, Makiko Watanabe, Tatsuo Niho, Toshiro Kawano, Yoichi Ikeda, Yasunori Sakuma, Osamu Shiono, Masanori Komatsu. (2010) Randomized controlled phase II comparison study of concurrent chemoradiotherapy with docetaxel, cisplatin, and 5-fluorouracil versus CCRT with cisplatin, 5-fluorouracil, methotrexate and leucovorin in patients with locally advanced squamous cell carcinoma of the head and neck. Cancer Chemotherapy and Pharmacology 66:4, 729-736
CrossRef176
Emily Crozier, Baran D. Sumer. (2010) Head and Neck Cancer. Medical Clinics of North America 94:5, 1031-1046
CrossRef177
Christof Röösli, Gabriela Studer, Sandro J. Stoeckli. (2010) Salvage treatment for recurrent oropharyngeal squamous cell carcinoma. Head & Neck 32:8, 989-996
CrossRef178
William M. Mendenhall, Charles E. Riggs, Mikhail Vaysberg, Robert J. Amdur, John W. Werning, David W. Eisele. (2010) Altered fractionation and adjuvant chemotherapy for head and neck squamous cell carcinoma. Head & Neck 32:7, 939-945
CrossRef179
Iris Gluck, Felix Y. Feng, Teresa Lyden, Marc Haxer, Francis Worden, Douglas B. Chepeha, Avraham Eisbruch. (2010) Evaluating and Reporting Dysphagia in Trials of Chemoirradiation for Head-and-Neck Cancer. International Journal of Radiation Oncology*Biology*Physics 77:3, 727-733
CrossRef180
A. Paccagnella, M. G. Ghi, L. Loreggian, A. Buffoli, H. Koussis, C. A. Mione, A. Bonetti, F. Campostrini, G. Gardani, A. Ardizzoia, D. Dondi, M. Guaraldi, R. Cavallo, L. Tomio, A. Gava, . (2010) Concomitant chemoradiotherapy versus induction docetaxel, cisplatin and 5 fluorouracil (TPF) followed by concomitant chemoradiotherapy in locally advanced head and neck cancer: a phase II randomized study. Annals of Oncology 21:7, 1515-1522
CrossRef181
Dirk Rades, Stefanie Kronemann, Thekla Meyners, Steven E. Schild, Samer G. Hakim. (2010) Acute toxicity of three versus two courses of cisplatin for radiochemotherapy of locally advanced squamous cell carcinoma of the head and neck (SCCHN): A matched pair analysis. Oral Oncology 46:7, 549-552
CrossRef182
Levon Igidbashian, Bernard Fortin, Louis Guertin, Denis Soulières, Geneviève Coulombe, Manon Belair, Danielle Charpentier, Jean-Claude Tabet, Phuc Felix Nguyen-Tan. (2010) Outcome With Neck Dissection After Chemoradiation for N3 Head-and-Neck Squamous Cell Carcinoma. International Journal of Radiation Oncology*Biology*Physics 77:2, 414-420
CrossRef183
Nele Platteaux, Piet Dirix, Eddy Dejaeger, Sandra Nuyts. (2010) Dysphagia in Head and Neck Cancer Patients Treated with Chemoradiotherapy. Dysphagia 25:2, 139-152
CrossRef184
Guillaume Buiret, Claire Combe, Véronique Favrel, Pascal Pommier, Laurent Martin, René Ecochard, Jérome Fayette, Sophie Tartas, Antoine Ramade, Philippe Céruse. (2010) A Retrospective, Multicenter Study of the Tolerance of Induction Chemotherapy With Docetaxel, Cisplatin, and 5-Fluorouracil Followed by Radiotherapy With Concomitant Cetuximab in 46 Cases of Squamous Cell Carcinoma of the Head and Neck. International Journal of Radiation Oncology*Biology*Physics 77:2, 430-437
CrossRef185
S.A. Bhide, C.M. Nutting. (2010) Advances in chemotherapy for head and neck cancer. Oral Oncology 46:6, 436-438
CrossRef186
Yasunao Kogashiwa, Hiroyuki Sakurai, Toru Kimura, Naoyuki Kohno. (2010) Docetaxel suppresses invasiveness of head and neck cancer cells in vitro. Cancer Science 101:6, 1382-1386
CrossRef187
Mohammad Hasan LARIZADEH, Mohammad Ali DAMGHANI. (2010) Sequential chemoradiotherapy in advanced laryngeal cancer: An institutional experience. Asia-Pacific Journal of Clinical Oncology 6:2, 106-110
CrossRef188
Sandro V PORCEDDU. (2010) Is induction chemotherapy the new standard in organ preservation treatment for locally advanced head and neck cancer in 2010?. Asia-Pacific Journal of Clinical Oncology 6:2, 75-76
CrossRef189
Jeffrey Meyer, Christopher Willett, Brian Czito. (2010) Current and Emerging Treatment Strategies for Anal Cancer. Current Oncology Reports 12:3, 168-174
CrossRef190
V. Gregoire, J.- L. Lefebvre, L. Licitra, E. Felip, . (2010) Squamous cell carcinoma of the head and neck: EHNS-ESMO-ESTRO Clinical Practice Guidelines for diagnosis, treatment and follow-up. Annals of Oncology 21:Supplement 5, v184-v186
CrossRef191
Walter T. Lee, Mark Rizzi, Joseph Scharpf, Robert R. Lorenz, Jerrod P. Saxton, David J. Adelstein, Ramon M. Esclamado. (2010) Impact of preepiglottic space tumor involvement on concurrent chemoradiation therapy. American Journal of Otolaryngology 31:3, 185-188
CrossRef192
Harry Quon, Sue S. Yom, Madhur Kumar Garg, Joshua Lawson, Mark W. McDonald, John A. Ridge, Nabil Saba, Joseph Salama, Richard Smith, Anamaria Reyna Yeung, Jonathan J. Beitler. (2010) ACR Appropriateness Criteria®: Local–Regional Therapy for Resectable Oropharyngeal Squamous Cell Carcinomas. Current Problems in Cancer 34:3, 175-192
CrossRef193
F. Christopher Holsinger, Brian Nussenbaum, Meijin Nakayama, Sonal Saraiya, Aniel Sewnaik, Nebil Ark, Robert L. Ferris, Ralph P. Tufano, Andrew J. McWhorter, David W. Eisele. (2010) Current concepts and new horizons in conservation laryngeal surgery: An important part of multidisciplinary care. Head & Neck 32:5, 656-665
CrossRef194
Shao Hui Huang, Brian O’Sullivan. (2010) 2010 Multidisciplinary Head and Neck Cancer Symposium. Expert Review of Anticancer Therapy 10:5, 651-653
CrossRef195
Alexandre Bozec, Gilles Poissonnet, Emmanuel Chamorey, François Demard, José Santini, Frédéric Peyrade, Cécile Ortholan, Karen Benezery, Juliette Thariat, Anne Sudaka, Katia Anselme, Brigitte Adrey, Paul Giacchero, Olivier Dassonville. (2010) Results of vocal rehabilitation using tracheoesophageal voice prosthesis after total laryngectomy and their predictive factors. European Archives of Oto-Rhino-Laryngology 267:5, 751-758
CrossRef196
José Miguel Dora, Walter Escouto Machado, Guilherme Geib, Karla Lais Pegas, José Ricardo Guimarães, Alceu Migliavaca, Ana Luiza Maia. (2010) Incidental Thyroid Cancer in Head and Neck Squamous Cell Carcinoma. The Endocrinologist 20:3, 112-114
CrossRef197
Alvaro Sanabria, Christian Domenge, Anil DʼCruz, Luiz P Kowalski. (2010) Organ preservation protocols in developing countries. Current Opinion in Otolaryngology & Head and Neck Surgery1
CrossRef198
C. H. Chung, J. Aulino, N. J. Muldowney, H. Hatakeyama, J. Baumann, B. Burkey, J. Netterville, R. Sinard, W. G. Yarbrough, A. J. Cmelak, R. J. Slebos, Y. Shyr, J. Parker, J. Gilbert, B. A. Murphy. (2010) Nuclear factor-kappa B pathway and response in a phase II trial of bortezomib and docetaxel in patients with recurrent and/or metastatic head and neck squamous cell carcinoma. Annals of Oncology 21:4, 864-870
CrossRef199
Andreas Dietz, Andreas Boehm, Iris-Susanne Horn, Pierre Kruber, Ingo Bechmann, Wojciech Golusinski, Dietger Niederwieser, Ralph Dollner, Torsten W. Remmerbach, Christian Wittekind, Stephan Dietzsch, Guido Hildebrandt, Gunnar Wichmann. (2010) Assay-based response evaluation in head and neck oncology: requirements for better decision making. European Archives of Oto-Rhino-Laryngology 267:4, 483-494
CrossRef200
S. Marur, A. A. Forastiere. (2010) Update on role of chemotherapy in head and neck squamous cell cancer. Indian Journal of Surgical Oncology 1:2, 85-95
CrossRef201
Dennis Shin-Shian Hsu, Shyue-Yih Chang, Chung-Ji Liu, Cheng-Hwai Tzeng, Kou-Juey Wu, Jung-Yie Kao, Muh-Hwa Yang. (2010) Identification of increased NBS1 expression as a prognostic marker of squamous cell carcinoma of the oral cavity. Cancer Science 101:4, 1029-1037
CrossRef202
Matthew G. Fury, Jatin P. Shah. (2010) Induction chemotherapy in the management of head and neck cancer. Journal of Surgical Oncology 101:4, 292-298
CrossRef203
Tiziana Rancati, Marco Schwarz, Aaron M. Allen, Felix Feng, Aron Popovtzer, Bharat Mittal, Avraham Eisbruch. (2010) Radiation Dose–Volume Effects in the Larynx and Pharynx. International Journal of Radiation Oncology*Biology*Physics 76:3, S64-S69
CrossRef204
A. Hartley, P. Sanghera, J. Glaholm, H. Mehanna, C. McConkey, J. Fowler. (2010) Radiobiological Modelling of the Therapeutic Ratio for the Addition of Synchronous Chemotherapy to Radiotherapy in Locally Advanced Squamous Cell Carcinoma of the Head and Neck. Clinical Oncology 22:2, 125-130
CrossRef205
Jesse C. Selber, Geoff Robb, Joseph M. Serletti, Gregory Weinstein, Randall Weber, F. Christopher Holsinger. (2010) Transoral Robotic Free Flap Reconstruction of Oropharyngeal Defects: A Preclinical Investigation. Plastic and Reconstructive Surgery 125:3, 896-900
CrossRef206
Louise Lambert, Bernard Fortin, Denis Soulières, Louis Guertin, Geneviève Coulombe, Danielle Charpentier, Jean-Claude Tabet, Manon Bélair, Nader Khaouam, Phuc Felix Nguyen-Tan. (2010) Organ Preservation With Concurrent Chemoradiation for Advanced Laryngeal Cancer: Are We Succeeding?. International Journal of Radiation Oncology*Biology*Physics 76:2, 398-402
CrossRef207
Ester Orlandi, Mauro Palazzi, Emanuele Pignoli, Carlo Fallai, Antonella Giostra, Patrizia Olmi. (2010) Radiobiological basis and clinical results of the simultaneous integrated boost (SIB) in intensity modulated radiotherapy (IMRT) for head and neck cancer: A review. Critical Reviews in Oncology/Hematology 73:2, 111-125
CrossRef208
Maroie Barkati, Bernard Fortin, Denis Soulières, Sébastien Clavel, Phillipe Després, Danielle Charpentier, Jean-Claude Tabet, Louis Guertin, Marie-Jo Olivier, Geneviève Coulombe, David Donath, Phuc Felix Nguyen-Tan. (2010) Concurrent Chemoradiation With Carboplatin–5-Fluorouracil Versus Cisplatin in Locally Advanced Oropharyngeal Cancers: Is More Always Better?. International Journal of Radiation Oncology*Biology*Physics 76:2, 410-416
CrossRef209
Takenori Ogawa, Toru Furukawa, Kiyoto Shiga, Sho Hashimoto, Kazumi Ogawa, Toshimitsu Kobayashi, Akira Horii. (2010) A cDNA microarray analysis identifies 52 genes associated with cis-diamminedichloroplatinum susceptibility in head and neck squamous cell carcinoma cell lines. European Archives of Oto-Rhino-Laryngology 267:1, 123-129
CrossRef210
Akira Kubota, Madoka Furukawa, Yoshifumi Fujita, Hiroaki Yagi. (2010) Concurrent Chemoradiotherapy for Resectable Locoregionally Advanced Squamous Cell Carcinoma of the Head and Neck-Analysis of Factors Associated with Toxicity and Efficacy. Nippon Jibiinkoka Gakkai Kaiho 113:3, 101-109
CrossRef211
Takahide Taguchi, Mamoru Tsukuda, Jun-ichi Nagao, Norio Kondo, Naoko Sakuma, Yoko Nii, Yasuhiro Arai, Gabor Toth, Goshi Nishimura, Choichi Horiuchi, Hideki Matsuda, Yukiko Ikui, Tomoko Morinobu, Satoshi Horiguchi, Hajime Hirose. (2010) Assessment of Laryngeal Functions in Patients with Squamous Cell Carcinoma of the Larynx or Hypopharynx Treated with Concurrent Chemoradiotherapy. Nihon Kikan Shokudoka Gakkai Kaiho 61:6, 483-492
CrossRef212
Young Chang Lim, Ki Woong Cho, Hak Cheol Kwon, Sung Un Kang, Jung Hee Pyun, Mi Hye Lee, Hye Sook Hwang, Jang Hee Kim, Ha Neul Lee, Eun Chang Choi, Chul-Ho Kim. (2010) Growth Inhibition and Apoptosis with H31 Metabolites from Marine Bacillus SW31 in Head and Neck Cancer Cells. Clinical and Experimental Otorhinolaryngology 3:4, 217
CrossRef213
Missak Haigentz, Carl E. Silver, Alessandra Rinaldo, Alfio Ferlito. (2010) Definitive chemotherapy: a new frontier in the fight against laryngeal cancer. European Archives of Oto-Rhino-Laryngology 267:1, 1-4
CrossRef214
Asanori Kiyuna, Masahiro Hasegawa, Asano Higa, Akihiko Shinhama, Mikio Suzuki. (2010) Swallowing Function before and after Concurrent Chemoradiotherapy for Pharyngeal Cancer. Nihon Kikan Shokudoka Gakkai Kaiho 61:3, 291-298
CrossRef215
Melanie Fesneau, Yoann Pointreau, Sophie Chapet, Laurent Martin, Pascal Pommier, Marc Alfonsi, Brigitte Laguerre, Nasreddine Feham, Christine Berger, Pascal Garaud, Gilles Calais. (2010) Concomitant Chemoradiotherapy Using Carboplatin, Tegafur-Uracil and Leucovorin for Stage III and IV Head-and-Neck Cancer: Results of GORTEC Phase II Study. International Journal of Radiation Oncology*Biology*Physics 76:1, 154-163
CrossRef216
Marc Hamoir, C.René Leemans, Gilles Dolivet, Sandra Schmitz, Vincent Grégoire, Guy Andry. (2010) Selective neck dissection in the management of the neck after (chemo)radiotherapy for advanced head and neck cancer. Proposal for a classification update. Head & NeckNA-NA
CrossRef217
A. S. Gokhale, B. T. McLaughlin, J. C. Flickinger, S. Beriwal, D. E. Heron, R. L. Ferris, J. Johnson, M. K. Gibson, A. Argiris, R. P. Smith. (2010) Clinical and dosimetric factors associated with a prolonged feeding tube requirement in patients treated with chemoradiotherapy (CRT) for head and neck cancers. Annals of Oncology 21:1, 145-151
CrossRef218
Satoru Shinriki, Mitsuharu Ueda, Kazutoshi Ota, Masaaki Nakamura, Mareina Kudo, Mutsuko Ibusuki, Jaemi Kim, Yoshihiro Yoshitake, Daiki Fukuma, Hirofumi Jono, Jun-ichi Kuratsu, Masanori Shinohara, Yukio Ando. (2010) Aberrant expression of serum amyloid A in head and neck squamous cell carcinoma. Journal of Oral Pathology & Medicine 39:1, 41-47
CrossRef219
Yosuke Nakanishi, Naohiro Wakisaka, Shigeyuki Murono, Satoru Kondo, Tomokazu Yoshizaki. (2010) Pharyngocutaneous fistula after total laryngectomy. Toukeibu Gan 36:1, 48-52
CrossRef220
Toshiki Tomita, Yorihisa Imanishi, Hiroyuki Ozawa, Ryoichi Fujii, Seiji Shigetomi, Noboru Habu, Kuninori Otsuka, Kaoru Ogawa, Junichi Fukada, Naoyuki Shigematsu, Yasunao Kogashiwa, Kohichi Yamauchi, Naoyuki Kohno. (2010) Chemotherapy for head and neck cancer: Current status and problems in Japan. Toukeibu Gan 36:3, 273-277
CrossRef221
Robert P. Takes, Primož Strojan, Carl E. Silver, Patrick J. Bradley, Missak Haigentz, Gregory T. Wolf, Ashok R. Shaha, Dana M. Hartl, Jan Olofsson, Johannes A. Langendijk, Alessandra Rinaldo, Alfio Ferlito, David W. Eisele. (2010) Current trends in initial management of hypopharyngeal cancer: The declining use of open surgery. Head & Neckn/a-n/a
CrossRef222
Byoung Chul Cho, Ki Chang Keum, Sang Joon Shin, Hye Jin Choi, Young Joo Lee, Se Hun Kim, Eun Chang Choi, Joo Hang Kim. (2009) Weekly docetaxel in patients with platinum-refractory metastatic or recurrent squamous cell carcinoma of the head and neck. Cancer Chemotherapy and Pharmacology 65:1, 27-32
CrossRef223
Fréderic Duprez, Indira Madani, Katrien Bonte, Tom Boterberg, Luc Vakaet, Cristina Derie, Werner De Gersem, Wilfried De Neve. (2009) Intensity-modulated radiotherapy for recurrent and second primary head and neck cancer in previously irradiated territory. Radiotherapy and Oncology 93:3, 563-569
CrossRef224
Minh Tam Truong, Gregory Grillone, Christine Tschoe, Lawrence Chin, Lisa Ann Kachnic, Scharukh Jalisi. (2009) Emerging applications of stereotactic radiotherapy in head and neck cancer. Neurosurgical FOCUS 27:6, E11
CrossRef225
Ibrahim T. Aldoss, Troy Plumb, Weining (Ken) Zhen, Daniel D. Lydiatt, Apar Kishor Ganti, Eben L. Rosenthal. (2009) Cetuximab in hemodialysis: A case report. Head & Neck 31:12, 1647-1650
CrossRef226
Sébastien Salas, Karine Baumstarck-Barrau, Marc Alfonsi, Laurence Digue, Danielle Bagarry, Nasreddine Feham, René Jean Bensadoun, Thierry Pignon, Anderson Loundon, Jean-Laurent Deville, Michel Zanaret, Roger Favre, Florence Duffaud, Pascal Auquier. (2009) Impact of the prophylactic gastrostomy for unresectable squamous cell head and neck carcinomas treated with radio-chemotherapy on quality of life: Prospective randomized trial. Radiotherapy and Oncology 93:3, 503-509
CrossRef227
Punita LAL, Anu TIWARI, Ashish VERMA, Koilpillai Joseph MARIA DAS, Sanjay Sharan BAIJAL, Ranjeet BAJPAI, Pavan KUMAR, Anurita SRIVASTAVA, Shaleen KUMAR. (2009) Role of videofluorography in assessing functional abnormalities in patients of head and neck cancer treated with chemoradiotherapy. Asia-Pacific Journal of Clinical Oncology 5:4, 264-269
CrossRef228
Elmer R. Cano, Stephen Y. Lai, Fatma Caylakli, Jonas T. Johnson, Robert L. Ferris, Ricardo L. Carrau, Carl H. Snyderman, William E. Gooding, Alfred A. Simenthal, Eugene N. Myers. (2009) Management of squamous cell carcinoma of the base of tongue with chemoradiation and brachytherapy. Head & Neck 31:11, 1431-1438
CrossRef229
Ian Ganly, Snehal G. Patel, Jeanette Matsuo, Bhuvanesh Singh, Dennis H. Kraus, Jay Boyle, Richard J. Wong, Nancy Lee, David G. Pfister, Ashok R. Shaha, Jatin P. Shah. (2009) Predictors of outcome for advanced-stage supraglottic laryngeal cancer. Head & Neck 31:11, 1489-1495
CrossRef230
Christine G. Gourin, Jonas T. Johnson. (2009) A contemporary review of indications for primary surgical care of patients with squamous cell carcinoma of the head and neck. The Laryngoscope 119:11, 2124-2134
CrossRef231
ChunLi Gao, Jun Pan, WeiYue Lu, Ming Zhang, Liang Zhou, Jie Tian. (2009) In-vitro evaluation of paclitaxel-loaded MPEG–PLGA nanoparticles on laryngeal cancer cells. Anti-Cancer Drugs 20:9, 807-814
CrossRef232
Lawrence D. Koutcher, Suzanne Wolden, Nancy Lee. (2009) Severe Radiation Dermatitis in Patients With Locally Advanced Head and Neck Cancer Treated With Concurrent Radiation and Cetuximab. American Journal of Clinical Oncology 32:5, 472-476
CrossRef233
Mamoru Tsukuda, Junichi Ishitoya, Yasukazu Mikami, Hideki Matsuda, Choichi Horiuchi, Takahide Taguchi, Kenichi Satake, Toshiro Kawano, Masahiro Takahashi, Goshi Nishimura, Mariko Kawakami, Yasunori Sakuma, Makiko Watanabe, Osamu Shiono, Masanori Komatsu, Yukiko Yamashita. (2009) Analysis of feasibility and toxicity of concurrent chemoradiotherapy with S-1 for locally advanced squamous cell carcinoma of the head and neck in elderly cases and/or cases with comorbidity. Cancer Chemotherapy and Pharmacology 64:5, 945-952
CrossRef234
Avi Khafif, Shahar Lev-Ari, Akiva Vexler, Itai Barnea, Alex Starr, Vicki Karaush, Sasha Haif, Rami Ben-Yosef. (2009) Curcumin: A potential radio-enhancer in head and neck cancer. The Laryngoscope 119:10, 2019-2026
CrossRef235
Pirus Ghadjar, Wieslawa Blank-Liss, Mathew Simcock, Ivan Hegyi, Karl T. Beer, Holger Moch, Daniel M. Aebersold, Yitzhak Zimmer. (2009) MET Y1253D-activating point mutation and development of distant metastasis in advanced head and neck cancers. Clinical & Experimental Metastasis 26:7, 809-815
CrossRef236
Diana Steinmann, Bettina Cerny, Johann Hinrich Karstens, Michael Bremer. (2009) Chemoradiotherapy with Weekly Cisplatin 40 mg/m2 in 103 Head-and-Neck Cancer Patients. Strahlentherapie und Onkologie 185:10, 682-688
CrossRef237
Ly Do, Ajmel Puthawala, Nisar Syed, Samar Azawi, Richard Williams, Nayana Vora. (2009) Treatment Outcomes of T4 Locally Advanced Head and Neck Cancers With Soft Tissue Invasion or Bone and Cartilage Invasion. American Journal of Clinical Oncology 32:5, 477-482
CrossRef238
Carl E. Silver, Jonathan J. Beitler, Ashok R. Shaha, Alessandra Rinaldo, Alfio Ferlito. (2009) Current trends in initial management of laryngeal cancer: the declining use of open surgery. European Archives of Oto-Rhino-Laryngology 266:9, 1333-1352
CrossRef239
O. Matzinger, A. Zouhair, R.O. Mirimanoff, M. Ozsahin. (2009) Radiochemotherapy in Locally Advanced Squamous Cell Carcinomas of the Head and Neck. Clinical Oncology 21:7, 525-531
CrossRef240
Tatsuya Nakamura, Takeshi Kodaira, Hiroyuki Tachibana, Natsuo Tomita, Jun-ichi Yokouchi, Nobukazu Fuwa. (2009) Clinical outcome of oropharyngeal carcinoma treated with platinum-based chemoradiotherapy. Oral Oncology 45:9, 830-834
CrossRef241
Jason T. Rich, Simon Milov, James S. Lewis, Wade L. Thorstad, Douglas R. Adkins, Bruce H. Haughey. (2009) Transoral laser microsurgery (TLM) ± adjuvant therapy for advanced stage oropharyngeal cancer. The Laryngoscope 119:9, 1709-1719
CrossRef242
Ariel Birnbaum, Thomas Dipetrillo, Ritesh Rathore, Elliott Anderson, Harry Wanebo, Yacoub Puthwala, Donald Joyce, Howard Safran, Denise Henderson, Theresa Kennedy, Neal Ready, Terence Tai-Weng Sio. (2009) Cetuximab, Paclitaxel, Carboplatin, and Radiation For Head and Neck Cancer. American Journal of Clinical Oncology1
CrossRef243
Francis P. Worden, Jeffrey Moyer, Julia S. Lee, Jeremy M. G. Taylor, Susan G. Urba, Avraham Eisbruch, Theodoros N. Teknos, Douglas B. Chepeha, Mark E. Prince, Norman Hogikyan, Amy Anne D. Lassig, Kevin Emerick, Suresh Mukherji, Lubomir Hadjiski, Christina I. Tsien, Tamara H. Miller, Nancy E. Wallace, Heidi L. Mason, Carol R. Bradford, Gregory T. Wolf. (2009) Chemoselection as a strategy for organ preservation in patients with T4 laryngeal squamous cell carcinoma with cartilage invasion. The Laryngoscope 119:8, 1510-1517
CrossRef244
Aron Popovtzer, Iris Gluck, Douglas B. Chepeha, Theodoros N. Teknos, Jeffrey S. Moyer, Mark E. Prince, Carol R. Bradford, Avraham Eisbruch. (2009) The Pattern of Failure After Reirradiation of Recurrent Squamous Cell Head and Neck Cancer: Implications for Defining the Targets. International Journal of Radiation Oncology*Biology*Physics 74:5, 1342-1347
CrossRef245
Michael B Prystowsky, Alfred Adomako, Richard V Smith, Nicole Kawachi, Wendy McKimpson, Peter Atadja, Quan Chen, Nicolas F Schlecht, Joanna L Parish, Geoffrey Childs, Thomas J Belbin. (2009) The histone deacetylase inhibitor LBH589 inhibits expression of mitotic genes causing G2/M arrest and cell death in head and neck squamous cell carcinoma cell lines. The Journal of Pathology 218:4, 467-477
CrossRef246
Ezra E. W. Cohen, Joshua Baru, Dezheng Huo, Daniel J. Haraf, Maureen Crowley, Mary Ellyn Witt, Elizabeth A. Blair, Ralph R. Weichselbaum, Fred Rosen, Everett E. Vokes, Kerstin Stenson. (2009) Efficacy and safety of treating T4 oral cavity tumors with primary chemoradiotherapy. Head & Neck 31:8, 1013-1021
CrossRef247
Andreas Dietz, Volker Rudat, Jens Dreyhaupt, Maria Pritsch, Florian Hoppe, Rudolph Hagen, Leo Pfreundner, Ursula Schröder, Hans Eckel, Markus Hess, Michael Schröder, Petra Schneider, Bünzel Jens, Hans P. Zenner, Jochen A. Werner, Rita Engenhardt-Cabillic, Bernhard Vanselow, Peter Plinkert, Marcus Niewald, Thomas Kuhnt, Wilfried Budach, Michael Flentje. (2009) Induction chemotherapy with paclitaxel and cisplatin followed by radiotherapy for larynx organ preservation in advanced laryngeal and hypopharyngeal cancer offers moderate late toxicity outcome (DeLOS-I-trial). European Archives of Oto-Rhino-Laryngology 266:8, 1291-1300
CrossRef248
Lilie L. Lin, Stephen M. Hahn. (2009) Combined Modality Therapy in the Elderly Population. Current Treatment Options in Oncology 10:3-4, 195-204
CrossRef249
Joshua D. Lawson, Jennifer Gaultney, Nabil Saba, William Grist, Lawrence Davis, Peter A.S. Johnstone. (2009) Percutaneous feeding tubes in patients with head and neck cancer: rethinking prophylactic placement for patients undergoing chemoradiation. American Journal of Otolaryngology 30:4, 244-249
CrossRef250
Christine G. Gourin, Bryant T. Conger, W. Chris Sheils, Paul A. Bilodeau, Teresa A. Coleman, Edward S. Porubsky. (2009) The Effect of treatment on survival in patients with advanced laryngeal carcinoma. The Laryngoscope 119:7, 1312-1317
CrossRef251
Xavier León, Montserrat López, Jacinto García, Miquel Quer. (2009) Resultados de un protocolo de preservación de órgano en pacientes con tumores localmente avanzados de la laringe. Acta Otorrinolaringológica Española 60:3, 176-185
CrossRef252
C. Arturo Solares, Benjamin Wood, Cristina P. Rodriguez, Robert R. Lorenz, Joseph Scharpf, Jerrold Saxton, Lisa A. Rybicki, Marshall Strome, Ramon Esclamado, Pierre Lavertu, David J. Adelstein. (2009) Does vocal cord fixation preclude nonsurgical management of laryngeal cancer?. The Laryngoscope 119:6, 1130-1134
CrossRef253
Nicholas Pavlidis, George Pentheroudakis, George Plataniotis. (2009) Cervical lymph node metastases of squamous cell carcinoma from an unknown primary site: a favourable prognosis subset of patients with CUP. Clinical and Translational Oncology 11:6, 340-348
CrossRef254
Cathy L Lazarus. (2009) Effects of chemoradiotherapy on voice and swallowing. Current Opinion in Otolaryngology & Head and Neck Surgery 17:3, 172-178
CrossRef255
Naoki Kunii, Shigetoshi Horiguchi, Shinichiro Motohashi, Heizaburo Yamamoto, Naoyuki Ueno, Seiji Yamamoto, Daiju Sakurai, Masaru Taniguchi, Toshinori Nakayama, Yoshitaka Okamoto. (2009) Combination therapy of in vitro -expanded natural killer T cells and α-galactosylceramide-pulsed antigen-presenting cells in patients with recurrent head and neck carcinoma. Cancer Science 100:6, 1092-1098
CrossRef256
L. Licitra, E. Felip, . (2009) Squamous cell carcinoma of the head and neck: ESMO Clinical Recommendations for diagnosis, treatment and follow-up. Annals of Oncology 20:Supplement 4, iv121-iv122
CrossRef257
Sarah L Scarpace, Frank A Brodzik, Syed Mehdi, Robert Belgam. (2009) Treatment of Head and Neck Cancers: Issues for Clinical Pharmacists. Pharmacotherapy 29:5, 578-592
CrossRef258
Nabil F Saba, Fadlo R Khuri. (2009) Optimizing systemic therapy in squamous cell carcinoma of the head and neck with a focus on targeted agents. Current Opinion in Oncology 21:3, 232-237
CrossRef259
R. Knecht. (2009) Strahlen-, Chemo- und Targettherapie von Kopf-Hals-Karzinomen. HNO 57:5, 436-445
CrossRef260
Giovanni Franchin, Emanuela Vaccher, Doriano Politi, Emilio Minatel, Carlo Gobitti, Renato Talamini, Simon Spazzapan, Maria Gabriella Savignano, Mauro G. Trovò, Luigi Barzan. (2009) Organ preservation in locally advanced head and neck cancer of the larynx using induction chemotherapy followed by improved radiation schemes. European Archives of Oto-Rhino-Laryngology 266:5, 719-726
CrossRef261
T Nakashima, T Mihoki, T Ono, H Umeno, N Tanaka. (2009) Selective (intra-arterial), rapid infusion chemo-radiotherapy to preserve the larynx in advanced laryngeal carcinoma: preliminary results. The Journal of Laryngology & Otology 123:S31, 30
CrossRef262
Sreenivasa R Chandana, Barbara A Conley. (2009) Neoadjuvant chemotherapy for locally advanced squamous cancers of the head and neck: current status and future prospects. Current Opinion in Oncology 21:3, 218-223
CrossRef263
Arno Olthoff, Andreas Ewen, Hendrik Andreas Wolff, Robert Michael Hermann, Hilke Vorwerk, Andrea Hille, Ralph Rödel, Clemens F. Hess, Wolfgang Steiner, Olivier Pradier, Hans Christiansen. (2009) Organ Function and Quality of Life after Transoral Laser Microsurgery and Adjuvant Radiotherapy for Locally Advanced Laryngeal Cancer. Strahlentherapie und Onkologie 185:5, 303-309
CrossRef264
Jean-Louis Lefebvre, K. Kian Ang. (2009) Larynx Preservation Clinical Trial Design: Key Issues and Recommendations—A Consensus Panel Summary. International Journal of Radiation Oncology*Biology*Physics 73:5, 1293-1303
CrossRef265
Jean-Louis Lefebvre, K. Kian Ang, . (2009) Larynx preservation clinical trial design: Key issues and recommendations-A consensus panel summary. Head & Neck 31:4, 429-441
CrossRef266
Jatin P. Shah, Ziv Gil. (2009) Current concepts in management of oral cancer – Surgery. Oral Oncology 45:4-5, 394-401
CrossRef267
Yi-Fen Wang, Ren-Shyan Liu, Pen-Yuan Chu, Feng-Chi Chang, Shyh-Kuan Tai, Tung-Lung Tsai, Jui-Lin Huang, Shyue-Yih Chang. (2009) Positron emission tomography in surveillance of head and neck squamous cell carcinoma after definitive chemoradiotherapy. Head & Neck 31:4, 442-451
CrossRef268
Renaud Mazeron, Yungan Tao, Antoine Lusinchi, Jean Bourhis. (2009) Current concepts of management in radiotherapy for head and neck squamous-cell cancer. Oral Oncology 45:4-5, 402-408
CrossRef269
Pol M. Specenier, Jan B. Vermorken. (2009) Current concepts for the management of head and neck cancer: Chemotherapy. Oral Oncology 45:4-5, 409-415
CrossRef270
Stefan Michiels, Aurélie Le Maître, Marc Buyse, Tomasz Burzykowski, Emilie Maillard, Jan Bogaerts, Jan B Vermorken, Wilfried Budach, Thomas F Pajak, Kian K Ang, Jean Bourhis, Jean-Pierre Pignon. (2009) Surrogate endpoints for overall survival in locally advanced head and neck cancer: meta-analyses of individual patient data. The Lancet Oncology 10:4, 341-350
CrossRef271
Y. Pointreau, P. Garaud, S. Chapet, C. Sire, C. Tuchais, J. Tortochaux, S. Faivre, S. Guerrif, M. Alfonsi, G. Calais. (2009) Randomized Trial of Induction Chemotherapy With Cisplatin and 5-Fluorouracil With or Without Docetaxel for Larynx Preservation. JNCI Journal of the National Cancer Institute 101:7, 498-506
CrossRef272
Ajay Tejwani, Shenhong Wu, Yuxia Jia, Mark Agulnik, Laura Millender, Mario E. Lacouture. (2009) Increased risk of high-grade dermatologic toxicities with radiation plus epidermal growth factor receptor inhibitor therapy. Cancer 115:6, 1286-1299
CrossRef273
K. Bénézery, J. Thariat, C. Ortholan. (2009) La radiochimiothérapie dans les carcinomes épidermoïdes des voies aérodigestives supérieures. Oncologie 11:3, 140-146
CrossRef274
Eric M. Genden, Shaun Desai, Chih-Kwang Sung. (2009) Transoral robotic surgery for the management of head and neck cancer: A preliminary experience. Head & Neck 31:3, 283-289
CrossRef275
Ryan J Burri, Nancy Y Lee. (2009) Concurrent chemotherapy and radiotherapy for head and neck cancer. Expert Review of Anticancer Therapy 9:3, 293-302
CrossRef276
C Ko, D Citrin. (2009) Radiotherapy for the management of locally advanced squamous cell carcinoma of the head and neck. Oral Diseases 15:2, 121-132
CrossRef277
Susan E. Langmore, Gregory Grillone, Alphi Elackattu, Michael Walsh. (2009) Disorders of Swallowing: Palliative Care. Otolaryngologic Clinics of North America 42:1, 87-105
CrossRef278
Miriam N. Lango. (2009) Multimodal Treatment for Head and Neck Cancer. Surgical Clinics of North America 89:1, 43-52
CrossRef279
A. A. Forastiere, A. M. Trotti. (2009) Searching for Less Toxic Larynx Preservation: A Need for Common Definitions and Metrics. JNCI Journal of the National Cancer Institute 101:3, 129-131
CrossRef280
J. L. Lefebvre, F. Rolland, M. Tesselaar, E. Bardet, C. R. Leemans, L. Geoffrois, P. Hupperets, L. Barzan, D. de Raucourt, D. Chevalier, L. Licitra, F. Lunghi, R. Stupp, D. Lacombe, J. Bogaerts, J. C. Horiot, J. Bernier, J. B. Vermorken, . (2009) Phase 3 Randomized Trial on Larynx Preservation Comparing Sequential vs Alternating Chemotherapy and Radiotherapy. JNCI Journal of the National Cancer Institute 101:3, 142-152
CrossRef281
Masako Uno, Takeshi Akisada, Teruhito Aihara, Toshihiro Tachi, Kenji Fukutsuji, Tamotsu Harada. (2009) Superselective Intra-Arterial Chemo-Radiotherapy for Oral Cancer. Practica Oto-Rhino-Laryngologica 102:4, 267-271
CrossRef282
Jacques Bernier. (2009) Current State-of-the-Art for Concurrent Chemoradiation. Seminars in Radiation Oncology 19:1, 3-10
CrossRef283
David J. Adelstein, James Moon, Ehab Hanna, P. G. Shankar Giri, Glenn M. Mills, Gregory T. Wolf, Susan G. Urba. (2009) Docetaxel, cisplatin, and fluorouracil induction chemotherapy followed by accelerated fractionation/concomitant boost radiation and concurrent cisplatin in patients with advanced squamous cell head and neck cancer: A Southwest Oncology Group phase II trial (S0216). Head & NeckNA-NA
CrossRef284
John M. Watkins, A. Jason Zauls, Amy H. Wahlquist, Keisuke Shirai, Elizabeth Garrett-Mayer, M. Boyd Gillespie, Terry A. Day, Anand K. Sharma. (2009) Low-dose weekly platinum-based chemoradiation for advanced head and neck cancer. The LaryngoscopeNA-NA
CrossRef285
Kyung Tae, Kwang Soo Shin, Tae Heon Kim, Ji Hoon Shin, Jin Hyeok Jeong, Tae Hwan Ahn, Ha Chung Chun, Myung Za Lee. (2009) The Treatment Outcome of Hypopharynx Cancer: Surgery versus Organ Preservation Therapy. Korean Journal of Otorhinolaryngology-Head and Neck Surgery 52:8, 688
CrossRef286
Steven B. Cannady, Walter T. Lee, Joseph Scharpf, Robert R. Lorenz, Benjamin G. Wood, Marshall Strome, Pierre Lavertu, Ramon M. Esclamado, Jerrold P. Saxton, David J. Adelstein. (2009) Extent of neck dissection required after concurrent chemoradiation for stage IV head and neck squamous cell carcinoma. Head & NeckNA-NA
CrossRef287
David M. Brizel, Everett E. Vokes. (2009) Induction Chemotherapy: To Use or Not to Use? That Is the Question. Seminars in Radiation Oncology 19:1, 11-16
CrossRef288
Richard L. Scher, Ramon M. Esclamado. (2009) Organ and Function Preservation: The Role of Surgery as the Optimal Primary Modality or as Salvage After Chemoradiation Failure. Seminars in Radiation Oncology 19:1, 17-23
CrossRef289
Laura A. Goguen, Charles M. Norris, Michael T. Jaklitsch, Christopher A. Sullivan, Marshall R. Posner, Robert I. Haddad, Roy B. Tishler, Elaine Burke, Donald J. Annino. (2009) Combined antegrade and retrograde esophageal dilation for head and neck cancer-related complete esophageal stenosis. The Laryngoscopen/a-n/a
CrossRef290
Isabel Vilaseca, Manuel Bernal-Sprekelsen, José Luis Blanch. (2009) Transoral laser microsurgery for T3 laryngeal tumors: Prognostic factors. Head & NeckNA-NA
CrossRef291
Xiaoying Yin, Hong Zhang, Karen Lundgren, Lynn Wilson, Francis Burrows, Carol G. Shores. (2009) BIIB021, a novel HSP90 inhibitor, sensitizes head and neck squamous cell carcinoma to radiotherapy. International Journal of CancerNA-NA
CrossRef292
Hiang Khoon Tan, Roland Giger, Anne Auperin, Jean Bourhis, François Janot, Stephane Temam. (2009) Salvage surgery after concomitant chemoradiation in head and neck squamous cell carcinomas-Stratification for postsalvage survival. Head & NeckNA-NA
CrossRef293
George Fountzilas, Anna Kalogera-Fountzila, Sophia Lambaki, Ralph M. Wirtz, Angelos Nikolaou, Georgia Karayannopoulou, Mattheos Bobos, Vassiliki Kotoula, Samuel Murray, Alexandros Lambropoulos, Gerasimos Aravantinos, Konstantinos Markou, Eleni Athanassiou, Despina Misailidou, Konstantine T. Kalogeras, Demosthenis Skarlos. (2009) MMP9 but Not EGFR, MET, ERCC1, P16, and P-53 Is Associated with Response to Concomitant Radiotherapy, Cetuximab, and Weekly Cisplatin in Patients with Locally Advanced Head and Neck Cancer. Journal of Oncology 2009, 1-17
CrossRef294
Kerry D. Olsen. (2009) Reexamining the treatment of advanced laryngeal cancer. Head & NeckNA-NA
CrossRef295
A. Kubota. (2009) Effectiveness of Concurrent Chemoradiotherapy for Organ Preservation in T3 and T4 Locally Advanced Laryngeal Cancers. Nihon Kikan Shokudoka Gakkai Kaiho 60:2, 90-92
CrossRef296
Xiao Jie Ma, Xin Liang Pan, Zheng Hua Lv, Feng Lei Xu, Da Yu Liu, Da Peng Lei, Ming Xia, Xin Yong Luan. (2009) Therapeutic influence on circulating and monocyte-derived dendritic cells in laryngeal squamous cell carcinoma patients. Acta Oto-laryngologica 129:1, 84-91
CrossRef297
Naoki Otsuki, Miki Saito, Ken-ichi Nibu. (2009) The role of chemoradiotherapy in the treatment of laryngeal cancer. JOURNAL OF JAPAN SOCIETY FOR HEAD AND NECK SURGERY 19:1, 5-11
CrossRef298
Takashi Nasu, Shuji Koike, Daisuke Noda, Akihiro Ishida, Masaru Aoyagi. (2009) Stages III and IV Laryngeal Carcinomas: Long-term Results of Treatment and Indications for Laryngeal Preservation. Nihon Kikan Shokudoka Gakkai Kaiho 60:6, 457-463
CrossRef299
Ji Heui Kim, Yoon Se Lee, Min Su Kwon, Jong-Lyel Roh, Seung-Ho Choi, Sang Yoon Kim, Soon Yuhl Nam. (2009) Clinical Outcome of Salvage Treatment for Recurrent Supraglottic Cancer. Korean Journal of Otolaryngology-Head and Neck Surgery 52:5, 419
CrossRef300
Laura Ellen Millender. 2009. Complications of Radiation Therapy. , 167-179.
CrossRef301
Jean Louis Lefebvre. (2009) Surgery for Laryngopharyngeal SCC in the Era of Organ Preservation. Clinical and Experimental Otorhinolaryngology 2:4, 159
CrossRef302
Young Joo Lee, Chang Geol Lee, Byoung Chul Cho, Gwi Eon Kim, Hye Jin Choi, Eun Chang Choi, Joo Hyuk Sohn, Joo-Hang Kim. (2009) Weekly 5-fluorouracil plus cisplatin for concurrent chemoradiotherapy in patients with locally advanced head and neck cancer. Head & NeckNA-NA
CrossRef303
Richard V. Smith. 2009. Complications of Laryngeal Surgery. , 387-403.
CrossRef304
Jagruti A. Patel, Forum G. Shah, Jagdish M. Kothari, Kaustubh D. Patel. (2009) Prevalence of head and neck cancers in Ahmedabad, Gujarat. Indian Journal of Otolaryngology and Head & Neck Surgery 61:S1, 4-10
CrossRef305
John P. Kostrzewa, William P. Lancaster, Tim A. Iseli, Renee A. Desmond, William R. Carroll, Eben L. Rosenthal. (2009) Outcomes of salvage surgery with free flap reconstruction for recurrent oral and oropharyngeal cancer. The Laryngoscopen/a-n/a
CrossRef306
Missak Haigentz. 2009. Chemotherapy in Head and Neck Cancer. , 181-188.
CrossRef307
Susannah Yovino, Kathleen Settle, Rodney Taylor, Jeffrey Wolf, Young Kwok, Kevin Cullen, Robert Ord, Ann Zimrin, Scott Strome, Mohan Suntharalingam. (2009) Patterns of failure among patients with squamous cell carcinoma of the head and neck who obtain a complete response to chemoradiotherapy. Head & NeckNA-NA
CrossRef308
Miriam N. Lango, Jeffrey N. Myers, Adam S. Garden. (2009) Controversies in Surgical Management of the Node-Positive Neck After Chemoradiation. Seminars in Radiation Oncology 19:1, 24-28
CrossRef309
Gregory T. Wolf. (2009) Reexamining the treatment of advanced laryngeal cancer: The VA laryngeal cancer study revisited. Head & NeckNA-NA
CrossRef310
Arlene A. Forastiere. (2009) Larynx preservation and survival trends: Should there be concern?. Head & NeckNA-NA
CrossRef311
Xavier León, Montserrat López, Jacinto García, Miquel Quer. (2009) Results of an organ conservation protocol in patients with locally advanced laryngeal tumours. Acta Otorrinolaringologica (English Edition) 60:3, 176-185
CrossRef312
Rohan R. Walvekar, Ryan J. Li, William E. Gooding, Michael K. Gibson, Dwight Heron, Jonas T. Johnson, Robert L. Ferris. (2008) Role of Surgery in Limited (T1-2, N0-1) Cancers of the Oropharynx. The Laryngoscope 118:12, 2129-2134
CrossRef313
Cristina P. Rodriguez, David J. Adelstein, Lisa A. Rybicki, Jerrold P. Saxton, Robert R. Lorenz, Benjamin G. Wood, Marshall Strome, Ramon M. Esclamado, Pierre Lavertu, Marjorie A. Carroll. (2008) Clinical predictors of larynx preservation after multiagent concurrent chemoradiotherapy. Head & Neck 30:12, 1535-1542
CrossRef314
Peter Mu-Hsin Chang, Po-Min Chen, Pen-Yuan Chu, Ling-Wei Wang, Shyh-Kuan Tai, Tung-Lung Tsai, Jui-Lin Huang, Yi-Fen Wang, Shyue-Yih Chang, Muh-Hwa Yang. (2008) Effectiveness of pharmacokinetic modulating chemotherapy combined with cisplatin as induction chemotherapy in resectable locally advanced head and neck cancer: phase II study. Cancer Chemotherapy and Pharmacology 63:1, 9-17
CrossRef315
Yasushi Furuta, Akihiro Homma, Nobuhiko Oridate, Fumiyuki Suzuki, Hiromitsu Hatakeyama, Keishiro Suzuki, Takeshi Nishioka, Hiroki Shirato, Satoshi Fukuda. (2008) Surgical complications of salvage total laryngectomy following concurrent chemoradiotherapy. International Journal of Clinical Oncology 13:6, 521-527
CrossRef316
Thomas J. Belbin, Nicolas F. Schlecht, Richard V. Smith, Leslie R. Adrien, Nicole Kawachi, Margaret Brandwein-Gensler, Aviv Bergman, Quan Chen, Geoffrey Childs, Michael B. Prystowsky. (2008) Site-Specific Molecular Signatures Predict Aggressive Disease in HNSCC. Head and Neck Pathology 2:4, 243-256
CrossRef317
Jochen H. Lorch, Marshall R. Posner, Lori J. Wirth, Robert I. Haddad. (2008) Induction Chemotherapy in Locally Advanced Head and Neck Cancer: A New Standard of Care?. Hematology/Oncology Clinics of North America 22:6, 1155-1163
CrossRef318
Jeffrey S. Moyer, Ji Li, Shuang Wei, Seagal Teitz-Tennenbaum, Alfred E. Chang. (2008) Intratumoral Dendritic Cells and Chemoradiation for the Treatment of Murine Squamous Cell Carcinoma. Journal of Immunotherapy 31:9, 885-895
CrossRef319
E Soudry, Y Marmor, A Hazan, S Marx, R Sadov, R Feinmesser. (2008) Supracricoid partial laryngectomy: an alternative to total laryngectomy for locally advanced laryngeal cancers. The Journal of Laryngology & Otology 122:11, 1219
CrossRef320
Hale B. Caglar, Roy B. Tishler, Megan Othus, Elaine Burke, Yi Li, Laura Goguen, Lori J. Wirth, Robert I. Haddad, Carl M. Norris, Laurence E. Court, Donald J. Aninno, Marshall R. Posner, Aaron M. Allen. (2008) Dose to Larynx Predicts for Swallowing Complications After Intensity-Modulated Radiotherapy. International Journal of Radiation Oncology*Biology*Physics 72:4, 1110-1118
CrossRef321
J.A. Wilson. (2008) Does Pharma Fund the Pipers? – Scottish Intercollegiate Guidelines Network (SIGN) Guidelines 90 — Diagnosis and Management of Head and Neck Cancer, October 2006. Clinical Oncology 20:9, 661-663
CrossRef322
David I. Rosenthal, Mark S. Chambers, Clifton D. Fuller, Neal C.S. Rebueno, John Garcia, Merrill S. Kies, William H. Morrison, K. Kian Ang, Adam S. Garden. (2008) Beam Path Toxicities to Non-Target Structures During Intensity-Modulated Radiation Therapy for Head and Neck Cancer. International Journal of Radiation Oncology*Biology*Physics 72:3, 747-755
CrossRef323
Ramesh Rengan, David G. Pfister, Nancy Y. Lee, Dennis H. Kraus, Jatin P. Shah, Ashok R. Shaha, Leah S. Ben-Porat, Michael J. Zelefsky. (2008) Long-term Neck Control Rates After Complete Response to Chemoradiation in Patients With Advanced Head and Neck Cancer. American Journal of Clinical Oncology 31:5, 465-469
CrossRef324
Volker Rudat, Hans Eckel, Peter Volling, Michael Schröder, Susanne Staar, Frank Wallner, Michael Wannenmacher, Andreas Dietz. (2008) Long-term results of a prospective multicenter phase II study to preserve the larynx function using concomitant boost radiochemotherapy with Carboplatin. Radiotherapy and Oncology 89:1, 33-37
CrossRef325
Kyle E. Rusthoven, David Raben, Changhu Chen. (2008) Improved Survival in Patients With Stage III-IV Head and Neck Cancer Treated With Radiotherapy as Primary Local Treatment Modality. International Journal of Radiation Oncology*Biology*Physics 72:2, 343-350
CrossRef326
SV Porceddu, M Sidhom, M Foote, E Burmeister, A Stoneley, B El Hawwari, C Milross, L Kenny, M Poulsen, WB Coman. (2008) Predicting regional control based on pretreatment nodal size in squamous cell carcinoma of the head and neck treated with chemoradiotherapy: A clinican’s guide. Journal of Medical Imaging and Radiation Oncology 52:5, 491-496
CrossRef327
David M. Cognetti, Randal S. Weber, Stephen Y. Lai. (2008) Head and neck cancer. Cancer 113:S7, 1911-1932
CrossRef328
Marco Benasso, Viviana Vigo, Almalina Bacigalupo, Anna Ponzanelli, Michela Marcenaro, Renzo Corvò, Giovanni Margarino. (2008) A phase II trial of low-dose gemcitabine and radiation alternated to cisplatin and 5-fluorouracil: An active and manageable regimen for stage IV squamous cell carcinoma of the head and neck. Radiotherapy and Oncology 89:1, 44-50
CrossRef329
Narissa J. Nonzee, Neal A. Dandade, Talar Markossian, Mark Agulnik, Athanassios Argiris, Jyoti D. Patel, Robert C. Kern, Hidayatullah G. Munshi, Elizabeth A. Calhoun, Charles L. Bennett. (2008) Evaluating the supportive care costs of severe radiochemotherapy-induced mucositis and pharyngitis. Cancer 113:6, 1446-1452
CrossRef330
Haddad, Robert I., Shin, Dong M., . (2008) Recent Advances in Head and Neck Cancer. New England Journal of Medicine 359:11, 1143-1154
Full Text331
Jordi Giralt, Sergi Benavente. (2008) Controversies surrounding the use of neoadjuvant chemotherapy in locally advanced head and neck cancer. Expert Review of Anticancer Therapy 8:9, 1359-1363
CrossRef332
André Fortin, Richard Caouette, Chang Shu Wang, Éric Vigneault. (2008) A Comparison of Treatment Outcomes by Radiochemotherapy and Postoperative Radiotherapy in Locally Advanced Squamous Cell Carcinomas of Head and Neck. American Journal of Clinical Oncology 31:4, 379-383
CrossRef333
Y J Choi, J S Chung, H-J Shin, G J Cho, S G Wang, B J Lee, B M Cho, Y D Joo, C H Sohn. (2008) Induction chemotherapy with S-1 plus cisplatin in patients with locally advanced squamous cell carcinoma of the head and neck. The Journal of Laryngology & Otology 122:08,
CrossRef334
Dimitrios Nikolarakos, R. Bryan Bell. (2008) Management of the Node-Positive Neck in Oral Cancer. Oral and Maxillofacial Surgery Clinics of North America 20:3, 499-511
CrossRef335
Boris Hristov, Gopal K. Bajaj. (2008) Radiotherapeutic Management of Laryngeal Carcinoma. Otolaryngologic Clinics of North America 41:4, 715-740
CrossRef336
Heather M. Starmer, Donna C. Tippett, Kimberly T. Webster. (2008) Effects of Laryngeal Cancer on Voice and Swallowing. Otolaryngologic Clinics of North America 41:4, 793-818
CrossRef337
Nishant Agrawal, David Goldenberg. (2008) Primary and Salvage Total Laryngectomy. Otolaryngologic Clinics of North America 41:4, 771-780
CrossRef338
Adam S. Garden, Jonathan Harris, Andy Trotti, Christopher U. Jones, Luis Carrascosa, Jonathan D. Cheng, Sharon S. Spencer, Arlene Forastiere, Randal S. Weber, K. Kian Ang. (2008) Long-Term Results of Concomitant Boost Radiation Plus Concurrent Cisplatin for Advanced Head and Neck Carcinomas: A Phase II Trial of the Radiation Therapy Oncology Group (RTOG 99-14). International Journal of Radiation Oncology*Biology*Physics 71:5, 1351-1355
CrossRef339
S.-K. Tai, M.-H. Yang, L.-W. Wang, T.-L. Tsai, P.-Y. Chu, Y.-F. Wang, J.-L. Huang, S.-Y. Chang. (2008) Chemoradiotherapy Laryngeal Preservation for Advanced Hypopharyngeal Cancer. Japanese Journal of Clinical Oncology 38:8, 521-527
CrossRef340
H J Jun, M J Ahn, H S Kim, S Y Yi, J Han, S K Lee, Y C Ahn, H-S Jeong, Y-I Son, J-H Baek, K Park. (2008) ERCC1 expression as a predictive marker of squamous cell carcinoma of the head and neck treated with cisplatin-based concurrent chemoradiation. British Journal of Cancer 99:1, 167-172
CrossRef341
Fernando Rivera, M. Eugenia Vega-Villegas, Marta López-Brea, Dolores Isla, Marta Mayorga, Piedad Galdós, Antonio Rubio, Adolfo Valle, Fe García-Reija, Belen García-Montesinos, Julio Rodríguez-Iglesias, Jose Mayordomo, Julio Rama, Ramón Saiz-Bustillo, Jaime Sanz-Ortiz. (2008) Randomized phase II study of cisplatin and 5-FU continuous infusion (PF) versus cisplatin, UFT and vinorelbine (UFTVP) as induction chemotherapy in locally advanced squamous cell head and neck cancer (LA-SCHNC). Cancer Chemotherapy and Pharmacology 62:2, 253-261
CrossRef342
Olivier Ballivy, Ramón Galiana Santamaría, Alicia Lozano Borbalas, Ferrán Guedea Edo. (2008) Clinical application of intensity-modulated radiotherapy for head and neck cancer. Clinical and Translational Oncology 10:7, 407-414
CrossRef343
Jimmy J. Caudell, Stephen M. Sawrie, Sharon A. Spencer, Renee A. Desmond, William R. Carroll, Glenn E. Peters, Lisle M. Nabell, Ruby F. Meredith, James A. Bonner. (2008) Locoregionally Advanced Head and Neck Cancer Treated With Primary Radiotherapy: A Comparison of the Addition of Cetuximab or Chemotherapy and the Impact of Protocol Treatment. International Journal of Radiation Oncology*Biology*Physics 71:3, 676-681
CrossRef344
Theodore R. McRackan, John M. Watkins, Amy E. Herrin, Elizabeth M. Garrett-Mayer, Anand K. Sharma, Terry A. Day, M Boyd Gillespie, . (2008) Effect of Body Mass Index on Chemoradiation Outcomes in Head and Neck Cancer. The Laryngoscope 118:7, 1180-1185
CrossRef345
Jacques Bernier, Conny Vrieling. (2008) Docetaxel in the management of patients with head and neck squamous cell carcinoma. Expert Review of Anticancer Therapy 8:7, 1023-1032
CrossRef346
Bhuvanesh Singh. (2008) Molecular pathogenesis of head and neck cancers. Journal of Surgical Oncology 97:8, 634-639
CrossRef347
Corey J. Langer. (2008) Targeted therapy in head and neck cancer. Cancer 112:12, 2635-2645
CrossRef348
Arlene A. Forastiere. (2008) Chemotherapy in the treatment of locally advanced head and neck cancer. Journal of Surgical Oncology 97:8, 701-707
CrossRef349
Nancy Y. Lee, Quynh-Thu Le. (2008) New Developments in Radiation Therapy for Head and Neck Cancer: Intensity-Modulated Radiation Therapy and Hypoxia Targeting. Seminars in Oncology 35:3, 236-250
CrossRef350
Kathryn M. Greven, Douglas R. White, J Dale Browne, Daniel W. Williams, W Fred McGuirt, Ralph B. DʼAgostino. (2008) Swallowing Dysfunction is a Common Sequelae After Chemoradiation for Oropharynx Carcinoma. American Journal of Clinical Oncology 31:3, 209-212
CrossRef351
Ari Ballonoff, David Raben, Kyle E. Rusthoven, Michael Bassetti, Madeleine Kane, John I. Song, Changhu Chen. (2008) Outcomes of Patients with N3 Neck Nodes Treated with Chemoradiation. The Laryngoscope 118:6, 995-998
CrossRef352
Rubén Cabanillas, Juan Pablo Rodrigo, Jose Luis Llorente, Carlos Suárez. (2008) Oncologic outcomes of transoral laser surgery of supraglottic carcinoma compared with a transcervical approach. Head & Neck 30:6, 750-755
CrossRef353
Kenneth A. Krohn, Bevan Yeuh. (2008) Novel Imaging Approaches to Head and Neck Cancer. Seminars in Oncology 35:3, 262-273
CrossRef354
C. Simon, P.K. Plinkert. (2008) Multimodale Therapiestrategien bei der Behandlung von Kopf- und Halskarzinomen. HNO 56:6, 575-584
CrossRef355
Joseph K. Salama, Everett E. Vokes. (2008) Concurrent Chemotherapy and Re-irradiation for Locoregionally Recurrent Head and Neck Cancer. Seminars in Oncology 35:3, 251-261
CrossRef356
Hiroshi Iwai, Hisaya Yukawa, Motoki Nagata, Toshiya Inoue, Mariko Omae, Toshio Yamashita. (2008) Preoperative concurrent chemoradiotherapy versus pre- and postoperative radiotherapy for advanced hypopharyngeal carcinoma: A single-center study. Auris Nasus Larynx 35:2, 235-241
CrossRef357
Laurent Laccourreye, Dominique Garcia, Madeleine Ménard, Daniel Brasnu, Ollivier Laccourreye, F. Christopher Holsinger. (2008) Horizontal supraglottic partial laryngectomy for selected squamous carcinoma of the vallecula. Head & Neck 30:6, 756-764
CrossRef358
Naohiro Wakisaka, Shigeyuki Murono, Satoru Kondo, Mitsuru Furukawa, Tomokazu Yoshizaki. (2008) Post-operative pharyngocutaneous fistula after laryngectomy. Auris Nasus Larynx 35:2, 203-208
CrossRef359
David J. Adelstein, Cristina P. Rodriguez. (2008) Current and Emerging Standards of Concomitant Chemoradiotherapy. Seminars in Oncology 35:3, 211-220
CrossRef360
B. R. Knab, J. K. Salama, A. Solanki, K. M. Stenson, E. E. Cohen, M. E. Witt, D. J. Haraf, E. E. Vokes. (2008) Functional organ preservation with definitive chemoradiotherapy for T4 laryngeal squamous cell carcinoma. Annals of Oncology 19:9, 1650-1654
CrossRef361
Juan J. Cruz, Alberto Ocaña, Miguel Navarro, Elvira Del Barco, Emilio Fonseca. (2008) New options in the treatment of locally advanced head and neck cancer: Role for induction chemotherapy. Cancer Treatment Reviews 34:3, 268-274
CrossRef362
Gabriela Verena Kornek, Edgar Selzer. (2008) Organerhaltende Therapiemodalitäten – welche Therapie für welches Karzinom?. Wiener Medizinische Wochenschrift 158:9-10, 264-269
CrossRef363
F. J. P. Hoebers, D. Pluim, A. A. M. Hart, M. Verheij, A. J. M. Balm, G. Fons, C. R. N. Rasch, J. H. M. Schellens, L. J. A. Stalpers, H. Bartelink, A. C. Begg. (2008) Cisplatin-DNA adduct formation in patients treated with cisplatin-based chemoradiation: lack of correlation between normal tissues and primary tumor. Cancer Chemotherapy and Pharmacology 61:6, 1075-1081
CrossRef364
Sébastien Salas, Jean-Laurent Deville, Roch Giorgi, Thierry Pignon, Danielle Bagarry, Karine Barrau, Michel Zanaret, Antoine Giovanni, Aude Bourgeois, Roger Favre, Florence Duffaud. (2008) Nutritional factors as predictors of response to radio-chemotherapy and survival in unresectable squamous head and neck carcinoma. Radiotherapy and Oncology 87:2, 195-200
CrossRef365
Hans E. Eckel, Ursula Schröder, Markus Jungehülsing, Orlando Guntinas-Lichius, Michael Markitz, Wolfgang Raunik. (2008) Indikationen zur chirurgischen Therapie von Larynx- und Hypopharynxkarzinomen. Wiener Medizinische Wochenschrift 158:9-10, 255-263
CrossRef366
Jergin Chen, Dennis Charles Shrieve, Ying Jia Hitchcock. (2008) Comparison of cervical esophagus dose-volumes for three radiotherapy techniques for head and neck cancer. Radiotherapy and Oncology 87:2, 274-280
CrossRef367
Athanassios Argiris, Michalis V Karamouzis, David Raben, Robert L Ferris. (2008) Head and neck cancer. The Lancet 371:9625, 1695-1709
CrossRef368
J. Wang, R. R. Seethala, Q. Zhang, W. Gooding, C. van Waes, H. Hasegawa, R. L. Ferris. (2008) Autocrine and Paracrine Chemokine Receptor 7 Activation in Head and Neck Cancer: Implications for Therapy. JNCI Journal of the National Cancer Institute 100:7, 502-512
CrossRef369
S. Ghoshal, J.S. Goda, I. Mallick, T.S. Kehwar, S.C. Sharma. (2008) Concomitant Boost Radiotherapy Compared with Conventional Radiotherapy in Squamous Cell Carcinoma of the Head and Neck — a Phase III Trial from a Single Institution in India. Clinical Oncology 20:3, 212-220
CrossRef370
Aron Popovtzer, Avraham Eisbruch. (2008) Advances in radiation therapy of head and neck cancer. Expert Review of Anticancer Therapy 8:4, 633-644
CrossRef371
Daniel F. Brasnu, Dana M. Hartl. (2008) The Laryngologist in Organ Preservation for Laryngeal Cancer. The Laryngoscope 118:4, 759-760
CrossRef372
Steve C Lee, Carol G Shores, Mark C Weissler. (2008) Salvage surgery after failed primary concomitant chemoradiation. Current Opinion in Otolaryngology & Head and Neck Surgery 16:2, 135-140
CrossRef373
S. Marur, A. A. Forastiere. (2008) Head and Neck Cancer: Changing Epidemiology, Diagnosis, and Treatment. Mayo Clinic Proceedings 83:4, 489-501
CrossRef374
J H Gibcus, M F Mastik, L Menkema, G H de Bock, Ph M Kluin, Ed Schuuring, J E van der Wal. (2008) Cortactin expression predicts poor survival in laryngeal carcinoma. British Journal of Cancer 98:5, 950-955
CrossRef375
(2008) Treatment of Head and Neck Cancer. New England Journal of Medicine 358:10, 1076-1078
Full Text376
Johan Bussink, Albert J van der Kogel, Johannes HAM Kaanders. (2008) Activation of the PI3-K/AKT pathway and implications for radioresistance mechanisms in head and neck cancer. The Lancet Oncology 9:3, 288-296
CrossRef377
Joshua D. Lawson, Kristen Otto, Amy Chen, Dong M. Shin, Lawrence Davis, Peter A. S. Johnstone. (2008) Concurrent platinum-based chemotherapy and simultaneous modulated accelerated radiation therapy for locally advanced squamous cell carcinoma of the tongue base. Head & Neck 30:3, 327-335
CrossRef378
Raul Pellini, Barbara Pichi, Paolo Ruscito, Alberto Rinaldi Ceroni, Umberto Caliceti, Giuseppe Rizzotto, Antonio Pazzaia, Pasquale Laudadio, Cesare Piazza, Giorgio Peretti, Diana Giannarelli, Giuseppe Spriano. (2008) Supracricoid partial laryngectomies after radiation failure: A multi-institutional series. Head & Neck 30:3, 372-379
CrossRef379
F. Christopher Holsinger. (2008) Swing of the pendulum: Optimizing functional outcomes in larynx cancer. Current Oncology Reports 10:2, 170-175
CrossRef380
Dirk Rades, Monika Stoehr, Nadja Kazic, Samer G. Hakim, Annette Walz, Steven E. Schild, Juergen Dunst. (2008) Locally Advanced Stage IV Squamous Cell Carcinoma of the Head and Neck: Impact of Pre-Radiotherapy Hemoglobin Level and Interruptions During Radiotherapy. International Journal of Radiation Oncology*Biology*Physics 70:4, 1108-1114
CrossRef381
Urjeet A. Patel, Kunal H. Thakkar, Nathaniel Holloway. (2008) Patient Compliance to Radiation for Advanced Head and Neck Cancer at a Tertiary Care County Hospital. The Laryngoscope 118:3, 428-432
CrossRef382
Michelle L. Klem, James G. Mechalakos, Suzanne L. Wolden, Michael J. Zelefsky, Bhuvanesh Singh, Dennis Kraus, Ashok Shaha, Jatin Shah, David G. Pfister, Nancy Y. Lee. (2008) Intensity-Modulated Radiotherapy for Head and Neck Cancer of Unknown Primary: Toxicity and Preliminary Efficacy. International Journal of Radiation Oncology*Biology*Physics 70:4, 1100-1107
CrossRef383
Mauro Palazzi, Stefano Tomatis, Ester Orlandi, Marco Guzzo, Claudia Sangalli, Paolo Potepan, Simona Fantini, Cristiana Bergamini, Cecilia Gavazzi, Lisa Licitra, Gabriele Scaramellini, Giulio Cantu', Patrizia Olmi. (2008) Effects of Treatment Intensification on Acute Local Toxicity During Radiotherapy for Head and Neck Cancer: Prospective Observational Study Validating CTCAE, Version 3.0, Scoring System. International Journal of Radiation Oncology*Biology*Physics 70:2, 330-337
CrossRef384
Paolo Boscolo-Rizzo, Francesca Maronato, Carlo Marchiori, Alessandro Gava, Maria Cristina Da Mosto. (2008) Long-Term Quality of Life After Total Laryngectomy and Postoperative Radiotherapy Versus Concurrent Chemoradiotherapy for Laryngeal Preservation. The Laryngoscope 118:2, 300-306
CrossRef385
Vicente A. Resto, Annie W. Chan, Daniel G. Deschler, Derrick T. Lin. (2008) Extent of surgery in the management of locally advanced sinonasal malignancies. Head & Neck 30:2, 222-229
CrossRef386
Farzan Siddiqui, Thomas F. Pajak, Deborah Watkins-Bruner, Andre A. Konski, James C. Coyne, Clement K. Gwede, Adam S. Garden, Sharon A. Spencer, Christopher Jones, Benjamin Movsas. (2008) Pretreatment Quality of Life Predicts for Locoregional Control in Head and Neck Cancer Patients: A Radiation Therapy Oncology Group Analysis. International Journal of Radiation Oncology*Biology*Physics 70:2, 353-360
CrossRef387
Rehan Kazi, Ramachandran Venkitaraman, Catherine Johnson, Vyas Prasad, Peter Clarke, Peter Rhys-Evans, Christopher M. Nutting, Kevin J. Harrington. (2008) Electroglottographic Comparison of Voice Outcomes in Patients With Advanced Laryngopharyngeal Cancer Treated by Chemoradiotherapy or Total Laryngectomy. International Journal of Radiation Oncology*Biology*Physics 70:2, 344-352
CrossRef388
Dirk Rades, Fabian Fehlauer, Mashid Sheikh-Sarraf, Nadja Kazic, Hiba Basic, Robert Poorter, Samer G. Hakim, Steven E. Schild, Juergen Dunst. (2008) Toxicity of two cisplatin-based radiochemotherapy regimens for the treatment of patients with stage III/IV head and neck cancer. Head & Neck 30:2, 235-241
CrossRef389
Benedikt J. Folz, Carl E. Silver, Alessandra Rinaldo, Johannes J. Fagan, Loring W. Pratt, Neil Weir, Daniela Seitz, Alfio Ferlito. (2008) An outline of the history of head and neck oncology. Oral Oncology 44:1, 2-9
CrossRef390
Mee Sun Yoon, Woong-Ki Chung, Sung-Ja Ahn, Taek-Keun Nam, Byung-Sik Nah, Ju-Young Song, Sang Cheol Lim, Joon Kyoo Lee. (2008) Concurrent chemoradiotherapy with cisplatin and fluorouracil for locally advanced hypopharyngeal carcinoma. Acta Oto-laryngologica 128:5, 590-596
CrossRef391
Susumu Tominaga. (2008) Okayama Igakkai Zasshi (Journal of Okayama Medical Association) 120:2, 193-200
CrossRef392
J.M. Prades, A.P. Timoshenko, Th. Schmitt, M.P. Delolme, M. Francoz, C. Martin, L. Saban-roche, Ch. Martin. (2008) Planned neck dissection before combined chemoradiation for pyriform sinus carcinoma. Acta Oto-laryngologica 128:3, 324-328
CrossRef393
Eric M. Genden, Alfio Ferlito, Alessandra Rinaldo, Carl E. Silver, Johannes J. Fagan, Carlos Suárez, Johannes A. Langendijk, Jean Louis Lefebvre, Patrick J. Bradley, C. René Leemans, Amy Y. Chen, Jemy Jose, Gregory T. Wolf. (2008) Recent changes in the treatment of patients with advanced laryngeal cancer. Head & Neck 30:1, 103-110
CrossRef394
Joshua D. Lawson, Kristen Otto, William Grist, Peter A.S. Johnstone. (2008) Frequency of esophageal stenosis after simultaneous modulated accelerated radiation therapy and chemotherapy for head and neck cancer. American Journal of Otolaryngology 29:1, 13-19
CrossRef395
Seung-Hee Ryu, Soo-Young Moon, Eun Kyung Choi, Jong Hoon Kim, Seung Do Ahn, Si Yeol Song, Jin-hong Park, Young Ju Noh, Sang-wook Lee. (2008) Establishment of a Single Dose Radiation Model of Oral Mucositis in Mice. The Journal of the Korean Society for Therapeutic Radiology and Oncology 26:4, 257
CrossRef396
R. Mazeron, J. Bourhis. (2008) Carcinomes des voies aérodigestives supérieures: nouvelles approches en radiothérapie. Oncologie 10:1, 8-15
CrossRef397
Jagruti A. Patel, Forum G. Shah, Jagdish M. Kothari, Kaustubh D. Patel. (2008) Prevalence of head and neck cancers in ahmedabad, gujarat. Indian Journal of Otolaryngology and Head & Neck Surgery
CrossRef398
Eugene Y. Chang, Xin Li, Michael Jerosch-Herold, Ryan A. Priest, C. Kristian Enestvedt, Jingang Xu, Charles S. Springer, Blair A. Jobe. (2008) The Evaluation of Esophageal Adenocarcinoma Using Dynamic Contrast-Enhanced Magnetic Resonance Imaging. Journal of Gastrointestinal Surgery 12:1, 166-175
CrossRef399
Takeshi Kodaira. (2008) Application of Chemoradiation-Current status and problems of concurrent chemoradiotherapy for patients with head and neck cancer. Toukeibu Gan 34:3, 249-253
CrossRef400
Akihiro Shiotani, Koichiro Saito, Masayuki Tomifuji, Hideki Naganishi, Koji Inagaki. (2008) Function preservation surgeries for T2 and T3 laryngeal cancer-Supracricoid laryngectomy and transoral partial laryngopharyngectomy-. Toukeibu Gan 34:3, 338-344
CrossRef401
Fumihide Rikimaru, Ryunosuke Kogo, Yuichiro Higaki, Kichinobu Tomita. (2008) Neck dissection after concurrent chemoradiotherapy for head and neck squamous cell carcinoma with cervical metastases. Toukeibu Gan 34:4, 557-562
CrossRef402
Alberto Encinas Vicente, Rosalía Souvirón Encabo, Ángel Rodríguez Paramás, Marta Mancheño Losa, Fernando García de Pedro, Bartolomé Scola Yurrita. (2007) Complicaciones quirúrgicas en la cirugía de rescate de pacientes con carcinomas de cabeza y cuello tratados con quimioterapia y radioterapia concomitantes. Acta Otorrinolaringológica Española 58:10, 454-457
CrossRef403
James C. Coyne, Thomas F. Pajak, Jonathan Harris, Andre Konski, Benjamin Movsas, Kian Ang, Deborah Watkins Bruner. (2007) Emotional well-being does not predict survival in head and neck cancer patients. Cancer 110:11, 2568-2575
CrossRef404
Daisuke Sano, Jeffrey N. Myers. (2007) Metastasis of squamous cell carcinoma of the oral tongue. Cancer and Metastasis Reviews 26:3-4, 645-662
CrossRef405
Miquel Quer, Xavier León. (2007) Modalidades de preservación de órgano en carcinomas de laringe e hipofaringe. Acta Otorrinolaringológica Española 58:10, 476-482
CrossRef406
Maria Agustina Sevilla, Juan Pablo Rodrigo, José Luis Llorente, Rubén Cabanillas, Fernando López, Carlos Suárez. (2007) Supraglottic laryngectomy: analysis of 267 cases. European Archives of Oto-Rhino-Laryngology 265:1, 11-16
CrossRef407
Matthew C. Biagioli, Mark Harvey, Eloy Roman, Luis E. Raez, Aaron H. Wolfson, Subhakar Mutyala, Hyo S. Han, Arnold Markoe. (2007) Intensity-Modulated Radiotherapy With Concurrent Chemotherapy for Previously Irradiated, Recurrent Head and Neck Cancer. International Journal of Radiation Oncology*Biology*Physics 69:4, 1067-1073
CrossRef408
Andrean L. Simons, Melissa A. Fath, David M. Mattson, Brian J. Smith, Susan A. Walsh, Michael M. Graham, Richard D. Hichwa, John M. Buatti, Ken Dornfeld, Douglas R. Spitz. (2007) Enhanced Response of Human Head and Neck Cancer Xenograft Tumors to Cisplatin Combined With 2-Deoxy-d-Glucose Correlates With Increased 18F-FDG Uptake as Determined by PET Imaging. International Journal of Radiation Oncology*Biology*Physics 69:4, 1222-1230
CrossRef409
Merrill S. Kies. (2007) Induction Chemotherapy for Head and Neck Squamous Cell Carcinomas (SCCHN). Current Treatment Options in Oncology 8:3, 252-260
CrossRef410
Posner, Marshall R., Hershock, Diane M., Blajman, Cesar R., Mickiewicz, Elizabeth, Winquist, Eric, Gorbounova, Vera, Tjulandin, Sergei, Shin, Dong M., Cullen, Kevin, Ervin, Thomas J., Murphy, Barbara A., Raez, Luis E., Cohen, Roger B., Spaulding, Monica, Tishler, Roy B., Roth, Berta, Viroglio, Rosana del Carmen, Venkatesan, Varagur, Romanov, Ilya, Agarwala, Sanjiv, Harter, K. William, Dugan, Matthew, Cmelak, Anthony, Markoe, Arnold M., Read, Paul W., Steinbrenner, Lynn, Colevas, A. Dimitrios, Norris, Charles M. Jr., Haddad, Robert I., . (2007) Cisplatin and Fluorouracil Alone or with Docetaxel in Head and Neck Cancer. New England Journal of Medicine 357:17, 1705-1715
Full Text411
Ian M. Smith, Wojciech K. Mydlarz, Suhail K. Mithani, Joseph A. Califano. (2007) DNA global hypomethylation in squamous cell head and neck cancer associated with smoking, alcohol consumption and stage. International Journal of Cancer 121:8, 1724-1728
CrossRef412
Tanguy Y. Seiwert, Everett E. Vokes. 2007. Head and Neck Cancer. .
CrossRef413
D.G. Grant, M.A. Birchall. (2007) Concurrent chemoradiotherapy is not the only answer. Clinical Otolaryngology 32:5, 416-417
CrossRef414
Teresa Guerrero Urbano, Catharine H. Clark, Vibeke N. Hansen, Elizabeth J. Adams, Roger A’Hern, Elizabeth A. Miles, Helen McNair, Margaret Bidmead, Alan P. Warrington, David P. Dearnaley, Kevin J. Harrington, Christopher M. Nutting. (2007) A phase I study of dose-escalated chemoradiation with accelerated intensity modulated radiotherapy in locally advanced head and neck cancer. Radiotherapy and Oncology 85:1, 36-41
CrossRef415
F. Christopher Holsinger, Randal S. Weber. (2007) Swing of the Surgical Pendulum: A Return to Surgery for Treatment of Head and Neck Cancer in the 21st Century?. International Journal of Radiation Oncology*Biology*Physics 69:2, S129-S131
CrossRef416
Renzo Corvò. (2007) Evidence-based radiation oncology in head and neck squamous cell carcinoma. Radiotherapy and Oncology 85:1, 156-170
CrossRef417
Nancy Y. Lee, William O’Meara, Kelvin Chan, Cesar Della-Bianca, James G. Mechalakos, Joanne Zhung, Suzanne L. Wolden, Ashwatha Narayana, Dennis Kraus, Jatin P. Shah, David G. Pfister. (2007) Concurrent Chemotherapy and Intensity-Modulated Radiotherapy for Locoregionally Advanced Laryngeal and Hypopharyngeal Cancers. International Journal of Radiation Oncology*Biology*Physics 69:2, 459-468
CrossRef418
David J. Adelstein. (2007) Concurrent Chemoradiotherapy in the Management of Squamous Cell Cancer of the Oropharynx: Current Standards and Future Directions. International Journal of Radiation Oncology*Biology*Physics 69:2, S37-S39
CrossRef419
Russell B. Smith. (2007) Surgery in the Management of Laryngeal and Hypopharyngeal Carcinoma. International Journal of Radiation Oncology*Biology*Physics 69:2, S28-S30
CrossRef420
William M. Mendenhall, Anthony A. Mancuso, Russell W. Hinerman, Robert S. Malyapa, John W. Werning, Robert J. Amdur, Douglas B. Villaret. (2007) Multidisciplinary Management of Laryngeal Carcinoma. International Journal of Radiation Oncology*Biology*Physics 69:2, S12-S14
CrossRef421
Frank J.P. Hoebers, Wilma Heemsbergen, Alfons J.M. Balm, Mathilde van Zanten, Jan H. Schornagel, Coen R.N. Rasch. (2007) Concurrent chemoradiation with daily low dose cisplatin for advanced stage head and neck carcinoma. Radiotherapy and Oncology 85:1, 42-47
CrossRef422
Pol M. Specenier, Jan B. Vermorken. (2007) Neoadjuvant chemotherapy in head and neck cancer: Should it be revisited?. Cancer Letters 256:2, 166-177
CrossRef423
Ulrich Reinhart Goessler, Jens Stern-Straeter, Katrin Riedel, Gregor M. Bran, Karl Hörmann, Frank Riedel. (2007) Tissue engineering in head and neck reconstructive surgery: what type of tissue do we need?. European Archives of Oto-Rhino-Laryngology 264:11, 1343-1356
CrossRef424
R. Ljumanovic, P.J.W. Pouwels, J.A. Langendijk, D.L. Knol, P. van der Valk, C.R. Leemans, J.A. Castelijns. (2007) Has the Degree of Contrast Enhancement with MR Imaging in Laryngeal Carcinoma Added Value to Anatomic Parameters Regarding Prediction of Response to Radiation Therapy?. American Journal of Neuroradiology 28:8, 1540-1546
CrossRef425
J.-L. Roh, K.H. Pae, S.-H. Choi, J.S. Kim, S. Lee, S.-B. Kim, S.Y. Nam, S.Y. Kim. (2007) 2-[18F]-Fluoro-2-deoxy-d-glucose positron emission tomography as guidance for primary treatment in patients with advanced-stage resectable squamous cell carcinoma of the larynx and hypopharynx. European Journal of Surgical Oncology (EJSO) 33:6, 790-795
CrossRef426
Rajagopalan Sudha, Nicole Kawachi, Peicheng Du, Edward Nieves, Thomas J Belbin, Abdissa Negassa, Ruth Hogue Angeletti, Michael B Prystowsky. (2007) Global proteomic analysis distinguishes biologic differences in head and neck squamous carcinoma. Laboratory Investigation 87:8, 755-766
CrossRef427
Felix Y. Feng, Hyungjin M. Kim, Teresa H. Lyden, Marc J. Haxer, Mary Feng, Frank P. Worden, Douglas B. Chepeha, Avraham Eisbruch. (2007) Intensity-Modulated Radiotherapy of Head and Neck Cancer Aiming to Reduce Dysphagia: Early Dose–Effect Relationships for the Swallowing Structures. International Journal of Radiation Oncology*Biology*Physics 68:5, 1289-1298
CrossRef428
L. Thomas, J.A. Wilson. (2007) Surgical evidence ? not an open and shut case?. Clinical Otolaryngology 32:4, 322-323
CrossRef429
Mohit Kasibhatla, John P. Kirkpatrick, David M. Brizel. (2007) How Much Radiation is the Chemotherapy Worth in Advanced Head and Neck Cancer?. International Journal of Radiation Oncology*Biology*Physics 68:5, 1491-1495
CrossRef430
Andy Trotti, Thomas F Pajak, Clement K Gwede, Rebecca Paulus, Jay Cooper, Arlene Forastiere, John A Ridge, Deborah Watkins-Bruner, Adam S Garden, K Kian Ang, Wally Curran. (2007) TAME: development of a new method for summarising adverse events of cancer treatment by the Radiation Therapy Oncology Group. The Lancet Oncology 8:7, 613-624
CrossRef431
Peter W.M. Chung, Robert G. Bristow, Michael F. Milosevic, Qi-long Yi, Michael A.S. Jewett, Padraig R. Warde, Charles N. Catton, Michael McLean, Malcolm Moore, Ian F. Tannock, Mary K. Gospodarowicz. (2007) Long-term outcome of radiation-based conservation therapy for invasive bladder cancer. Urologic Oncology: Seminars and Original Investigations 25:4, 303-309
CrossRef432
Rajendra L. Bhalavat, Kumar Alok Pathak, Umesh Mahantshetty, Swamidas V. Jamema. (2007) Brachytherapy boost: A novel approach for epiglottic carcinoma. Brachytherapy 6:3, 212-217
CrossRef433
Andrea Cavalot, Tiziana Martone, Nicolò Roggero, Gabriele Brondino, Marco Pagano, Giorgio Cortesina. (2007) Prognostic impact ofHER-2/neu expression on squamous head and neck carcinomas. Head & Neck 29:7, 655-664
CrossRef434
Marc Bennett, David Kaylie, Frank Warren, C Gary Jackson. (2007) Chronic Ear Surgery in Irradiated Temporal Bones. The Laryngoscope 117:7, 1240-1244
CrossRef435
Michael E. Kupferman, William H. Morrison, Alfredo A. Santillan, Dianna Roberts, Eduardo M. Diaz, Adam S. Garden, Randal Weber. (2007) The role of interstitial brachytherapy with salvage surgery for the management of recurrent head and neck cancers. Cancer 109:10, 2052-2057
CrossRef436
Martin C. Jäckel, Alexios Martin, Wolfgang Steiner. (2007) Twenty-five years experience with laser surgery for head and neck tumors. European Archives of Oto-Rhino-Laryngology 264:6, 577-585
CrossRef437
Hwan Jung Yun, Jan Bogaerts, Ahmad Awada, Denis Lacombe. (2007) Clinical trial design limitations in head and neck squamous cell carcinomas. Current Opinion in Oncology 19:3, 210-215
CrossRef438
Kevin Fung, Theodoros N. Teknos, Curtis D. Vandenberg, Teresa H. Lyden, Carol R. Bradford, Norman D. Hogikyan, Jennifer Kim, Mark E. P. Prince, Gregory T. Wolf, Douglas B. Chepeha. (2007) Prevention of wound complications following salvage laryngectomy using free vascularized tissue. Head & Neck 29:5, 425-430
CrossRef439
Eric M. Genden, Alfio Ferlito, Carl E. Silver, Adam S. Jacobson, Jochen A. Werner, Carlos Suárez, C. René Leemans, Patrick J. Bradley, Alessandra Rinaldo. (2007) Evolution of the management of laryngeal cancer. Oral Oncology 43:5, 431-439
CrossRef440
Eugene Y. Chang, Christina A. Smith, Christopher L. Corless, Charles R. Thomas, John G. Hunter, Blair A. Jobe. (2007) Accuracy of pathologic examination in detection of complete response after chemoradiation for esophageal cancer. The American Journal of Surgery 193:5, 614-617
CrossRef441
Wei-Ciao Wu, Jenn-Ren Hsiao, Yu-Yan Lian, Chun-Yu Lin, Bu-Miin Huang. (2007) The apoptotic effect of cordycepin on human OEC-M1 oral cancer cell line. Cancer Chemotherapy and Pharmacology 60:1, 103-111
CrossRef442
S.F. Preuss, J.P. Klussmann, C. Wittekindt, M. Damm, R. Semrau, U. Drebber, O. Guntinas-Lichius. (2007) Long-term results of the combined modality therapy for advanced cervical metastatic head and neck squamous cell carcinoma. European Journal of Surgical Oncology (EJSO) 33:3, 358-363
CrossRef443
Anthony J. Cmelak, Barbara A. Murphy, Brian Burkey, Stacy Douglas, Yu Shyr, James Netterville. (2007) Taxane-based chemoirradiation for organ preservation with locally advanced head and neck cancer: Results of a phase II multi-institutional trial. Head & Neck 29:4, 315-324
CrossRef444
Roi Dagan, Christopher G. Morris, Jeffrey A. Bennett, Anthony A. Mancuso, Robert J. Amdur, Russell W. Hinerman, William M. Mendenhall. (2007) Prognostic Significance of Paraglottic Space Invasion in T2N0 Glottic Carcinoma. American Journal of Clinical Oncology 30:2, 186-190
CrossRef445
Russell W. Hinerman, William M. Mendenhall, Christopher G. Morris, Robert J. Amdur, John W. Werning, Douglas B. Villaret. (2007) T3 and T4 True Vocal Cord Squamous Carcinomas Treated With External Beam Irradiation. American Journal of Clinical Oncology 30:2, 181-185
CrossRef446
Petra Ambrosch. (2007) The role of laser microsurgery in the treatment of laryngeal cancer. Current Opinion in Otolaryngology & Head and Neck Surgery 15:2, 82-88
CrossRef447
Robert L. Foote, Paul D. Brown, Yolanda I. Garces, Scott H. Okuno, Robert C. Miller, Scott E. Strome. (2007) Informed consent in advanced laryngeal cancer. Head & Neck 29:3, 230-235
CrossRef448
Tanguy Y Seiwert, Joseph K Salama, Everett E Vokes. (2007) The chemoradiation paradigm in head and neck cancer. Nature Clinical Practice Oncology 4:3, 156-171
CrossRef449
John G Devlin, Corey J Langer. (2007) Combined modality treatment of laryngeal squamous cell carcinoma. Expert Review of Anticancer Therapy 7:3, 331-350
CrossRef450
Par S Mehta, Louis B Harrison. (2007) Function and organ preservation in adult cancers of the head and neck. Expert Review of Anticancer Therapy 7:3, 361-371
CrossRef451
Søren M Bentzen, Paul M Harari, Jacques Bernier. (2007) Exploitable mechanisms for combining drugs with radiation: concepts, achievements and future directions. Nature Clinical Practice Oncology 4:3, 172-180
CrossRef452
Mike Yao, Joel B. Epstein, Bijal J. Modi, Kristen B. Pytynia, Arno J. Mundt, Lawrence E. Feldman. (2007) Current surgical treatment of squamous cell carcinoma of the head and neck. Oral Oncology 43:3, 213-223
CrossRef453
Jay S. Cooper, Suresh K. Mukherji, Alicia Y. Toledano, Clifford Beldon, Ilona M. Schmalfuss, Robert Amdur, Scott Sailer, Laurie A. Loevner, Phil Kousouboris, K. Kian Ang, Jean Cormack, JoRean Sicks. (2007) An evaluation of the variability of tumor-shape definition derived by experienced observers from CT images of supraglottic carcinomas (ACRIN protocol 6658). International Journal of Radiation Oncology*Biology*Physics 67:4, 972-975
CrossRef454
Richard L. Scher. (2007) Role of Nitric Oxide in the Development of Distant Metastasis From Squamous Cell Carcinoma. The Laryngoscope 117:2, 199-209
CrossRef455
Aaron M. Allen, Mohamed Elshaikh, Francis P. Worden, Carol R. Bradford, Theodoros N. Teknos, Douglas B. Chepeha, Christina Tsien, Laura A. Dawson, Susan Urba, Gregory T. Wolf, Daniel Normolle, Avraham Eisbruch. (2007) Acceleration of hyperfractionated chemoradiation regimen for advanced head and neck cancer. Head & Neck 29:2, 137-142
CrossRef456
A. Dietz, U. Keilholz, M. Flentje. (2007) Organerhalt bei Larynx-Hypopharynx-Karzinomen. Der Onkologe 13:2, 118-128
CrossRef457
Merrill S. Kies. (2007) Induction chemotherapy for squamous cancer of the head and neck. Current Oncology Reports 9:2, 129-133
CrossRef458
Akira Kubota, Madoka Furukawa, Hideaki Hanamura, Yoshifumi Fujita, Masato Sugiyama. (2007) Concurrent Chemoradiotherapy for Squamous Cell Carcinoma of the Oropharynx. Nippon Jibiinkoka Gakkai Kaiho 110:9, 635-642
CrossRef459
Takahide Taguchi, Mamoru Tsukuda, Yasukazu Mikami, Hideki Matsuda, Choichi Horiuchi, Gabor Toth, Jun-ichi Ishitoya. (2007) Concurrent Chemoradiotherapy for Advanced Resectable Squamous Cell Carcinoma of the Hypopharynx. Nihon Kikan Shokudoka Gakkai Kaiho 58:3, 327-334
CrossRef460
Amy Y. Chen, Nicole Schrag, Yongping Hao, Andrew Stewart, Elizabeth Ward. (2007) Changes in Treatment of Advanced Oropharyngeal Cancer, 1985???2001. The Laryngoscope 117:1, 16-21
CrossRef461
Gilles Crehange, Mathieu Bosset, Fabrice Lorchel, Jean Luc Dumas, Joëlle Buffet-Miny, Marc Puyraveau, Mariette Mercier, Jean François Bosset. (2007) Combining Cisplatin and Mitomycin with Radiotherapy in Anal Carcinoma. Diseases of the Colon & Rectum 50:1, 43-49
CrossRef462
X Zhang, JA Moche, D Farber, SE Strome. (2007) Vaccine-based approaches to squamous cell carcinoma of the head and neck. Oral Diseases 13:1, 17-22
CrossRef463
Jonathan J. Beitler, Richard V. Smith, Randall P. Owen, Carl E. Silver, Madhu Mazumdar, Scott Wadler. (2007) Phase II clinical trial of parenteral hydroxyurea and hyperfractionated, accelerated external beam radiation therapy in patients with advanced squamous cell carcinoma of the head and neck: Toxicity and efficacy with continuous ribonucleoside reductase inhibition. Head & Neck 29:1, 18-25
CrossRef464
Takahide Taguchi. (2007) Concurrent Chemoradiotherapy for Patients with Squamous Cell Carcinoma of the Hypopharynx. Nihon Kikan Shokudoka Gakkai Kaiho 58:2, 127-129
CrossRef465
Woo-Jin Jeong, Eun-Jung Jung, J. Hun Hah, Tack-Kyun Kwon, Hong-Gyun Wu, Dae Seog Heo, Myung-Whun Sung, Kwang Hyun Kim. (2007) Preliminary results of pre-radiation neck dissection in head and neck cancer patients undergoing organ preservation treatment. Acta Oto-laryngologica 127:s558, 121-127
CrossRef466
Osamu Shiono, Junichi Ishitoya, Toshiro Kawano, Masahiro Takahashi, Ryo Endo, Masaki Komatsu, Makiko Watanabe, Daiki Mitake, Mamoru Tsukuda. (2007) Concurrent chemoradiotherapy in patients with T3 or T4 hypopharyngeal carcinoma. Toukeibu Gan 33:1, 30-34
CrossRef467
Akira Kubota. (2007) Chemotherapy for salivary gland carcinoma. Toukeibu Gan 33:3, 254-259
CrossRef468
Chiaki Shibayama, Masanori Nakazawa, Tadashi Sugawara. (2007) Accelerated Fractionated Radiotherapy for Head-and-Neck Cancer: A 20-year Single-Institution Experience. Toukeibu Gan 33:3, 293-296
CrossRef469
Yasushi Furuta, Akihiro Homma, Nobuhiko Oridate, Fumiyuki Suzuki, Hiromitsu Hatakeyama, Shigenari Taki, Tomohiro Sakashita, Takeshi Nishioka, Keishiro Suzuki, Hiroki Shirato, Mitsuru Sekido, Yuhei Yamamoto, Satoshi Fukuda. (2007) Surgical complications of salvage surgery following concurrent chemoradiotherapy for laryngeal cancer. Toukeibu Gan 33:3, 356-360
CrossRef470
Miquel Quer, Xavier León. (2007) Organ Preservation in Laryngeal and Hypopharyngeal Cancer. Acta Otorrinolaringologica (English Edition) 58:10, 476-482
CrossRef471
Alberto Encinas Vicente, Rosalía Souvirón Encabo, Ángel Rodríguez Paramás, Marta Mancheño Losa, Fernando García de Pedro, Bartolomé Scola Yurrita. (2007) Surgical Complications in Salvage Surgery of Patients With Head and Neck Carcinomas Treated With Concomitant Chemoradiotherapy (CCR). Acta Otorrinolaringologica (English Edition) 58:10, 454-457
CrossRef472
Akihiro Homma, Yasushi Furuta, Nobuhiko Oridate, Fumiyuki Suzuki, Eisaku Higuchi, Takeshi Nishioka, Hiroki Shirato, Tatsumi Nagahashi, Katsunori Yagi, Satoshi Fukuda. (2006) “Watch-and-see” policy for the clinically positive neck in head and neck cancer treated with chemoradiotherapy. International Journal of Clinical Oncology 11:6, 441-448
CrossRef473
Min Yao, Thanh Nguyen, John M. Buatti, Kenneth J. Dornfeld, Huaming Tan, Judith Wacha, John E. Bayouth, Gerald H. Clamon, Gerry F. Funk, Russell B. Smith, Kristi Chang, Henry T. Hoffman. (2006) Changing Failure Patterns in Oropharyngeal Squamous Cell Carcinoma Treated With Intensity Modulated Radiotherapy and Implications for Future Research. American Journal of Clinical Oncology 29:6, 606-612
CrossRef474
Jose Guilherme Vartanian, Andre Lopes Carvalho, Bevan Yueh, Cristina Lemos B. Furia, Julia Toyota, Jennifer A. McDowell, Ernest A. Weymuller, Luiz Paulo Kowalski. (2006) Brazilian–Portuguese validation of the University of Washington Quality of Life Questionnaire for patients with head and neck cancer. Head & Neck 28:12, 1115-1121
CrossRef475
F. Christopher Holsinger, Eduardo M. Diaz. (2006) Commentary. Head & Neck 28:12, 1058-1060
CrossRef476
Nasfat J. Shehadeh, John F. Ensley, Omer Kucuk, Carri Black, George H. Yoo, John Jacobs, Ho-Sheng Lin, Lance K. Heilbrun, Daryn Smith, Harold Kim. (2006) Benefit of postoperative chemoradiotherapy for patients with unknown primary squamous cell carcinoma of the head and neck. Head & Neck 28:12, 1090-1098
CrossRef477
Han Ching Liu, George G. Chen, Alexander C. Vlantis, Billy C.S. Leung, Michael C.F. Tong, C. Andrew van Hasselt. (2006) 5-Fluorouracil Mediates Apoptosis and G1/S Arrest in Laryngeal Squamous Cell Carcinoma via a p53-Independent Pathway. The Cancer Journal 12:6, 482-493
CrossRef478
Gino Marioni, Rosario Marchese-Ragona, Giuseppe Cartei, Fortunata Marchese, Alberto Staffieri. (2006) Current opinion in diagnosis and treatment of laryngeal carcinoma. Cancer Treatment Reviews 32:7, 504-515
CrossRef479
Shi-Long Lu, Heather Herrington, Xiao-Jing Wang. (2006) Mouse models for human head and neck squamous cell carcinomas. Head & Neck 28:10, 945-954
CrossRef480
Lori Wirth, Aaron M Allen, Mitchell Machtay. (2006) Altered fractionation: a fractional benefit?. The Lancet 368:9538, 819-821
CrossRef481
Margarita Majem, Ricard Mesia, Manel Ma????s, Joaquin Gomez, Ramon Galiana, Felipe Cardenal, Amparo Juan, Ana Montes, Francisco Javier Perez, Julio Nogues, Josep Ramon Germa Llluch. (2006) Does Induction Chemotherapy Still Have a Role in Larynx Preservation Strategies? The Experience of Institut Catala d??Oncologia in Stage III Larynx Carcinoma. The Laryngoscope 116:9, 1651-1656
CrossRef482
C. Mariette, J.P. Triboulet. (2006) Which treatment for squamous cell carcinoma of the pharyngoesophageal junction?. Journal of Surgical Oncology 94:3, 175-177
CrossRef483
Walter T. Lee, Lee M. Akst, David J. Adelstein, Jerrod P. Saxton, Benjamin G. Wood, Marshall Strome, Robert S. Butler, Ramon M. Esclamado. (2006) Risk factors for hypopharyngeal/upper esophageal stricture formation after concurrent chemoradiation. Head & Neck 28:9, 808-812
CrossRef484
Igor Astsaturov, Roger B Cohen, Paul Harari. (2006) Targeting epidermal growth factor receptor signaling in the treatment of head and neck cancer. Expert Review of Anticancer Therapy 6:9, 1179-1193
CrossRef485
Eloy Roman, Luis E Raez, Edgardo S Santos. (2006) Induction chemotherapy in the management of squamous cell carcinoma of the head and neck. Expert Review of Anticancer Therapy 6:9, 1205-1215
CrossRef486
Jean Louis Lefebvre. (2006) Laryngeal preservation in head and neck cancer: multidisciplinary approach. The Lancet Oncology 7:9, 747-755
CrossRef487
Robert Haddad, Lori Wirth, Marshall Posner. (2006) Emerging drugs for head and neck cancer. Expert Opinion on Emerging Drugs 11:3, 461-467
CrossRef488
Frank J.P. Hoebers, Dick Pluim, Marcel Verheij, Alfons J.M. Balm, Harry Bartelink, Jan H.M. Schellens, Adrian C. Begg. (2006) Prediction of treatment outcome by cisplatin-DNA adduct formation in patients with stage III/IV head and neck squamous cell carcinoma, treated by concurrent cisplatin-radiation (RADPLAT). International Journal of Cancer 119:4, 750-756
CrossRef489
Robert L. Foote, R. Tyler Foote, Paul D. Brown, Yolanda I. Garces, Scott H. Okuno, Scott E. Strome. (2006) Organ preservation for advanced laryngeal carcinoma. Head & Neck 28:8, 689-696
CrossRef490
Alexander D. Rapidis, Miltiades Trichas, Elias Stavrinidis, Alexandra Roupakia, Georgia Ioannidou, George Kritselis, Panaiyota Liossi, George Giannakouras, Emmanuel E. Douzinas, Ioannis Katsilieris. (2006) Induction chemotherapy followed by concurrent chemoradiation in advanced squamous cell carcinoma of the head and neck: Final results from a phase II study with docetaxel, cisplatin and 5-fluorouracil with a four-year follow-up. Oral Oncology 42:7, 675-684
CrossRef491
K. Oechsle, T. Brümmendorf. (2006) Induktionschemotherapie zur Evaluation einer definitiven Radiochemotherapie bei Patienten mit Larynxkarzinomen. Der Onkologe 12:8, 796-797
CrossRef492
David Chin, Glen M Boyle, Sandro Porceddu, David R Theile, Peter G Parsons, William B Coman. (2006) Head and neck cancer: past, present and future. Expert Review of Anticancer Therapy 6:7, 1111-1118
CrossRef493
Victoria S. Brkovich, Frank R. Miller, Anand B. Karnad, David H. Hussey, H Stan McGuff, Randal A. Otto. (2006) The Role of Positron Emission Tomography Scans in the Management of the N-Positive Neck in Head and Neck Squamous Cell Carcinoma After Chemoradiotherapy. The Laryngoscope855-858
CrossRef494
C Schäfer, B Dietl, O Kölbl. (2006) Radiochemotherapy in stage III/IV nonmetastatic squamous cell head and neck cancer. British Journal of Cancer 94:10, 1544-1545
CrossRef495
Elke Hayn, Martin Burian, Johannes Gobertus Meran. (2006) Therapiekonzepte bei fortgeschrittenen Larynxkarzinomen in Hinblick auf die Lebensqualität der betroffenen Patienten. Wiener Medizinische Wochenschrift 156:9-10, 263-269
CrossRef496
A. F. Kovács, K. Eberlein, A. Smolarz, S. Weidauer, S. Rohde. (2006) Organerhaltende Therapie bei inoperablen Patienten mit primären Mundhöhlen- und Oropharynxkarzinomen. Mund-, Kiefer- und Gesichtschirurgie 10:3, 168-177
CrossRef497
P.A. Groome, K.M. Schulze, S. Keller, W.J. Mackillop, B. O'Sullivan, J.C. Irish, R.J. Bissett, P.F. Dixon, L.J. Eapen, S.P.P. Gulavita, J.A. Hammond, D.I. Hodson, R.G. Mackenzie, K.M. Schneider, P.R. Warde. (2006) Explaining Socioeconomic Status Effects in Laryngeal Cancer. Clinical Oncology 18:4, 283-292
CrossRef498
Christine G. Gourin, Haydn T. Williams, Wesley N. Seabolt, Anne V. Herdman, Jed W. Howington, David J. Terris. (2006) Utility of Positron Emission Tomography-Computed Tomography in Identification of Residual Nodal Disease after Chemoradiation for Advanced Head and Neck Cancer. The Laryngoscope 116:5, 705-710
CrossRef499
Kundan S. Chufal, Madhup Rastogi, Madhu Srivastava, M.C. Pant, M.L.B. Bhatt. (2006) Late chemo-intensification with cisplatin and 5-fluorouracil as an adjunct to radiotherapy: A pragmatic approach for locally advanced head and neck squamous cell carcinoma. Oral Oncology 42:5, 517-525
CrossRef500
Yungpo Bernard Su, Andrew J. Vickers, Michael J. Zelefsky, Dennis H. Kraus, Ashok R. Shaha, Jatin P. Shah, Angel M. Serio, Louis B. Harrison, George J. Bosl, David G. Pfister. (2006) Double-Blind, Placebo-Controlled, Randomized Trial of Granulocyte-Colony Stimulating Factor During Postoperative Radiotherapy for Squamous Head and Neck Cancer. The Cancer Journal 12:3, 182-188
CrossRef501
D.L. Schwartz, A.S. Garden. (2006) Radiotherapy for Head and Neck Cancer. Hematology/Oncology Clinics of North America 20:2, 259-285
CrossRef502
Adam S. Garden, Jan S. Lewin, Mark S. Chambers. (2006) How to reduce radiation-related toxicity in patients with cancer of the head and neck. Current Oncology Reports 8:2, 140-145
CrossRef503
Robert I. Haddad, Marshall R. Posner, Paul M. Busse, Charles M. Norris, Laura A. Goguen, Lori J. Wirth, Russell Blinder, Jeffrey F. Krane, Roy B. Tishler. (2006) Chemoradiotherapy for Adenoid Cystic Carcinoma. American Journal of Clinical Oncology 29:2, 153-157
CrossRef504
Robert Haddad. (2006) Current and future directions in the treatment of squamous cell carcinoma of the head and neck: multidisciplinary symposium on head and neck cancer. Expert Opinion on Therapeutic Targets 10:2, 333-336
CrossRef505
Harold Lau, Sony Brar, Desiree Hao, Jack MacKinnon, Don Yee, Stefan Gluck. (2006) Concomitant low-dose cisplatin and three-dimensional conformal radiotherapy for locally advanced squamous cell carcinoma of the head and neck: Analysis of survival and toxicity. Head & Neck 28:3, 189-196
CrossRef506
Mark Agulnik, Lillian L Siu. (2006) Multidisciplinary Symposium on Head and Neck Cancer. Expert Opinion on Pharmacotherapy 7:4, 489-494
CrossRef507
S Ghosh Laskar, J P Agarwal, C Srinivas, K A Dinshaw. (2006) Radiotherapeutic management of locally advanced head and neck cancer. Expert Review of Anticancer Therapy 6:3, 405-417
CrossRef508
R Glynne-Jones, J Grainger, M Harrison, P Ostler, A Makris. (2006) Neoadjuvant chemotherapy prior to preoperative chemoradiation or radiation in rectal cancer: should we be more cautious?. British Journal of Cancer 94:3, 363-371
CrossRef509
Mohamed Elshaikh, Mats Ljungman, Randall Ten Haken, Allen S. Lichter. (2006) Advances in Radiation Oncology. Annual Review of Medicine 57:1, 19-31
CrossRef510
B. Zach Fowler, Susan Muller, Amy Y. Chen, Peter A. S. Johnstone. (2006) Factors influencing long-term survival following salvage total laryngectomy after initial radiotherapy or conservative surgery. Head & Neck 28:2, 99-106
CrossRef511
A.K. D'cruz, G.H. Pantvaidya, J.P. Agarwal, D.A. Chaukar, K.A. Pathak, M.S. Deshpande, P.S. Pai, P. Chaturvedi, K.A. Dinshaw. (2006) Split therapy: Planned neck dissection followed by definitive radiotherapy for a T1, T2 pharyngolaryngeal primary cancer with operable N2, N3 nodal metastases—A prospective study. Journal of Surgical Oncology 93:1, 56-61
CrossRef512
Takahide Taguchi, Mamoru Tsukuda, Yasukazu Mikami, Hideki Matsuda, Choichi Horiuchi, Takafumi Yoshida, Goshi Nishimura, Jun-Ichi Ishitoya, Hideaki Katori. (2006) Concurrent chemoradiotherapy with cisplatin, 5-fluorouracil, methotrexate, and leucovorin in patients with advanced resectable squamous cell carcinoma of the larynx and hypopharynx. Acta Oto-laryngologica 126:4, 408-413
CrossRef513
J Gershon Spector, Donald G. Sessions, Jason Lenox, Joseph Simpson. (2006) Management of T3N1 Glottic Carcinoma: Therapeutic Outcomes. The Laryngoscope 116:1, 106-110
CrossRef514
N. Kohno. (2006) The Role of Chemotherapy for Head and Neck Cancer. Nihon Kikan Shokudoka Gakkai Kaiho 57:2, 181-185
CrossRef515
Ricardo Hitt, Maria L. Amador, Miguel Quintela-Fandino, Antonio Jimeno, Olga del Val, Susana Hernando, Hernan Cortes-Funes. (2006) Weekly docetaxel in patients with recurrent and/or metastatic squamous cell carcinoma of the head and neck. Cancer 106:1, 106-111
CrossRef516
Toshiki TOMITA, Hiroyuki OZAWA, Takamasa TAGAWA, Koji SAKAMOTO, Kaoru OGAWA, Masato FUJII. (2006) EVIDENCE OF HEAD AND NECK SURGERY AND FUTURE STRATEGY FOR MULTI-INSTITUTIONAL STUDIES. Toukeibu Gan 32:3, 300-305
CrossRef517
Ken-ichi NIBU, Naoki OTSUKI, Miki SAITO, Ryohei SASAKI, Yoshiki OKAMOTO, Daisuke SHIRASAKA, Tatsuya OKUNO. (2006) TREATMENT RESULTS OF GLOTTIC AND HYPOPHARYNGEAL CANCERS-FROM THE VIEWPOINT OF HEAD AND NECK SURGEON-. Toukeibu Gan 32:3, 328-331
CrossRef518
Tomokazu YOSHIZAKI, Shigeyuki MURONO, Naohiro WAKISAKA, Satoru KONDO, Mitsuru FURUKAWA. (2006) SUPERSELECTIVE INTRA-ARTERIAL CHEMORADIOTHERAPY FOR LARYNGEAL CANCER-IS IT REASONABLE TO TREAT GLOTTIC CANCER IN A SIMILAR WAY TO SUPRAGLOTTIC CANCER?-. Toukeibu Gan 32:4, 464-467
CrossRef519
M Tsukuda, A Kida, M Fujii, N Kono, T Yoshihara, Y Hasegawa, M Sugita. (2005) Randomized scheduling feasibility study of S-1 for adjuvant chemotherapy in advanced head and neck cancer. British Journal of Cancer 93:8, 884-889
CrossRef520
Ángel Segura Huerta, Laura Palomar Abad. (2005) Problemática asistencial del tratamiento combinado en los pacientes con tumores de cabeza y cuello localmente avanzados (réplica). Clinical and Translational Oncology 7:8, 370-371
CrossRef521
Hilkka A. Jääskelä-Saari, Reidar Grénman, Hans A. Ramsay, Jussi Tarkkanen, Timo Paavonen, Kalevi J.A. Kairemo. (2005) Indium-111-Bleomycin Complex in Squamous Cell Cancer Xenograft Tumors of Nude Mice. Cancer Biotherapy & Radiopharmaceuticals 20:4, 426-435
CrossRef522
Christine G. Gourin, William J. McAfee, Kimberly M. Neyman, Jed W. Howington, Robert H. Podolsky, David J. Terris. (2005) Effect of Comorbidity on Quality of Life and Treatment Selection in Patients with Squamous Cell Carcinoma of the Head and Neck. The Laryngoscope 115:8, 1371-1375
CrossRef523
Sue S. Yom, Mitchell Machtay, Merrill A. Biel, Robert J. Sinard, Adel K. El-Naggar, Randal S. Weber, David I. Rosenthal. (2005) Survival Impact of Planned Restaging and Early Surgical Salvage Following Definitive Chemoradiation for Locally Advanced Squamous Cell Carcinomas of the Oropharynx and Hypopharynx. American Journal of Clinical Oncology 28:4, 385-392
CrossRef524
Beverly A. Guadagnolo, Robert I. Haddad, Marshall R. Posner, Linda Weeks, Lori J. Wirth, Charles M. Norris, Christopher A. Sullivan, Laura Goguen, Paul M. Busse, Roy Tishler. (2005) Organ Preservation and Treatment Toxicity With Induction Chemotherapy Followed by Radiation Therapy or Chemoradiation for Advanced Laryngeal Cancer. American Journal of Clinical Oncology 28:4, 371-378
CrossRef525
Brian A. Moore, F. Christopher Holsinger, Eduardo M. Diaz, Randal S. Weber. (2005) Organ-Preservation Laryngeal Surgery in the Era of Chemoradiation. Current Problems in Cancer 29:4, 169-179
CrossRef526
Wei Lin, Xioayu Zhang, Zhaorong Chen, Nancy Borson, Steve Voss, Schuyler Sanderson, Linda Murphy, Peter Wettstein, Scott E. Strome. (2005) Development and Immunophenotyping of Squamous Cell Carcinoma Xenografts: Tools for Translational Immunology. The Laryngoscope 115:7, 1154-1162
CrossRef527
C. Simon. (2005) Magnetisches Drug-Targeting. HNO 53:7, 600-601
CrossRef528
Suresh K. Mukherji, Alicia Y. Toledano, Clifford Beldon, Ilona M. Schmalfuss, Jay S. Cooper, JoRean D. Sicks, Robert Amdur, Scott Sailer, Laurie A. Loevner, Phil Kousouboris, Kian Ang. (2005) Interobserver reliability of computed tomography-derived primary tumor volume measurement in patients with supraglottic carcinoma. Cancer 103:12, 2616-2622
CrossRef529
Boris Freidlin, Edward L. Korn. (2005) Testing treatment effects in the presence of competing risks. Statistics in Medicine 24:11, 1703-1712
CrossRef530
David I Rosenthal, Angel I Blanco. (2005) Head and neck squamous cell carcinoma: optimizing the therapeutic index. Expert Review of Anticancer Therapy 5:3, 501-514
CrossRef531
Bijal J Modi, Brian Knab, Lawrence E Feldman, Arno J Mundt, Mike Yao, Kristen B Pytynia, Joel Epstein. (2005) Review of current treatment practices for carcinoma of the head and neck. Expert Opinion on Pharmacotherapy 6:7, 1143-1155
CrossRef532
Geoff Delaney, Susannah Jacob, Michael Barton. (2005) Estimation of an optimal external beam radiotherapy utilization rate for head and neck carcinoma. Cancer 103:11, 2216-2227
CrossRef533
Ian Ganly, Snehal Patel, Jeanette Matsuo, Bhuvanesh Singh, Dennis Kraus, Jay Boyle, Richard Wong, Nancy Lee, David G. Pfister, Ashok Shaha, Jatin Shah. (2005) Postoperative complications of salvage total laryngectomy. Cancer 103:10, 2073-2081
CrossRef534
Noel M. Kramer, Eric M. Horwitz, Jonathan Cheng, John A. Ridge, Steven J. Feigenberg, Roger B. Cohen, Nicos Nicolaou, Eric J. Sherman, James S. Babb, Jason A. Damsker, Corey J. Langer. (2005) Toxicity and outcome analysis of patients with recurrent head and neck cancer treated with hyperfractionated split-course reirradiation and concurrent cisplatin and paclitaxel chemotherapy from two prospective phase I and II studies. Head & Neck 27:5, 406-414
CrossRef535
Omur Karakoyun-Celik, Charles M. Norris, Roy Tishler, Anand Mahadevan, John R. Clark, Saveli Goldberg, Phillip Devlin, Paul M. Busse. (2005) Definitive radiotherapy with interstitial implant boost for squamous cell carcinoma of the tongue base. Head & Neck 27:5, 353-361
CrossRef536
Guy Andry, Marc Hamoir, C Ren?? Leemans. (2005) The evolving role of surgery in the management of head and neck tumors. Current Opinion in Oncology 17:3, 241-248
CrossRef537
T Y Seiwert, E E W Cohen. (2005) State-of-the-art management of locally advanced head and neck cancer. British Journal of Cancer 92:8, 1341-1348
CrossRef538
Ozden Altundag, Kadri Altundag, Paolo Morandi, Emer Hanrahan. (2005) Cisplatin as a radiosensitizer in the treatment of locally advanced head and neck cancer. Oral Oncology 41:4, 435
CrossRef539
Joseph K. Salama, Daniel J. Haraf, Kerstin Stenson, Michael T. Milano, Mary Ellyn Witt, Everett E. Yokes. (2005) Phase I Study of Concomitant Chemoradiotherapy with Irinotecan, 5-FU., and Hydroxyurea for Patients with Advanced and/or Recurrent Head and Neck Cancer. The Cancer Journal 11:2, 140-146
CrossRef540
Tiziana Martone, Paola Rosso, Roberto Albera, Giuseppe Migliaretti, Flavio Fraire, Lorenzo Pignataro, Giancarlo Pruneri, Graziella Bellone, Giorgio Cortesina. (2005) Prognostic relevance of CD105+ microvessel density in HNSCC patient outcome. Oral Oncology 41:2, 147-155
CrossRef541
Hedda Haugen, Karl-Axel Johansson, Hasse Ejnell, Staffan Edström, Claes Mercke. (2005) Accelerated radiotherapy for advanced laryngeal cancer. Acta Oncologica 44:5, 481-489
CrossRef542
Primoz Strojan, Matjaz Zwitter. (2005) Mental Disorders after Laryngectomy. Onkologie 28:12, 617-618
CrossRef543
Ozden Altundag, Ibrahim Gullu, Kadri Altundag, Suayib Yalcin, Enis Ozyar, Mustafa Cengiz, Fadil Akyol, Taskin Yucel, Sefik Hosal, Bulent Sozeri. (2005) Induction chemotherapy with cisplatin and 5-fluorouracil followed by chemoradiotherapy or radiotherapy alone in the treatment of locoregionally advanced resectable cancers of the larynx and hypopharynx: Results of single-center study of 45 patients. Head & Neck 27:1, 15-21
CrossRef544
Terry A. Day, Ricardo A. Beas, Rodney J. Schlosser, Bradford A. Woodworth, Julio Barredo, Anand K. Sharma, M. Boyd Gillespie. (2005) Management of paranasal sinus malignancy. Current Treatment Options in Oncology 6:1, 3-18
CrossRef545
Masanori Komatsu, Akira Kubota, Madoka Furukawa, Mamoru Tsukuda. (2005) A Clinical Study of Stage IV Cases of Laryngeal and Hypopharyngeal Cancer according to Treatments. Nihon Kikan Shokudoka Gakkai Kaiho 56:3, 255-264
CrossRef546
Akira KUBOTA, Madoka FURUKAWA, Hideaki HANAMURA, Kohsuke YAMASHITA, Masato SUGIYAMA. (2005) CONCURRENT CHEMORADIOTHERAPY FOR SQUAMOUS CELL CARCINOMA OF THE HYPOPHARYNX. Toukeibu Gan 31:4, 541-547
CrossRef547
Subir Nag, Mehmet Koc, David E. Schuller, Douglas Tippin, John C. Grecula. (2005) Intraoperative single fraction high-dose-rate brachytherapy for head and neck cancers. Brachytherapy 4:3, 217-223
CrossRef548
K HU, L HARRISON. (2005) Point. Brachytherapy 4:1, 1-4
CrossRef549
R Hitt, A Jimeno, M Rodríguez-Pinilla, J L Rodríguez-Peralto, J M Millán, A López-Martín, A Brandariz, C Peña, H Cortés-Funes. (2004) Phase II trial of cisplatin and capecitabine in patients with squamous cell carcinoma of the head and neck, and correlative study of angiogenic factors. British Journal of Cancer 91:12, 2005-2011
CrossRef550
Bruce Brockstein, Everett E. Vokes. (2004) Concurrent chemoradiotherapy for head and neck cancer. Seminars in Oncology 31:6, 786-793
CrossRef551
Marshall R. Posner, Robert I. Haddad, Lori Wirth, Charles M. Norris, Laura A. Goguen, Anand Mahadevan, Christopher Sullivan, Roy B. Tishler. (2004) Induction chemotherapy in locally advanced squamous cell cancer of the head and neck: Evolution of the sequential treatment approach. Seminars in Oncology 31:6, 778-785
CrossRef552
Graeme Morgan, Robyn Ward, Michael Barton. (2004) The contribution of cytotoxic chemotherapy to 5-year survival in adult malignancies. Clinical Oncology 16:8, 549-560
CrossRef553
Marcy A. List, S. Pinar Bilir. (2004) Evaluations of quality of life and organ function. Seminars in Oncology 31:6, 827-835
CrossRef554
P. L. Zorat, A. Paccagnella, G. Cavaniglia, L. Loreggian, A. Gava, C. A. Mione, F. Boldrin, C. Marchiori, F. Lunghi, A. Fede, A. Bordin, M. C. Da Mosto, V. C. Sileni, A. Orlando, A. Jirillo, L. Tomio, G. L. Pappagallo, M. G. Ghi. (2004) Randomized Phase III Trial of Neoadjuvant Chemotherapy in Head and Neck Cancer: 10-Year Follow-Up. JNCI Journal of the National Cancer Institute 96:22, 1714-1717
CrossRef555
A. A. Forastiere. (2004) Is There a New Role for Induction Chemotherapy in the Treatment of Head and Neck Cancer?. JNCI Journal of the National Cancer Institute 96:22, 1647-1649
CrossRef556
Edward I. Cho, Diane P. Kowalski, Clarence T. Sasaki, Bruce G. Haffty. (2004) Tissue Microarray Analysis Reveals Prognostic Significance of COX-2 Expression for Local Relapse in T1???2N0 Larynx Cancer Treated with Primary Radiation Therapy. The Laryngoscope 114:11, 2001-2008
CrossRef557
Tracy E. Alpert, Stefania Morbidini-Gaffney, Chung T. Chung, Jeffrey A. Bogart, Seung S. Hahn, Jack Hsu, Robert M. Kellman. (2004) Radiotherapy for the Clinically Negative Neck in Supraglottic Laryngeal Cancer. The Cancer Journal 10:6, 335-338
CrossRef558
Jean Louis Lefebvre, Bernard Coche-Dequéant, Marian Degardin, Ahmed Kara, Yann Mallet, Jean Ton Van. (2004) Treatment of laryngeal cancer: the permanent challenge. Expert Review of Anticancer Therapy 4:5, 913-920
CrossRef559
Luc George, Franck Bladou, Valérie Jeanne Bardou, Gwenaelle Gravis, Agnes Tallet, Claude Alzieu, Gérard Serment, Naji Salem. (2004) Clinical outcome in patients with locally advanced bladder carcinoma treated with conservative multimodality therapy. Urology 64:3, 488-493
CrossRef560
M Boyd Gillespie, Martin B. Brodsky, Terry A. Day, Fu-Shing Lee, Bonnie Martin-Harris. (2004) Swallowing-Related Quality of Life After Head and Neck Cancer Treatment. The Laryngoscope 114:8, 1362-1367
CrossRef561
Randal S. Weber, Arlene Forastiere, David I. Rosenthal, Ollivier Laccourreye. (2004) Controversies in the management of advanced laryngeal squamous cell carcinoma. Cancer 101:2, 211-219
CrossRef562
Mark C Weissler, Scott Scharer. (2004) What’s new in otolaryngology—head and neck surgery1 1No competing interests declared.. Journal of the American College of Surgeons 199:1, 114-123
CrossRef563
Ehab Y. Hanna. (2004) Laryngeal preservation: What is the best treatment strategy?. Current Oncology Reports 6:3, 167-169
CrossRef564
Cooper, Jay S., Pajak, Thomas F., Forastiere, Arlene A., Jacobs, John, Campbell, Bruce H., Saxman, Scott B., Kish, Julie A., Kim, Harold E., Cmelak, Anthony J., Rotman, Marvin, Machtay, Mitchell, Ensley, John F., Chao, K.S. Clifford, Schultz, Christopher J., Lee, Nancy, Fu, Karen K., . (2004) Postoperative Concurrent Radiotherapy and Chemotherapy for High-Risk Squamous-Cell Carcinoma of the Head and Neck. New England Journal of Medicine 350:19, 1937-1944
Full Text565
Michael K Gibson, Arlene A Forastiere. (2004) Multidisciplinary approaches in the management of advanced head and neck tumors: state of the art. Current Opinion in Oncology 16:3, 220-224
CrossRef566
Ahmad Awada. (2004) Improving the management of head and neck cancers: dream or reality?. Current Opinion in Oncology 16:3, 209-210
CrossRef567
Jean Bourhis, Atoussa Etessami, Pierre Wilbault, Antoine Lusinchi, Gilles Calais, Michel Lapeyre, Jean Pierre Pignon. (2004) Altered fractionated radiotherapy in the management of head and neck carcinomas: advantages and limitations. Current Opinion in Oncology 16:3, 215-219
CrossRef568
Li Mao, Waun K Hong, Vassiliki A Papadimitrakopoulou. (2004) Focus on head and neck cancer. Cancer Cell 5:4, 311-316
CrossRef569
(2004) Nonsurgical Treatment of Laryngeal Cancer. New England Journal of Medicine 350:10, 1049-1053
Full Text570
Paul M Harari, Mark A Ritter, Daniel G Petereit, Minesh P Mehta. (2004) Chemoradiation for upper aerodigestive tract cancer: balancing evidence from clinical trials with individual patient recommendations. Current Problems in Cancer 28:1, 7-40
CrossRef571
Takafumi TOITA, Nobukazu FUWA, Sadayuki MURAYAMA. (2004) CHEMORADIATION FOR HEAD AND NECK CANCER FROM VIEWPOINTS OF RADIATION ONCOLOGY. Toukeibu Gan 30:3, 413-418
CrossRef572
Vokes, Everett E., Stenson, Kerstin M., . (2003) Therapeutic Options for Laryngeal Cancer. New England Journal of Medicine 349:22, 2087-2089
Full Text
- Letters
